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ABSTRACT 
 
To better understand the genetics and function(s) of biofilm formation in Escherichia coli 
O157:H7, a series of studies were performed beginning with a genome wide mutational 
analysis. A mini-Tn5 transposon library was constructed and screened for biofilm phenotype 
using a microtiter plate assay. Ninety-five of 11,000 independent insertions (0.86%) were 
biofilm-negative, and transposon insertions were located in 51 distinct genes/intergenic 
regions. Thirty-six genes were unique to this study. All of the fifty-one biofilm-negative 
phenotype (bnp) mutants showed reduced biofilm formation on both hydrophilic and 
hydrophobic surfaces. Notably, the involvement of virulence plasmid pO157 genes ehxD, an 
enterohemolysin auto transporter, and espP were identified. In addition, EhxD and EspP 
were also shown to be important for adherence to T84 intestinal epithelial cells suggesting a 
role for these genes in tissue interactions in vivo.  
The involvement of Z2086, a phage-encoded putative regulator, in biofilm formation was 
confirmed, the first such demomstration of a function for the cryptic phage-encoded genes in 
biofilm formation. Transcriptional analysis of a Z2086 deletion (∆Z2086) compared to wild 
type showed that at p < 0.01, 363 genes were differentially expressed. Six (1.6%) were up-
regulated and 357 (98.3%) were down-regulated. The function of the differentially-regulated 
genes varied widely and included 11 biofilm-related genes, 20 virulence genes, genes of 
metabolic pathways, ABC transporters, ribosomal proteins and DNA binding proteins. Of the 
357 down-regulated genes, 213 (59.6%) were phage-encoded, 16 (4.5%) were pO157-
encoded.  
During the establishment of E. coli O157:H7 infection, its capacity to adhere to host 
intestinal epithelial cells is the critical first step in pathogenesis. To gain insight into a 
potential linkage between biofilm formation and adherence to epithelial cells, the ability of 
the fifty-one bnp mutants to adhere to two human epithelial-like cell lines was examined. The 
analysis showed that all bnp mutants were incapable of adhering to T84 and HEp2 cells. In 
addition, adherence mutants ∆eae and ∆espAB were fully competent in biofilm formation. 
Thus, these results show that while the biofilm forming activity is required for adherence to 
these cells, it is not sufficient. Additional adhesins or other supplemental structures are also 
required; the loss of either activity results in an inability to adhere.  
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CHAPTER 1. GENERAL INTRODUCTION 
 
Introduction 
Enterohemorrhagic Escherichia coli O157:H7, a world-wide human food borne 
pathogen, causes mild to severe diarrhea, hemorrhagic colitis and hemolytic uremic 
syndrome. The ability of this pathogen to persist in the environment contributes to its 
dissemination to a wide range of food and food processing surfaces. The high persistence of 
the organism together with its low infectious dose makes this organism problematic in both 
the health and food industries leading to significant social and economical impacts. In 2007 
several outbreaks occurred in 19 states of the United States leading to an economic cost of 
illness of over $450 million (2). Apart from these medical costs, E. coli O157:H7 is a major 
economic burden in terms of food recalls due to product contamination. Escherichia coli 
O157:H7 has the capability to form biofilms on inert surfaces, which is thought to assist with 
environmental persistence. However, the process of biofilm formation is complex and poorly 
understood in E. coli O157:H7. The focus of this study is to delineate the genes involved in 
the complex network of biofilm formation and to provide further insight into the role of 
biofilms in pathogenesis. As biofilms are highly complex, heterogeneous and dynamic 
structures in nature, a large scale genetic analysis was performed utilizing high-throughput 
methods such as global mutational and transcriptome analysis. The work outlined in this 
dissertation will aid in expansion of our knowledge of the genetics of E. coli O157:H7 
biofilm formation and function. 
Dissertation Organization 
This dissertation is organized into five chapters and three appendices. The first chapter is 
a general introduction of E. coli with a focus on E. coli O157:H7. It also includes a review of 
biofilms in E. coli O157:H7. Chapter 2, published in the journal Infection and Immunity, 
contains a study of the genetic analysis of E. coli O157:H7 biofilm formation. It delineates 
the genes involved in biofilm formation as measured in a microtiter plate assay. It also 
describes the involvement of pO157 genes in biofilm formation. Chapter 3 describes the 
study of linkage between biofilm formation and cellular adherence and was published in 
FEMS Microbiology Letters. Chapter 4 presents the results of the transcriptome analysis 
between wild type E. coli O157:H7 and a Z2086 deletion mutant, a putative phage regulator 
that was one of the biofilm negative phenotype (bnp) genes identified. The last chapter of the 
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dissertation, Chapter 5, contains a general discussion, final summary and suggestions for 
future studies. Appendix A shows microscopic pictures of adherence of E. coli O157:H7 
biofilm negative phenotype mutants to HEp2 cells, and Appendix B shows pictures of 
adherence of the same mutants to T84 cells. Appendix C lists the differentially expressed 
genes of ∆Z2085/6. Bibliography and acknowledgments complete this dissertation. The 
bibliographies of each chapter follows the journal Infection and Immunity format except for 
chapter 3, which follows the format of FEMS Microbiology Letters.  
 
Literature Review 
General information of Escherichia coli 
Escherichia coli, named after its discoverer German pediatrician Theodor Escherich in 
1885, belongs to family Enterobacteriaceae and class Gamma Proteobacteria of phylum 
Proteobacteria (8). Most of the E. coli strains are harmless and are part of the normal flora of 
the gut of endotherms. They can benefit their hosts by exerting a protective effect against 
pathogenic bacteria within the intestine (64). However these commensals can cause disease 
in immunocompromised or debilitated host.  
Escherichia coli Pathotypes  
Some strains of E. coli acquire virulence attributes and are pathogenic to humans and 
animals. These pathotypes can cause variety of intestinal as well as extra intestinal diseases 
including gasteroenteritis, urinary tract infections and meningitis (72). There are over 700 
serotypes of pathogenic E. coli, and they have been classified as enteropathogenic E. coli 
(EPEC), enterohaemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), 
enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC) and diffusely adherent E. 
coli (DAEC) (123).  
Enteropathogenic E. coli causes infantile watery diarrhea in developing countries. The 
organisms adhere to the intestinal mucosa by the formation of characteristic attaching and 
effacing (A/E) lesions and are moderately invasive. The diarrhea and other symptoms are 
caused by invasion of the host cells and interference with cellular process rather than by 
production of toxins (26).  
Enterohaemorrhagic E. coli, a sub set of shigatoxin producing E. coli (STEC), causes 
bloody diarrhea, and fatal hemolytic uremic  syndrome. STEC do produce A/E lesions like 
EPEC. EHEC do not invade the intestinal mucosa as readily as Shigella but do produce two 
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toxins that are similar to Shiga toxin. The toxins play a role in the intense inflammatory 
response and are enhanced by iron deficiency. In addition to the effects of Shiga toxin, 
EHEC producesd non-Stx molecules such as cytolethal distending toxin which can also cause 
endothelial and vascular injury (74).  
Enterotoxigenic E. coli are important in causing infant and travelers diarrhea especially in 
regions of poor sanitation. The disease may vary from minor discomfort to a severe cholera-
like secretory diarrhea. The organisms colonize the surface of the small bowel mucosa and 
elaborate either or both of the enterotoxins, heat-stable (ST) enterotoxin and heat-labile (LT) 
enterotoxin. These toxins lead to secretion of fluid and resulting diarrhea (168).  
Enteroaggregative E. coli attach to tissue culture cells in an aggregative manner. These 
strains are associated with persistent mucoid diarrhea in young children. The pathogenesis of 
EAEC is not well understood, however they do produce some cytotoxic effects (122). They 
adhere to the intestinal mucosa and form characteristic biofilms and cause non-bloody 
diarrhea and inflammation (195). The biofilm formation is thought to be involved with its 
persistent diarrhea.  
Enteroinvasive E. coli closely resembles shigellosis in its mechanism. EIEC invade the 
cell wall of the epithelial cells in colon and then multiply within them, causing cell 
destruction and extreme diarrhea. They do not produce shiga toxin but do produce one or 
more secretory enterotoxins that may play a role in the production of watery diarrhea (123).  
Diffusely adherent E. coli causes watery and persistent diarrhea in young children. This 
group of E. coli exhibit diffuse adherence to epithelial cells in-vitro to HEp-2 or HeLa cells. 
The pathophysiological processes behind the development of infection are not well 
understood (90).  
Escherichia coli O157:H7 
Discovery and economic impact 
Escherichia coli O157:H7 is a predominate serotype of EHEC, that expresses the 157th 
somatic (O) antigen and the 7th flagellar (H) antigen (113). E. coli O157:H7 was first 
recognized as the probable cause of hemorrhagic colitis in humans in 1982 in an outbreak 
associated with contaminated hamburgers (153). In 1983 this organism was reported to be 
associated with sporadic cases of hemolytic uremic syndrome (66) (75). Since then, there has 
been increase in the number of outbreaks caused by E. coli O157:H7. This organism has 
become an emerging cause of food borne illness in several countries around the world 
leading to significant social and economical impacts. In 1993, medical costs of E. coli 
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O157:H7 illness was estimated between $29.4 and $59.9 million and the productivity losses 
were estimated between $263.3 and $646.6 million (18). In 2007 there were several 
outbreaks occurred in 19 states of USA leading to economic cost of illness over $450 million 
(2). Apart from causing a significant number of outbreaks, E. coli O157:H7 is a major 
economic burden in terms of food recalls due to product contamination. The cost includes 
both the direct costs from the recall and the related legal proceedings. In 1996, Odwalla apple 
juice was recalled due to contamination with E. coli O157:H7, ultimately costing the 
company 14.5% of sales (193). In 2007, Topps Meat Co. was forced out of business due to a 
recall of 21.7 million pounds of hamburger patties contaminated with E. coli O157:H7 (3).  
Genomic information 
Toxigenic E. coli O157:H7 evolved from its recent ancestor, E. coli O55:H7, in a step-
wise manner by acquiring shiga toxin genes and large virulence plasmid pO157 through 
horizontal gene transfer. The serotype O55:H7 is non toxigenic and is associated with 
infantile diarrhea (198). 
The E. coli O157:H7 strain EDL933 chromosome is 5.5 megabases in length and encodes 
5416 genes (139). This chromosome length is approximately 850 kb larger than E. coli K12 
strain MG1655. The pathogenic serotype O157:H7 and the laboratory strain K12 MG1655 
evolved from the common ancestor about 4.5 million years ago (148). Comparison of O157 
and K12 genome sequence shows that the two strains share a common backbone of 4.1 mega 
bases with similar gene order and 75,168 single nucleotide polymorphisms. Within each 
genome there are hundreds of sections of DNA that are unique to one strain or the other. The 
regions that are unique to the O157 genome are O-islands and comprise 1.34 mega bases 
coding for 1,387 (26%) genes. The regions unique to K12 are K islands and comprise 0.53 
mega bases coding for 528 (12%) genes. Of the 1,387 O-island genes, 40% have assigned 
function and 24% genes are in bacteriophage related clusters.  Within the backbone there are 
3,574 protein-coding genes with an average nucleotide identity between O157 and K12 of 
98.5%. Eighty nine percent of the orthologous genes are of equal length and only 25% 
encode identical proteins (139). E. coli O157:H7 consists of a large 92 kb F-like virulence 
plasmid called pO157. This plasmid has low G+C content of 47.7% with 87% of the 
sequence encoding one hundred open reading frames (ORFs) (16). Twenty of these ORFs 
encode virulence factors including hemolysin (161), catalase peroxidase (15), serine protease 
(14), a type II secretory system (162), and cytotoxin (16). 
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Transmission 
The primary mode of transmission of E. coli O157:H7 to people is through consumption 
of contaminated food. In a majority of the outbreaks, the culprit is consumption of 
contaminated foods derived from cattle such as ground beef (153) and non-pasteurized milk 
(76). Other food sources include, but are not limited to, vegetables (5, 116), apple cider (7), 
and deer meat (76). The outbreaks can also occur through water sources such as drinking 
(179) and swimming waters (77). Due to its very low infectious dose, secondary cases can 
occur as a result of person- person contact. This type of transmission can occur dominantly in 
day care centers (6) and nursing homes (21, 136). Interestingly, houseflies were shown to be 
an important vector for carrying and transmitting E. coli O157:H7 in Japan (120). In addition 
to food, water, and human sources of transmission, the transmission from calves to human, 
presumably through oral contact with feces has also been reported (149). 
The infectious dose of E. coli O157:H7 is extremely low but the actual dose is unknown. 
According to FDA, the infectious dose can be as low as 10 organisms (1). The outbreak data 
shows variation in infectious dose. In a large outbreak occurring in 1992 in US, the infectious 
dose was fewer than 700 organisms (185).  In another outbreak with salami, the infection 
dose was estimated to be 2-45 organisms (182).  This infectious dose is very low when 
compared to other intestinal pathogens, >105 for Salmonella, 106 for EPEC, 107 for ETEC and 
108 for EAEC (102). 
Ecology 
Ruminants such as cattle and sheep are considered as primary reservoirs of EHEC (23, 
24, 131). The prevalence of E. coli O157:H7 levels in calf feces can be high, ranging from 
<103 colony forming unit (CFU)/g to 105 CFU/g (202). Shedding is intermittent and can vary 
in duration from several weeks to months (13). Several studies showed that E. coli O157:H7 
can also be carried by deer, pigs, wild birds, rabbits and ducks (22, 92, 151, 192). This 
organism persists very well in numerous environments including soil (107), water (107), raw 
and undercooked foods (34, 66), food processing surfaces (199), households (106) and farm 
implement surfaces (95, 200). Because of this persistence, these materials are important as 
potential vehicles for dissemination and transmission within the environment. E. coli 
O157:H7 can be introduced into food crops via contaminated animal derived fertilizer or 
polluted irrigation water (49, 170) and can lead to large outbreaks (5, 55).  
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Disease characteristics 
The disease primarily occurs as sporadic cases but outbreaks do occur (91, 132). Since 
the discovery of E. coli O157:H7 as a human pathogen in 1982, numerous outbreaks in the 
United States (145), Europe (38, 39, 69, 104), Japan (115) and Australia (85) have been 
traced back to this organism. The incidence is highest during warmer months. About 88 
percent of all outbreak cases have occurred between May and November. However the 
reason(s) for seasonality of the disease is yet to be confirmed. 
The incubation period of E. coli O157:H7 is usually 3 to 4 days, although it can be 
anywhere from 2-12 days. The clinical symptoms start with the onset of mild non-bloody 
diarrhea with abdominal pain and cramps. In some patients, fever and vomiting may be seen 
for short duration. The diarrhea becomes bloody within 1 to 2 days with increased abdominal 
pain. In about 85% of the cases, the bloody diarrhea resolves with no obvious sequelae. In 
the remaining individuals, the disease can progress to hemolytic uremic syndrome (66) which 
has 5-8% of mortality rate (113, 180). Hemolytic uremic syndrome is characterized by a triad 
of symptoms described as thrombocytopenia, microangiopathic hemolytic anemia and acute 
renal failure (73). Those who develop chronic kidney failure may require lifelong dialysis or 
a kidney transplant. Other complications with E. coli O157:H7 include central nervous 
system deterioration, blindness, partial paralysis, thrombotic thrombocytopenic purpura, 
diabetes, intussusception, colonic perforation with peritonitis and sepsis, rectal prolapse, 
pancreatitis, hemiplegia, and seizures (10). The children under 5 years of age and the 
immunocompromised elderly are at high risk of developing HUS. Other risk factors include 
previous gastrectomy and recent antimicrobial use.  
Virulence factors and known mechanisms of pathogenesis of E. coli O157:H7 
The pathological features and the life threatening sequelae of E. coli O157:H7 infection is 
attributed to the two critical and well studied virulence factors, a pathogenicity island known 
as locus of enterocyte effacement  (LEE), and shiga like toxins (126, 135).   
The locus of enterocyte effacement contains all the necessary genes for creation of the 
Attaching-Effacing (A/E) lesion (109, 110). The A/E lesion is characterized by the loss of 
microvilli and accumulation of cytoskeletal components to form a pedestal on the host cell 
upon which the bacteria rests (48).  The LEE island of E. coli O157:H7 EDL933 strain is 
43.3 kb long and encodes fifty-four ORFs. Of these fifty-four ORFs, forty-one are previously 
described in EPEC and the rest are part of a cryptic prophage (138). These genes are 
organized in 5 LEE operons, LEE1, LEE2, LEE3, LEE4 and LEE 5 (121) and encode for a 
 7  
regulator Ler, structural components of Type III Secretion System (TTSS), secretory 
proteins, adhesins, translocators and effector proteins (138). 
The TTSS is the common virulence mechanism used by Gram-negative pathogens to 
export bacterial virulence factors and effectors directly into the host cell (65). E. coli 
O157:H7 also secretes effectors that are necessary for the formation of A/E lesions into host 
cells via TTSS (68). The basal TTSS of E. coli O157:H7 requires the products of 22 ORFs 
that are encoded on the first three operons of the LEE (138). The structural component of the 
TTSS is highly conserved among several bacterial species (156). However, the TTSS of 
EHEC has a unique filamentous extension formed by secretory proteins called Esps (138), 
which play an important role in the development of A/E lesions. EspA forms a translocon 
syringe at the end of the TTSS needle and facilitates the transfer of effectors such as EspB, 
EspD and Tir (48). Apart from its translocator properties, EspA also forms a filamentous 
structure that helps initial contact to the host cell prior to A/E lesion formation (40). Once the 
initial contact is established and the effectors are translocated, the translocon syringe is lost 
before intimate attachment and A/E lesion is established (83). 
The adhesin encoded on the LEE is a surface protein named intimin. Intimin mediates the 
intimate binding to the host intestinal cell by binding to Tir receptor (70). Apart from Tir, 
intimin can bind to some of the eukaryotic receptors such as nucloelin (166) and β-1 integrin 
(47). There are several subtypes of intimins (143), and the type of intimin determines the site 
of colonization. The intimin-α producing strains colonize both small and large intestine and 
the intimin-γ producing strains colonize only large intestine (140). E. coli O157:H7 produces 
intimin-γ and its adherence is primarily associated with the follicle associated epithelium of 
ileal Peyers Patches (140).  
Like EPEC, EHEC also transfers their own receptors known as translocated intimin 
receptor (Tir) into the host cell membrane by TTSS (79).  Following translocation, Tir gets 
inserted into the plasma membrane of the host cell and acts as a receptor for intimin. Apart 
from its function as a receptor, Tir also triggers actin polymerization in the host cell (51). In 
EPEC, the actin rearrangement is initiated by the tyrosine phosphorylation of Tir which 
begins as a signal transduction cascade (78). However in EHEC, Tir is not tyrosine 
phosphorylated (35) but initiates the actin polymerization by using another bacterial effector 
protein called Tir cytoskelton coupling protein (TccP) (52). 
The expression of genes in the LEE region are controlled by a regulator known as Ler 
(114), which is encoded on the first operon of the LEE region (138). Ler functions as a 
regulator by directly activating the transcription of LEE promoters (42). Apart from functions 
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as an activator of LEE genes, Ler also acts as a global regulator by regulating adherence and 
toxin production genes elsewhere in the genome (42). 
Once the adherence of bacteria to the bowel mucosa is established, the bacteria will 
secrete extracellular shiga-like cytotoxins (126). These toxins are also known as verotoxins 
as they are active on Vero cells (126). The genes encoded for shiga-like toxins are located on 
a lambdoid bacteriophage (125). These shiga-like toxins produced by E. coli O157:H7 are 
structurally, genetically and functionally similar to Shigella toxins (126). There are two kinds 
of shiga-like toxins: Stx1, that can be neutralized by anti-shiga toxin, and Stx2 (176). The 
Stx1 is homogeneous and Stx2 has several variants, Stx2c, Stx2d, Stx2e, etc. The toxin is 
shown to be responsible for the microvascular endothelial injury that underlines HUS (180). 
The variants of Stx2 differ in their capability to produce clinical symptoms (50). Shiga-like 
toxins have compound AB5 structure where A subunit is enzymatically active portion while 
the B subunits mediate the toxin binding to the eukaryotic cell membrane glycosphingolipid 
receptor (103). The A subunit acts as glycanase and removes an adenine residue from 28S 
RNA which in turn prevents the binding of amino acyl tRNA to 60S ribosome and halts the 
protein synthesis (43). Although both Stx1 and Stx2 have a common function and receptor, 
they do differ in their affinities to the receptor and hence differ in their toxicities. In human 
renal endothelial cells, Stx2 was 1000 times more toxic and 10 times less avid than Stx1 (99). 
Since the EHEC are non-invasive, the toxin must translocate to the blood stream from the gut 
lumen to produce its systemic effects. The actual process of the translocation is not well 
understood. The evidence supports both possibilities that toxin can transfer either through the 
lesions of damaged epithelium (135) or through the intact tissue via trans-cellular pathways 
(4). Once the toxin is in the blood stream, the toxin targets the tissues expressing glycolipid 
receptors Gb3 or Gb4. Human renal tissue is rich in Gb3 receptors. Gb3 levels are higher in 
the renal glomerulus, the site of renal lesions in patients with HUS (11). The 
lipopolysaccharide, TNF-α and interleukin-1β can enhance the cytotoxicity of Stx (97, 98) 
by increasing the concentration of the Stx receptor, Gb3, on the cell surface (189). Once the 
toxin is internalized, it inhibits protein synthesis leading to the loss of normal endothelial cell 
function, which increases concentrations of thrombin and plasminogen activator inhibitor 1 
(PAI-1). A rise in PAI-1 is followed by fibrin accumulation and coagulopathy which leads to 
hemolytic anemia and renal failure (180). 
Other putative virulence factors include enterohemolysin, serine protease, catalase 
peroxidase and cytotoxin. The large virulence plasmid pO157 encodes a member of the E. 
coli α-hemolysin family known as Enterohemolysin (Ehx) (163). The genes for Ehx are 
arranged in operon fashion with the order of hlyCABD. Ehx produces small turbid zones of 
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hemolysis on sheep blood agar plates after 18-24 hours of incubation (161). The role of Ehx 
in pathogenesis is not clear, but there is a strong association between production of stx and 
ehx, and ehx is reactive to sera of HUS patients (161).  
Another pO157 encoded virulence factor is an extracellular serine protease, EspP. EspP is 
an autotransporter and has proteolytic activity against pepsinA and human coagulation factor 
V. The cleavage of factor V in bowel mucosa can contribute to hemorrhage in the 
gastrointestinal tract (14). 
The pO157 plasmid also encodes for catalase/peroxidase. This enzyme is mainly located 
in the periplasm. In general, catase/peroxidases can contribute to maintenance of bacteria by 
assisting them in escaping the host response. This enzyme also helps the bacterium to recover 
from heat stress (15). 
To summarize the pathogenesis, once the bacteria establishs the initial attachment in the 
gut, they produce A/E lesions triggering diarrhea followed by production of stx toxins.  The 
toxins with the aid of other putative virulence attributes triggers the onset of bloody diarrhea 
and colitis. Stx then crosses the epithelial barrier to the blood stream via damaged epithelium 
or trans-cellular pathway to develop its systemic sequelae such as HUS. 
Biofilms 
Many bacterial species prefer to lead a multi-cellular life and commonly form densely 
populated communities known as biofilms. Biofilms can be simply defined as an 
extracellular polymeric matrix-enclosed bacterial population firmly adherent to each other 
and/or to surfaces (19). Even though there is evidence of biofilm formation in the fossil 
record (146), the actual understanding of biofilms started only 3 decades ago after the 
discovery of aquatic biofilms (53). Once the concept of the biofilm formation was 
established, biofilms have been reported in almost every environment that has even the 
remotest chance of sustaining life, including extreme environments such as acid mine 
drainage (41) and hot springs (144). 
Ecological importance of biofilms  
Clearly biofilm formation is a key factor for microbe survival in diverse environments. 
The ecological advantages of biofilm formation include: 1) a niche where the cells localize in 
close proximity and might have catalytic functions by pooling their biochemical resources 
and divide the labor (165);  2) protection from a variety of environmental stresses such as 
acidification (112), high temperatures (160), desiccation (130), UV exposure (45), metal 
toxicity (181), phagocytosis (94), antibiotics (62) and sanitizers (134); and 3) interactive 
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communities that allow higher rates of gene transfer, which is important for evolution and 
genetic diversity (29, 154).  
Characteristics of biofilms 
Biofilms are complex. They can be formed either by a single or mixed bacterial species 
or multiple populations such as bacteria, fungi, yeast, algae and protozoa. Single species 
biofilms can be seen in the clinical environment while mixed biofilms are dominant in 
natural environments.  
Biofilms are dynamic and adaptive. They are responsive to their environmental 
conditions such as nutrient availability and hydrodynamics. For example, biofilms formed in 
running waters are filamentous and patchy, biofilms in standing waters have mushroom or 
mound like structures (58), biofilms under sheer stress are stratified and compacted, biofilms 
from sludge reactors are aggregative (101). In addition, the composition of the microbial 
community within the biofilm and nutritional availability can influence the overall 
architecture of the biofilms. Proteus mirabilis biofilms grown in Luria-Bertani broth and 
artificial urine have different architectures, the former has mushroom structures and the later 
were more flat and almost devoid of nutrient channels (71).  
Biofilms are highly heterogeneous. Even within single species biofilms there is genetic 
diversity. This type of diversity allows the subpopulations of a sessile community to have 
metabolic heterogenity and provide advantage over homogenous planktonic populations (9). 
Within biofilms, cells communicate through intercellular signaling in order to coordinate 
their activities and divide their labor (165).  
Biofilms are resilent. As mentioned above in the ecological advantages, bacteria in 
biofilms are protected from environmental stresses and host defense mechanisms. For 
example Pseudomonas aeruginosa is 1000 times more resistant to antibiotics when it is in 
biofilms than when grown planktonically (124). Biofilms of Mycobacterium species were at 
least 300 times more resistant to chlorine than their planktonic counterparts (171). Even 
sensitive bacteria that do not have a known genetic basis for resistance can have profoundly 
reduced susceptibility when they form a biofilm. The sensitivity of Klebsiella pneumoniae 
cells to both ampicillin and ciprofloxacin was reduced in biofilms compared to planktonic 
cells. There are two different theories to explain the antibiotic resistance within biofilms 
(173). The first theory suggests that the resistance is due to decrease in growth and metabolic 
activity of the cells within biofilms. The second theory suggests that it is a small collection of 
super-resistant cells that increase the overall resistance of the biofilm. The mechanisms of 
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super-resistant cells and the ability to transfer the traits within the biofilm are unknown 
(173). 
Structure of biofilms 
The structure of biofilms is not simple and uniform, but rather more complex and 
differentiated. Initially when microbial biofilms were observed using light microscopy, the 
biofilm structure was perceived to be a thick layer of microbial cells packed together. The 
development of more sophisticated and advanced microscopic tools such as confocal 
microscopy enabled non-destructive direct analysis of biofilms and provided insights into the 
structural organization of biofilm communities. The biofilms are structurally heterogeneous, 
fluid and constantly fluctuate over time and space (59). Despite the heterogeneity, the basic 
structure of biofilms is common and is composed of several microcolonies embedded in 
extracellular polymeric substance (55) and filled with water channels (89). The cells within 
the biofilm produce EPS and are held together by these sugary molecular strands, allowing 
them to develop complex, three-dimensional, resilient, attached communities. The EPS is 
mainly composed of exopolysaccharides, lipids, proteins such as lectins, humic acids and 
nucleic acids. The EPS helps bacteria to attach to surfaces and also protects them from 
environmental stresses and antimicrobials by providing a physical barrier (191). The EPS 
maintains water, alters the pH and can create abundant nutrients for biofilm members to 
enhance survival. In addition, the EPS can influence the biofilm architecture. Mucoid strains 
of P. aeruginosa produce more extensive biofilms when compared to nonmucoid strains (61). 
The exopolysaccharides constitute about 50-90% of the total organic carbon of the biofilms 
and act as carbon and energy sources during starvation. The exopolysaccharides synthesized 
by different species vary greatly in their composition and hence in their chemical and 
physical properties. The exopolysaccharides are either neutral or anionic or cationic, and they 
help in obtaining the nutrients from the outer environment by an ion-exchange system (177). 
Water channels within the biofilm helps in the circulation of nutrients, the exchange of 
metabolic products and the transport of oxygen within biofilms (28). 
Process of biofilm development  
Biofilms are ubiquitous in nature as well as on manmade materials. Biofilms can form on 
all kinds of surfaces including natural materials above and below ground (27), metals (157, 
158), plastics (172) , medical implant materials (56), plant (30) and animal tissues (108). 
Biofilms form when bacteria adhere to surfaces in moist environments by excreting a slimy, 
glue-like polymeric substance (28).  
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Biofilm development is a highly complex and regulated process, and proceeds via four 
stages of development: initial reversible attachment, robust irreversible attachment, 
maturation and dispersal (175). In the first stage, the bacteria attach reversibly to either 
biological or non-biological surfaces through weak chemical interactions such as van der 
Waals forces. Then the surface appendages such as pili, fimbriae and curli help the transition 
from reversible to irreversible attachment. In addition, production of extracellular polymers 
by the bacteria aids the process. Once the firm attachment is established, the cells grow and 
multiply in three dimensions to form microcolonies. During the maturation of the biofilm, the 
cells continue to grow and produce more EPS resulting in enlargement of microcolonies, 
which later coalesce and form thicker complex architectures with void regions filled with 
water. In the final stage, the cells within biofilms are sloughed and dispersed either 
individually or in groups into the surrounding environment and return to the planktonic state 
(133).  
Impact of biofilms 
In industrial environments, biofilms have both detrimental as well as constructive effects. 
Biofilms can develop on the interiors of pipes and can corrode and clog the pipes (20). 
Biofilms on cooling towers and heat exchangers can reduce heat exchange resulting in 
lowering the efficiency of the equipment (142). Biofilms in marine environments are 
responsible for fouling of ship hulls (96). Biofilms are being used for constructive purposes. 
For example, many sewage treatment plants use biofilms grown on filters, which extract and 
digest undesirable compounds thereby purifying the water (57). Biofilms have potential in 
bio-fuel production (194), and biofilms are also used to recover metals by microbial leaching 
(178). In addition, the biofilms can act as good industrial catalysts and can be used in 
production of bulk chemicals (155). 
In medicine, biofilms generally have detrimental effects. For example, dental plaque is a 
biofilm and if not removed regularly can cause dental caries (105). Bacteria can form 
biofilms on implants such as prosthetic valves, contact lenses, and can lead to implant based 
infections such as endocarditis and keratitis (37). Biofilms on indwelling devices such as 
central venous catheters, urinary catheters and ventilators play a major role in hospital-
acquired infections such as septicemia, urinary track infections and pneumonia (31). Among 
the intensive care unit patients in USA, 95% of the urinary tract infections are catheter 
associated and 86% of pneumonias are linked to ventilators (152). In addition, biofilms are 
potential factors in the pathogenesis of otitis media (141), tonsillitis (25) and lung infections 
in cystic fibrosis patients (54).   
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Biofilms formed in the pipelines are potential sources of drinking water contamination 
(80) and unpleasant odors (169). The biofilms developed in food processing environments 
create hygienic problem and can be a public health threat. Several food-borne pathogens such 
as Listeria, Salmonella and E. coli O157:H7 can persist on food processing surfaces by 
forming biofilms. The biofilms formed on these surfaces can contaminate food products and 
can lead to food spoilage and transmission of diseases (203). Biofilms avidly colonize many 
household surfaces, including toilets, sinks, countertops, and cutting boards in the kitchen 
and bath, which may increase the dissemination of pathogenic organisms in the household 
environment (147). The biofilms formed on the biotic surfaces such as plants and fruits poses 
threat to minimally processed produce products.  
Biofilms can negatively impact environments by mobilizing toxic elements such as 
mercury, arsenic and selenium, and contribute to toxic algal blooms and create oxygen 
depletion zones (eutrophication). Positively, biofilms play a major role in the recycling of 
vital elements. 
Regulation of biofilm development 
The regulation of biofilm formation is as complex as its structure and is controlled by both 
genetic factors and environmental signals. There is evidence that quorum sensing is 
important in regulation of structural as well as spatial organization of biofilms. 
The majority of bacteria live either in a free-living planktonic state or in a sessile 
community in the form of biofilms. Genetic regulation systems switch their mode of growth 
from planktonic to sessile mode and vice versa. The gene expression level of bacteria that 
adapt free-living state of growth differs profoundly from their sessile counterparts. In 
congruence with these differences in gene expression levels, there are dramatic physiological 
differences between biofilm and planktonic bacteria.  As mentioned earlier above, the 
bacteria in biofilms are metabolically less active, resistant to environmental stress and engage 
in more genetic exchange. With the advancement of genetic technology such as comparative 
proteome analysis and microarray analysis, it is now possible to test differences in gene 
expression levels on a large scale between biofilm and planktonic bacteria. The comparative 
proteome analysis of Staphylococcous aureus (150) showed that a total of 258 non-redundant 
proteins expressed at different levels in biofilm and planktonic cells. In biofilms bacterial 
proteins involved in cell attachment, peptidoglycan synthesis and pyruvate/formate 
metabolism were expressed at higher levels and proteases such as immunodominant antigen 
A and staphylococcal secretory antigen were expressed at lower levels. The transcriptome 
analysis of Desulfovibrio vulgaris (201) biofilm and planktonic cells revealed 472 
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differentially expressed genes that include genes encoding flagellin, exopolysaccharide 
biosynthesis genes, chemotaxis proteins and outer membrane proteins. The biofilm cells 
showed decreased expression of protein synthesis genes, energy metabolism genes and genes 
involved in stress responses. All of the above findings suggest that the average physiology of 
the bacterium within the biofilm were similar to stationary phase cells. However, a proteomic 
analysis by H. Mikkelsen et al. (117) showed in Pseudomonas aeruginosa that the protein 
profiles of biofilms were found to more closely resemble those of exponentially growing 
planktonic cells, suggesting a possible role of constitutively-expressed genes in biofilm 
formation in this species.  
Since the concept of biofilm formation gained attention there have been several target 
gene-directed studies reported that identified genes involved in biofilms and their possible 
role in biofilm formation.  With the advancement of technology, global scale studies are 
possible and such studies have identified a plethora of genes linked in biofilm formation. 
However, to delineate the roles of all of these genes is exceedingly complex task. 
 Complicating the biofilm genetics even further, the same set of genes were expressed at 
different levels in different stages of biofilm development. For example the flagellar and pili 
genes are up-regulated and are known to be involved in the early stages of biofilm 
development (127) while the same set of genes are down-regulated in stable and mature 
biofilms (197). To summarize, it is likely, therefore, that more than one complex regulatory 
pathway is important for the development of biofilm formation. 
Environmental clues play a major role in the development of biofilms. The environmental 
signals not only allow the bacteria to switch between planktonic and sessile modes of growth 
but are also involved in controlling the structure of the biofilm. Some of the environmental 
factors that are shown to be involved in biofilm formation include temperature, nutrient, 
carbon source, static/ dynamic conditions and pH.    
Quorum sensing is a process in which bacteria regulate their gene expression in response 
to fluctuations in cell density. Bacteria use quorum sensing in regulation of a diverse array of 
physiological activities such as symbiosis, virulence, antibiotic production, motility and 
sporulation (118). Bacteria release several different types of signaling molecules called 
autoinducers for intercellular communication in quorum sensing. The most common 
autoinducers of the Gram-negative bacteria is autoinducer-2 (AI-2). Other signaling 
molecules include AHL (N-Acyl homoserine lactone) and 2-heptyl-3-hydroxy-4-quinolone 
(PQS). These autoinducers help the bacteria to sense their density and quickly respond in a 
positive feedback mechanism to alter their gene expression and hence, the physiological 
change adaptive to that particular environment (118). 
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Quorum sensing is thought to be one of the major controlling mechanisms that bacteria 
use to control biofilm formation. The multicellular nature of biofilms provides a suitable 
environment for communication based on quorum sensing. The role of cell-to-cell signaling 
in the differentiation of biofilms was first demonstrated in P. aeruginosa biofilm 
development (32). Since then, quorum sensing was shown to be important in control of 
biofilm development in several other organisms such as Aeromonas hydrophila (100), 
Burkholderia cepacia (63) and Serratia liquefaciens (88). The autoinducer AHL was 
detected in both naturally occurring aquatic biofilms (111) and also in clinical setting on 
indwelling urethral catheters (174). Many bacteria use quorum sensing to regulate the 
secretion of sticky extracellular slime, an integral feature of biofilm life. In Pseudomonas 
AHLs play an important role during the early stages of biofilm formation when cells are 
adhering to a surface and forming microcolonies (33). They were also shown to be involved 
in several other aspects such as biofilm architecture, sloughing and dispersal of bacteria from 
biofilm (82). Even though several studies showed the importance of quorum sensing in 
biofilm formation, the question of how the quorum sensing is affecting biofilm formation in 
terms of structural genes has yet to be answered. Indeed, some of the recent in vitro studies 
showed there is no obvious link between quorum sensing and biofilm formation phenotypes. 
One example is in the food processing environment where 68 Gram-negative stains isolated 
from raw vegetable processing line showed no correlation between biofilm formation and 
production of quorum sensing signal molecules (190).  
Escherichia coli O157:H7 biofilms 
Escherichia coli O157:H7 has the capability to form biofilms on inert surfaces such as 
stainless steel, glass and plastic surfaces (137, 158). As these materials are possible food 
contact surfaces in the processing industry, biofilms formed on such surfaces serve as a 
continuous source of cross-contamination during food processing and pose a threat to food 
industry and public health (87, 119). Moreover, the resistance of biofilms to commonly used 
sanitizers and cleaners (134) and the low human infectious dose of this organism enhance the 
contamination and infection issues. Apart from forming biofilms on a variety of food 
processing surfaces, E. coli O157:H7 can also attach, colonize and form biofilms on a variety 
of food surfaces such as spinach (44), lettuce (164), alfalfa sprouts (46), and apples (17). In 
addition, persistence of this organism in agricultural environments such as animal manure, 
manure slurry (84) and irrigation water (67) leads to contamination of food crops such as 
spinach and lettuce. Once E. coli O157:H7 attachs to these food surfaces, the common 
washing and sanitation steps such as chlorine water wash cannot effectively remove it. Some 
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times E. coli O157:H7 can be internalized into produce. For example, E. coli O157:H7 has 
been identified inside the stomata of contaminated radishes and lettuce. With its extremely 
low infectious dose for humans, the persistence even of low numbers of microorganisms on 
produce that are to be consumed in the raw or minimally processed state can lead to 
infecetions (5, 55). There has been an increase in E. coli O157:H7 outbreaks associated with 
produce products, such as lettuce, spinach, apple cider, cantaloupe, and alfalfa sprouts in 
recent years (167). In summery, the ability of this pathogen to attach and form biofilms on a 
wide range of surfaces makes E. coli O157:H7 persistance and dissemination in the 
environment problematic in both the health and food industries (86). 
Since E. coli O157:H7 was shown to form biofilms (36), studies have focused primarily 
on biofilm formation on food processing surface materials and on genetic pathways and their 
importance in the biofilm formation on these surfaces. Many of these studies have focused on 
curli and curli-related genes. The curli fibers are thin and coiled fimbriae-like extracellular 
structure composed mainly of a single 15-kDa protein (129). Curli are produced under stress 
conditions and bind to several host extracellular matrix and contact phase proteins and were 
assumed to have a role in pathogenesis (128). Curli fibers are encoded by csg gene cluster 
comprised of two divergently transcribed operons. One operon encodes the csgB, csgA, and 
csgC genes, while the other encodes csgD, csgE, csgF, and csgG. The CsgD is a 
transcriptional activator essential for expression of these two curli operons (60). In E. coli 
O157:H7 curli production is uncommon but can occur in a temperature-independent phase-
variant manner in association with csg promoter point mutations (188). The curli genes are 
shown to play an important role in biofilm formation in E. coli O157:H7 (158, 186). CsgD 
acts as a global regulator and can function as an activator as well as a repressor (12). In E. 
coli O157:H7, CsgD stimulates biofilm formation by activation of adhesion positive 
determinants, the csg operons and yaiC gene and repression of biofilm negative effectors 
such as yagS and pepD (12). Another gene called calcium binding antigen 43 homologue, 
cah, has been shown to contribute to biofilm formation of E. coli O157:H7 in glucose-
minimal medium (183). The gene cah encodes an autotransporter and heat-extracted protein. 
In strains EDL933 and 86-24, the gene cah has a duplicated copy and cah1 and cah2 genes 
are mapped at two different locations in O-islands, where as in strain Sakai there is only one 
copy. A proteomic analysis of planktonic vs sessile cells showed several proteins that are 
involved in biofilm formation. These proteins include metabolism proteins such as malate 
dehydrogenase, thiamine-phosphate pyrophosphorylase; sugar and amino acid transporters 
such as D-ribose-binding periplasmic protein, D-galactose-binding protein; and regulator 
proteins such as DNA starvation protein and H-NS (184). The periplasmic oxidative defense 
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proteins, copper, zinc superoxide dismutase (SodC), and thiol peroxidase (Tpx) were also 
important in E. coli O157:H7 biofilm formation (81). Other genes that were shown to be 
involved in biofilm formation of E. coli O157:H7 are disulfide bond isomerase, dsbA (93), an 
autotransporter ehaA (196), cellulose (159) and lpp (187).   
Biofilm formation is a complex process that involves a variety of gene products. Despite 
our advances in knowledge concerning biofilms for many bacterial species, studies on the 
global analysis of biofilm formation in E. coli O157:H7 have not been reported. Thus, in this 
dissertation work we sought to first perform a genetic analysis of biofilm formation that is 
described in Chapter 2. Strain EDL933 was chosen for these studies because of its unique 
biofilm forming phenotype under standard growth conditions in the laboratory. Other E. coli 
O157:H7 strains either fail to produce biofilms in the laboratory or are incapable of 
producing biofilms. In addition, strain EDL933 was the first E. coli O157:H7 strain fully 
sequenced at the time this work began, thus allowing for rapid mutant mapping and 
facilitating the genetic analysis. The results of the phenotypic screen of the transposon library 
and the mapping of the transposon inserts in the approximately 100 biofilm-negative mutants 
led directly to our studies of the pO157 genes (Chapter 2) and the prophage genes (Chapter 
4). In addition, a serendipitous observation of the involvement of the pO157 Bnp genes in 
adherence to T84 cells (Chapter 2), led directly to our testing of the adherence of the full 
collection of Bnp mutants on the two human epithelial cell lines T84 and HEp2 (Chapter 3). 
These results show uneqivocably that biofilm formation is directly linked to cellular 
adherence in strain EDL933.  
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Abstract 
Enterohemorrhagic Escherichia coli O157:H7, a world-wide human food borne 
pathogen, causes mild to severe diarrhea, hemorrhagic colitis and hemolytic uremic 
syndrome. The ability of this pathogen to persist in the environment contributes to its 
dissemination to a wide range of food and food processing surfaces. Biofilms are thought to 
be involved in persistence, but the process of biofilm formation is complex and poorly 
understood in E. coli O157:H7. To better understand the genetics of this process, a mini-Tn5 
transposon insertion library was constructed in strain EDL933 and screened for biofilm-
negative mutants using a microtiter plate assay. Ninety-five of 11,000 independent insertions 
(0.86%) were biofilm-negative, and transposon insertions were located in 51 distinct 
genes/intergenic regions that must be involved either directly or indirectly in biofilm 
formation. All of the fifty-one biofilm-negative mutants showed reduced biofilm formation 
on both hydrophilic and hydrophobic surfaces. Thirty-six genes were unique to this study, 
including genes on the virulence plasmid pO157. The Type V-secreted autotransporter serine 
protease EspP and the enterohemolysin translocator EhxD were found to be directly involved 
in biofilm formation. In addition, EhxD and EspP were also important for adherence to T84 
intestinal epithelial cells suggesting a role for these genes in tissue interactions in vivo.  
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Introduction 
Enterohemorrhagic Escherichia coli O157:H7 was first recognized as the probable cause 
of hemorrhagic colitis in humans in 1982 (50). Since then this organism has emerged as a 
major cause of food borne illness in countries around the world including the United 
States(49), Europe (17, 18, 24, 36), Japan (39), and Australia (28). Outbreaks have been 
associated with a variety of food sources including ground beef (50), green leafy vegetables 
(1, 41), non-pasteurized milk (26), and from environments such as municipal water and 
lakes(27, 55). Symptoms in infected humans range from mild diarrhea to severe, 
hemorrhagic colitis with 15% of patients developing hemolytic uremic syndrome (HUS), 
making E. coli O157:H7 one of the leading causes of acute renal failure in children and the 
elderly(38).  
Early studies have shown that some strains of E. coli O157:H7 form biofilms on both 
abiotic and biotic surfaces outside the host (15, 51, 58). Biofilms are exo-polymeric matrix-
enclosed bacterial populations that are firmly adherent to each other and/or to surfaces (9). 
Biofilms have been shown to be responsible for protection from a variety of environmental 
stresses such as acidification, high temperatures and desiccation (52). Moreover, microbes in 
biofilms are highly resistant to other adverse conditions such as sanitizers and household 
cleaners (44, 45) as well as antibiotics (23, 34). The ability of this pathogen to form biofilms 
on a wide range of food surfaces, as well as, food processing surfaces makes E. coli O157:H7 
problematic in both the health and food industries (29).  
Biofilm formation is a dynamic and complex process and includes initial attachment of 
cells to the substratum, physiological changes within the organism, multiplication of the cells 
to form micro-colonies, and eventually maturation of the biofilm (42). Because of this 
complexity, the process of biofilm formation and its’ regulation is poorly understood. 
Previous studies in E. coli O157:H7 have focused on individual genes and the specific 
genetic pathways that are responsible for biofilm formation (10, 51, 58, 60). In contrast, few 
studies have focused on studying genetic factors that control E. coli O157:H7 biofilm 
formation on a global scale, although studies of this type have been performed with other 
bacterial pathogens (43, 47, 59).  
The goal of this study was to gain additional insights into biofilm formation in E. coli 
O157:H7. A global mutational approach with a mini-Tn5 transposon was used to study the 
process of biofilm formation in strain EDL933, a strong biofilm-forming strain. This strain 
was first isolated during a multistate outbreak involving contaminated hamburgers (50). A 
library of >11,000 mutants was generated and screened for a biofilm-negative phenotype. 
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Our results reinforced the fact that the biofilm formation is a complex process involving a 
large number of genes and genetic pathways. This study discovered several pO157 genes that 
were not previously known to be linked to biofilm formation. 
 
Materials and Methods 
Bacteria. The E. coli strains used in this study are shown in Table 2.1. A spontaneous 
nalidixic acid-resistant mutant of Escherichia coli O157:H7 strain EDL933 was selected to 
serve as a counter selection for these studies. This mutation had no effect on biofilm 
formation or on the ability of EDL933 to colonize and persist in a sheep model of 
colonization (unpublished). For all biofilm assays, the cultures were grown in Luria-Bertani 
(LB) broth for 24 h at 30°C under stationary conditions. For all other experiments the 
cultures were grown overnight in LB broth at 37°C and shaking at 200-220 rpm. The 
temperature-sensitive E. coli strain harboring the pRedET plasmid (Gene Bridges GmbH, 
Dresden, Germany) was grown at 30°C. Antibiotic concentrations were ampicillin (100 
µg/ml), kanamycin (50 µg/ml) and nalidixic acid (20 µg/ml) except where noted. All 
antibiotics were obtained from Sigma Chemical Co. (St. Louis, MO). The growth of 
individual mutants was assessed by measuring the growth endpoint at OD600 after 24 h 
growth in 96 well plates and compared to wild type EDL933.  
Mutant Library Construction. Transposon mutagenesis was performed as described 
with few modifications (22). To obtain random mini-Tn5Km2 insertion mutants, the conjugal 
donor strain E. coli BW19795 containing the plasmid pUTmini-Tn5Km2 (supplied by David 
Holden, Imperial College, London, UK) was conjugated with E. coli O157:H7 EDL933. One 
ml of overnight culture of each strain was pelleted, washed 3 times with phosphate buffered 
saline, resuspended in 5 ml of antibiotic-free LB broth and incubated at 37°C with shaking 
until an OD600 of 0.7-1.0 was reached. The BW19795 donor strain was then transferred to 
stationary conditions for 30 min to allow regeneration of pili. Two hundred µl of each strain 
was combined, and the mating mixture was plated onto a sterile membrane placed on a stack 
of sterile filter paper. Once the liquid media was removed by capillary action, the membrane 
was transferred to an LB agar plate cell side up. Following overnight incubation at 37°C, 
membranes were vortexed with LB media, the suspension was incubated with shaking for 1 h 
at 37°C and then plated in 100 µl aliquots on LB plates containing kanamycin plus nalidixic 
acid as a counter selection against the donor strain. Each plate yielded 300-400 colonies of 
kanamycin-resistant mutants. Colonies were picked into 96 well plates, and each was scored 
for ampicillin resistance. The ampicillin-sensitive mutants were re-arrayed into 96-well 
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plates and stored at -70°C for further analysis. A total of 11,000 independent mutants were 
obtained. 
Assays for biofilm formation. The screen for the biofilm negative phenotype was 
performed using a microtiter plate assay as described previously (16) with minor 
modifications. This assay is based on the ability of biofilm-forming bacteria to adhere to the 
wells of a 96-well microtiter plate, which are subsequently visualized by staining with crystal 
violet. Each plate of mini-Tn5 insertion mutants from an overnight LB culture was replica 
plated using a 96-prong replicator into fresh Costar 96 well flat bottom, non-treated 
polystyrene plates (Corning, Inc., New York, NY) containing 150 µl of LB broth per well. 
After 24 h of incubation at 30°C under stationary conditions, the plate was rinsed twice with 
water, and the adherent bacteria were stained with 0.01% crystal violet (175 µl/well) for 20 
min. After staining, the plates were washed again twice with water. At this point, biofilms 
were visible as a violet ring on the side of each well and as a generalized staining of the well 
(Fig. 2.1). Mutants that lacked ring formation were scored as a biofilm-negative phenotype. 
For growth assessment, a duplicate plate incubated over night was briefly vigorously shaken 
on a microtiter plate shaker, and the OD600 was measured and compared with the wild type 
control strain. Strains that differed from wild type growth (p < 0.01) were not considered 
further as were mutants that showed inconsistent biofilm formation. In each plate, E. coli 
BW19795 strain was used as a negative control, and a well containing medium only was used 
as a blank. 
For the quantitative biofilm assay (57) 12 x 75mm polystyrene tubes (Fisher) were used. 
An overnight culture of each mutant, plus controls, was diluted 1:100 into 2 ml of LB broth 
and incubated at 30°C under stationary conditions for 24 h. The tubes were then rinsed twice 
with water and stained with 2.5 ml of 0.01% crystal violet for 20 min. After washing three 
times with water, tubes were air dried and de-stained with 2.5 ml of 80% ethyl alcohol for 15 
min. The tubes were vortexed, 100 µl was transferred to a new 96 well plate, and the optical 
density was measured at 595 nm using a Spectra MAX 190 spectrophotometer (Molecular 
Devices, Union City, CA). The optical density measurements were used as a measure of 
relative amounts of biofilms formed. All experiments were performed in triplicate.  
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Table. 2.1. E. coli strains and plasmids 
 
Strain or Plasmid Genotype or description* Source  
E. coli strains   
 BW19795 
RP4-2-tet::Mu-1kan::Tn7 
integrant/srlC300creC510hsdR17endA1zbf-
5uidA(∆MluI)::pir+thi 
G. Phillips 
 DH5α 
F- φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 
endA1 hsdR17 (rk-, mk+) phoA supE44 λ- thi-1 
gyrA96 relA1 
Invitrogen 
 ISM1536 E. coli O157:H7 EDL933 N. Cornick 
 ISM1191 E. coli O157 :H7 EDL933, Nalr This study 
 ISM1205 BW19795 pUTminiTn5Km2; Ampr, Kanr (40) 
ISM1230 E. coli O157:H7 EDL933 lacking pO157 plasmid N. Cornick 
 ISM1893 ISM1191+miniTn5Km2 in hlyB Nalr, Kanr This study 
 ISM2014 ISM1536 ΔhlyA Kanr This study 
 ISM1211 ISM1536 ΔhlyB Kanr This study 
 ISM1216 ISM1536 ΔhlyD Kanr This study 
 ISM2013 ISM1216+pISM30 ampr, Kanr This study 
 ISM1978 ISM1536+pISM31 specr This study 
 ISM2015 ISM1230+pISM31 specr This study 
 ISM1944 ISM1893+pISM31 specr, Kanr This study 
 ISM2016 ISM 2014+pISM31 specr, Kanr This study 
 ISM2017 ISM1211 +pISM31 specr, Kanr This study 
 ISM2018 ISM1216 +pISM31 specr, Kanr This study 
 ISM2019 ISM2013 +pISM31 specr, Kanr This study 
 ISM1881 ISM1191+miniTn5Km2 in L7020 Nalr, Kanr This study 
 ISM1919 ISM1191+miniTn5Km2 in hlyC/A Nalr, Kanr This study 
 ISM1227 ISM1536 ΔL7020 Kanr This study 
Plasmids   
 pKD4 
Derivative of pANTSγ that contains an FRT-
flanked Kanr gene from pCP15 (13) 
 pRedET 
Derivative of pSC101, Ampr, temperature 
sensitive, carries lambda red recombinase  Gene Bridges 
pBAD18 Expression vector, Ampr Beckwith lab 
pISM30 pBAD18 expressing ehxCABD operon This study 
pISM31 pMHE6 expressing GFPuv G. Phillips 
* Nalr = nalidixic acid resistant; Ampr = ampicillin resistant; Kanr = kanamycin resistant;  
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Identification of mini-Tn5 insertion sites. The mini-Tn5 insertion sites in biofilm-
negative mutants were mapped by sequencing the amplified genomic region at the site of 
mini-Tn5 insertion. The amplification of the region of the DNA at the site of transposon 
insertion was done using either single primer polymerase chain reaction (PCR)(25) or Y-
Linker PCR(30). The PCR products were then sequenced and analyzed using BLAST against 
the E. coli O157: H7 EDL933 genome sequence.  
Construction of deletion mutants. To generate deletion mutations, a one-step gene 
inactivation method adapted from Datsenko and Wanner (13) was used. The temperature-
sensitive plasmid pRedET (Gene Bridges, Dresden, Germany) encoding lambda red 
recombinase was transformed into E. coli O157:H7 EDL933. The kanamycin resistance gene 
was amplified from pKD4 (13) using primers shown in Table 2.2. Each primer sequence 
contained target homologous sequences as well as sequences for amplification of the 
kanamycin gene. The products of this reaction were electroporated (2000V, 129 ohms using 
a BTX electro cell manipulator model 600, Harvard Apparatus, Holliston, MA) into E. coli 
O157:H7 EDL933+pRedET, previously induced with 0.4% L-arabinose for 1 h. The cells 
were incubated in SOC media (20 g tryptone, 5 g yeast extract, 2 g MgCl2•6H2O, 2.5 g 
MgSO4•7H2O, 3.6 g glucose per liter, pH 7.5) for 1 h and then plated on selective media (LB 
supplemented with 25 µg/ml of kanamycin) at 37°C.  
Confirmation of mutant constructions and determination of the locations of the 
kanamycin gene insertions were done by PCR. Primer F (homology within the kanamycin 
cassette) and primer R (homology immediately downstream of the gene sequences that were 
being replaced) were used to generate PCR products. To ensure curation of the temperature 
sensitive pRedET plasmid, confirmed mutants were first grown at 42°C for 2 h, and then 
plated on LB plates and incubated over night at 37°C. The isolated colonies were picked and 
screened for kanamycin resistance and ampicillin sensitivity. All the primers used are shown 
in Table 2.2. 
Construction of plasmid pISM30 for genetic complementation. The ehxCABD operon 
was amplified using primers that also incorporated upstream KpnI and downstream XbaI 
restriction sites (Table 2.2). The PCR was done using LongAmpTaq DNA polymerase (New 
England Biolabs) with the following parameters: 2 min at 95°C, 30 cycles of 95°C for 30 sec, 
58°C for 7 min and 72°C for 1 min, followed by 5 min of extension at 72°C. The fragments 
were digested with KpnI and XbaI, cloned into vector pBAD18, and then transformed into E. 
coli DH5α. One plasmid designated pISM30 was confirmed by restriction digestion and was 
electroporated into E. coli O157:H7 EDL933 ∆ehxD. 
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Table 2.2. Primers used in this study.  
Primer  Sequence (5’→3’) 
P6U CGAGCTCGAATTCGGCCTAG 
P7U CTGCAGGCATGCAAGCTTCG 
P6M GCCAGATCTGATCAAGAGAC 
P7M GCCGAACTTGTGTATAAGAGTC 
Tn5 GGCCAGATCTGATCAAGAGA 
Y-linker CTGCTCGAATTCAAGCTTCT 
Test F TGTGTAGGCTGGAGCTGCTTC 
ehxA F 
AGTAAAAAACAGACAAGATTTTAATTTTAATATTGAGAAAGAAAACTA
ATTGTGTAGGCTGGAGCTGCTTC 
ehxA R 
TATAACGATGACCATTCCTCCTGGAATGGCCATCACCTCCTCTTTTAGT
CCATATGAATATCCTCCTTA 
ehxA test R AGAACTACATTTACTCATCA 
ehxB F 
AGACTAAAAGAGGAGGTGATGGCCATTCCAGGAGGAATGGTCATCGT
TATTGTGTAGGCTGGAGCTGCTTC 
ehxB R 
TTATAACGGCAAACCAAATCCCATAAACCTTTCATGTAAAAGCGCATA
CGCATATGAATATCCTCCTTA 
ehxB test R A GACATCAGAAAAAACCGTC 
ehxD F 
CCAAAAAAGACAGTTTATATGCATATTTATATCAGTTGCAGGCATAAC
GTTGTGTAGGCTGGAGCTGCTTC  
ehxD R 
ATTATTTCAGAAATCTATATCATATAAAAAGCCAATATGTTATTTATAT
AATATGAATATCCTCCTTA 
ehxD test R ACATAGATAA TCTTTACAAG 
L7020F 
ATGAATAAAA TATACTCTCT TAAATACAGC CATATTACAG 
GAGGGTTAAT CGCTGTTTCTTGTGTAGGCTGGAGCTGCTTC 
L7020 R 
GCAATTTTAT TGAAAGACTG ATTATATCCG TTCAGGTCAA 
GAGTTCCGCC ATTTTTCGCACATATGAATATCCTCCTTA 
L7020 test R TACAGCACCT GAATCAGTTG CA 
ehx kpn1 F CTCAGGTACCTAGATGCTTCTTGCTTAAAA 
ehx xba1 R GATCTCTAGACTAACGTTCACGTAAACTTT 
 
 
Cell culture. The T84 human colonic adenocarcinoma cells were maintained in 25 cm2 
(Falcon) tissue culture flasks as monolayers at 37°C with 5% CO2. The cell cultures were 
grown in DMEM/F12 medium (Invitrogen) supplemented with 2.5 mM L-glutamine, 5% 
fetal bovine serum and gentamicin (50 µg/ml). The cells were passed every 7 days by 
treatment with 0.5% trypsin, and media was replaced every other day. 
Bacterial adhesion assay. Quantitative adhesion assays were performed using 
monolayers of T84 cells grown on glass cover slips. The glass cover slips were treated with 1 
N HCl for 10 min, washed 3X with sterile water and placed in 6-well tissue culture plates 
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(Costar polystyrene, Corning, Corning, NY). T84 cells (4 X105) were seeded onto the glass 
cover slips in each well and allowed to attach overnight. The monolayers were then washed 
with Hanks Balanced Salt Solution and replenished with 1 ml of culture media without 
antibiotics. An overnight culture of bacteria was diluted 1:20 in fresh LB and grown for 
another 2 hr. One hundred µl of this culture (approximately 4 X106 bacteria) was added to 
each well containing T84 monolayer cultures. Bacterial cultures were serially diluted and 
plated to enumerate bacteria added. The tissue culture plates were then incubated at 37°C 
with 5% CO2 for 1.5 h. The cover slips were washed three times with PBS to remove non-
adhered bacteria, and then the glass cover slip was transferred to a fresh 6-well tissue culture 
plate. The T84 cells were then detached and lysed using 1 ml of 0.1% Triton X100 for 15 
min. In preliminary studies, this concentration of Triton X100 had no effect on viability of E. 
coli O157:H7 EDL933. This solution was serially diluted in PBS, and spread onto LB agar to 
enumerate the bacteria adhered to T84 cells. The percentage of adherence was calculated as 
follows: the number of bacteria adhered/number of bacteria added to the well times 100, and 
the relative percentage of adherence was calculated as the percentage of adherence of 
mutant/percentage of adherence of wild type times 100. All experiments were done in 
triplicate. The paired student t test was performed to identify statistical differences. 
For microscopic analysis, bacteria were transformed with pISM31, a derivative of 
pMHE6 (20) expressing GFPuv(12). The T84 cells were seeded as described above and 
grown for 48 hr until they were semi-confluent. Bacterial cultures were prepared, and the 
adherence assays were performed as described above. The plates were then incubated at 37°C 
and 5% CO2 for 1.5 hr. Following this, the cover slips were washed three times with PBS, 
and the cells were fixed using 4% paraformaldehyde in PBS for 10 min. The cover slips were 
washed twice with PBS and treated with BSP buffer (250 mg bovine serum albumin, 100 mg 
saponin, per 100 ml PBS) for 5 min and then washed twice with BSP. The cells were stained 
for F-actin (54) with Alexa Fluor 546-labeled phalloidin (Invitrogen) (1:200 dilution in 
BSP) for 1 h, washed twice with BSP and then mounted on a glass slide using mounting 
solution with DAPI. Once the slides were dry, cover slips were sealed using clear nail polish, 
and images were captured using green and red filters on an Olympus IX70 inverted 
fluorescence microscope equipped with a DP70 digital camera. The images were merged 
using ImageJ software (National Institutes of Health).  
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Results 
Identification of biofilm genes in E. coli O157:H7 EDL933. In previous studies, E. coli 
O157:H7 EDL933 was shown to form biofilms on inert surfaces (15). Since there have been 
no reports of studies performed on a global scale to identify biofilm linked genes in E. coli 
O157:H7, we conducted a global mutational study using mini-Tn5Km2 to identify genes 
involved either directly or indirectly in biofilm formation. During the initial screen, 114 
mutants (1.04% of the total library) had a biofilm-negative phenotype (Fig. 2.1). Following 
the confirmation of the phenotype, growth of each strain was assessed. After eliminating 
mutants with inconsistent biofilm formation or a growth deficiency, 95 mutants that were 
biofilm negative (0.86% of the library) were studied further. For convenience, these mutants 
were designated as biofilm negative phenotype (Bnp) mutants.  
 
 
Figure 2.1. Microtiter plate assay showing screening of mini-Tn5Km2 mutants for 
biofilm-negative phenotype. Wells 4 and 9 contained the wild type biofilm-positive cells, 
wells 5 and 10 contained the biofilm-negative control (BW19795), wells 3 and 6 contained 
biofilm-negative transposon mutants and wells 1, 2, 7, and 8 contained biofilm-positive 
transposon mutants. 
 
The precise mini-Tn5 insertion site of these Bnp mutants was identified by DNA 
sequencing. Our results indicated that there was only a single transposon insertion within the 
genome in each mutant. This was evident from the Y-Linker PCR, which showed 
amplification of only one fragment, and from the DNA sequence trace chromatograms that 
gave a single sequence. The mini-Tn5 insertion sites in 19 of the Bnp mutants could not be 
identified due to a failure to amplify the region at the transposon insertion sites despite 
repeated attempts. 
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The 76 insertions that could be identified were distributed randomly throughout the 
genome of E. coli O157:H7 EDL933. In some cases, there were multiple insertions in the 
same gene coding region but at different locations. Fifty-one distinct genes/intergenic regions 
were identified (Table 2.3). Thirty-two insertions were in coding sequences of known 
function, and 19 were in hypothetical genes whose functions are yet to be assigned. Twenty-
five insertions occurred in sequences having homology to E. coli K-12 sequences, and 
nineteen occurred in sequences not shared with K-12 (O islands), three are on the pO157 
plasmid and five are phage encoded. The functions of these genes vary from those that 
encode structural components (ecpD, csgG, csgB, csgA, tolQ, waaL, waaP), enzymes (yahF, 
yaiH, galU, cls, manC, wbdQ, fcI, aroC, relA, rfaC, dsbA), regulators (Z2086, yihF, hns), 
receptors (Z1178, Z0700, Z3635) and hypothetical proteins. Three independent insertions 
were identified in the curli pili operon (csgG, csgB, csgA) and four independent insertions in 
the LPS biosynthesis operon (waaL, waaP, waaD, waaJ). 
Plasmid pO157 genes involved in biofilm formation. In our mutational analysis we 
identified three independent insertions of mini-Tn5km2 in pO157, one in the Type V-
secreted serine protease espP (7) and two in the enterohemolysin operon ehxCABD (3, 4), 
one in ehxB and one between ehxC and ehxA. We confirmed the role of pO157 in biofilm 
formation by testing strain ISM1230, a derivative of EDL933 lacking the plasmid. This strain 
failed to make biofilms (Fig. 2.2). To confirm the linkage between specific genes and the 
biofilm phenotype, deletion mutants were constructed for three of the genes that were 
biofilm-negative during screening, espP, ehxB, and ehxA. The deletion mutants were then 
compared for their growth and biofilm phenotype using a quantitative tube assay with the 
corresponding mini-Tn5km2 Bnp mutants (Bnp6, Bnp18, Bnp44, respectively) (Fig. 2.2). 
Two of the deletion mutants (ΔehxB and ΔehxA) showed no difference in biofilm formation 
when compared to wild type, but their corresponding mini-Tn5km2 Bnp mutants, Bnp18 and 
Bnp44, were deficient in biofilm formation. The other deletion-insertion mutant (ΔespP) 
behaved in similar manner as its corresponding mini-Tn5km2 Bnp mutant (Bnp6). One 
explanation for the inconsistency in ehxCABD mutations is that the insertion of the 
transposon caused polarity effects on down-stream expression of ehxD (8) that would not 
occur with the deletion mutations. All deletions were constructed in-frame, and the 
kanamycin marker used in the deletion reaction lacks a transcriptional stop signal, allowing 
for continued transcription and expression of downstream genes. Thus, these results indicate 
that ehxD may be the critical element in biofilm formation and not ehxA or ehxB. To test this 
hypothesis, we constructed ΔehxD and tested it for the biofilm phenotype. Our quantitative 
assay showed that the deletion of ehxD caused a negative biofilm phenotype (Fig. 2.2). To 
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further confirm this linkage we constructed a plasmid for genetic complementation by 
cloning the ehxCABD operon under its native promoter into plasmid pBAD18. When this 
plasmid was transformed in the ΔehxD mutant (ΔehxD+pISM30), the biofilm phenotype was 
restored up to the levels comparable to the wild type (Fig. 2.2). 
 
Table. 2.3. Mini-Tn5 transposon biofilm-negative mutants of E. coli O157:H7 EDL933. 
 
Mutant Locus Tag Gene name Product/Function 
Bnp1† Z3917*  Hypothetical protein 
Bnp2† Z4881*  Putative aldolase 
Bnp3† Z5856  Putative aspartate carbamoyltransferase 
Bnp4† Z2256*  
Unknown protein associated with Rhs 
element 
Bnp5† Z5890*  Partial putative integrase 
Bnp6† L7020*** espP Putative exoprotein precursor 
Bnp7† Z3635  Putative Receptor Protein 
Bnp8† Z3182* hisD L-histidinal: NAD+ oxidoreductase 
Bnp9† Z4625 acrE Protein affects cell membrane permeability 
Bnp10 Z0472 yaiH Putative Enzyme 
Bnp11† Z1555*  Hypothetical Protein 
Bnp12† Z2436 ynaJ Hypothetical Protein 
Bnp13† Z1921**  Unknown protein encoded by CP933X 
Bnp14† Z0151 ecpD Putative Fimbrial chaperone protein 
Bnp15† 
Z1456**/ 
Z1457**  
Hypothetical Protein, Encoded by BP-
933W/ Putative DNA binding protein of 
BP-933W 
Bnp16 Z3592 aroC Chorismate synthase 
Bnp17 Z2026 Cls Cardiolipin synthase 
Bnp18† L7049*** ehxB Hemolysin Transport protein 
Bnp19† Z3497 * glpQ Glycerophosphodiester phosphodiesterase 
Bnp20 Z4099 relA (p)ppGpp synthetase I 
Bnp21 Z5049 waaL Surface Polymer ligase 
Bnp22† 
Z3199*/ 
Z3200* wbdP/ Per 
Putative glycosyl transferase/ Perosamine 
synthetase 
Bnp23 Z5050* waaD LPS biosynthesis enzyme 
Bnp24† Z2163 ydeH Hypothetical Protein 
Bnp25 
Z1675/ 
Z1676 csgB/ csgA 
Minor curlin subunit precursor/ Curlin 
major subunit, coiled surface structures 
Bnp26† Z2086**  Putative Regulator 
† Genes not previously shown to be involved with biofilm formation.  
* On O-Islands 
** Encoded in prophage, 
*** On p0157 
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Table 2.3. (continued) 
 
Mutant Locus Tag Gene name Product/Function 
Bnp27† Z3660 yfeA Hypothetical Protein 
Bnp28† Z5214*  Hypothetical Protein 
Bnp29 Z5051* waaJ LPS alpha1 2-glucosyltransferase 
Bnp31† 
Z1212*/ 
Z1213*  Hypothetical Protein 
Bnp30 Z1670 csgG 
Curli production assembly/transport 
component. 
Bnp31† 
Z1212*/ 
Z1213*  Hypothetical Protein 
Bnp32† Z1213*  Hypothetical Protein 
Bnp33 
Z2012/ 
Z2013 galU/ hns 
Glucose-1-phosphate uridylyltransferase/ 
DNA-binding protein; pleiotropic regulator" 
Bnp34 
Z3195/ 
Z3196 
manC/ 
wbdQ 
Mannose-1-P guanosyltransferase/ GDP-
mannose mannosylhydrolase 
Bnp35† Z0340**  
Unknown protein encoded in Prophage 
CP933I 
Bnp36 Z1676 csgA 
Curlin major subunit, coiled surface 
structures 
Bnp37 Z0905 tolQ Inner membrane protein 
Bnp38 Z5054 waaP LPS biosynthesis enzyme 
Bnp39† Z4328*  Hypothetical Protein 
Bnp40† Z0700*  Putative receptor 
Bnp41† Z3918*  Putative chaperone protein 
Bnp42† Z1494**  Unknown protein encoded by BP-933W 
Bnp43† Z0021*  Hypothetical Protein 
Bnp44† L7047/48*** ehxC/ehxA Hemolysin protein 
Bnp45† Z1977 ychM Hypothetical Protein 
Bnp46† 
Z0408/ 
Z0409 yahE/ yahF 
Hypothetical Protein/ Putative 
oxidoreductase subunit 
Bnp47† Z3197 fcI Fucose synthetase 
Bnp48† Z0904 ybgC Hypothetical Protein 
Bnp49† Z4327*  Hypothetical Protein 
Bnp50 Z5392 dsbA Protein disulfide isomerase I 
Bnp51† 
Z1177*/ 
Z1178*  
Partial putative phage inhibition protein/ 
Putative receptor 
 
 
 
Role of pO157 genes in adherence to T84 cells. To analyze the role of ehxCABD in 
adherence to T84 cells; E. coli O157:H7 EDL933 wild type, wild type without pO157, Bnp6, 
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Bnp18, Bnp44, ∆espP, ΔehxA, ΔehxB, ΔehxD, ΔehxD+pISM30 were tested for adherence to 
T84 cells. Both microscopic and quantitative analysis was done. For microscopic analysis, all 
of the bacterial strains were transformed with a green fluorescent protein expressing plasmid, 
pISM31. As shown in Fig. 2.3, E. coli O157:H7 EDL933 wild type, ΔehxA, ΔehxB and 
ΔehxD+pISM30 adhered to T84 cells while E. coli O157:H7 EDL933 minus pO157, Bnp6, 
Bnp18, Bnp44, ∆espP and ΔehxD failed to adhere. The quantitative analysis also showed that 
there is no significant difference in relative adherence to T84 cells between E. coli O157:H7 
EDL933 wild type, ΔehxA, ΔehxB and ΔehxD+pISM30, but there was a significant reduction 
in relative adherence of E. coli O157:H7 EDL933 minus pO157, Bnp6, Bnp18, Bnp44, 
∆espP and ΔehxD (Fig. 2.4). For this experiment, the percentage of wild-type bacteria 
adhering to the T84 monolayers was 32.6%. Strains with less than 4% adherence were 
considered negative.  
 
 
 
 
 
Figure 2.2. Comparison of biofilm formation on polystyrene by E. coli O157:H7 EDL933 
transposon insertion and deletion mutants along with wild type (WT) and negative control 
(BW19795). Data represent mean plus standard error of three replicates. Bnp6 is espP::Tn5, 
Bnp18 is ehxB::Tn5, Bnp44 is Tn5 inserted at the ehxC:ehxA junction, ∆ehxD+ehx is ∆ehxD 
complemented with pISM30. (*) indicates significantly different from the wild type control 
at p < 0.01.  
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Figure 2.3. Fluorescent microscopic pictures of adhering GFPuv expressing E. coli O157:H7 
EDL933 wild type, transposon insertion and deletion mutants to T84 cells. All figures are 
merged images of DAPI (blue), F-actin (orange) and GFPuv expressing bacteria (green) 
staining.  
 
 
 
Figure 2.4. Adherence of E. coli O157:H7 EDL933 wild type, transposon insertion and 
deletion mutants to T84 cells are shown quantitatively. Data represent mean plus standard 
error of three replicates. (*) indicates significantly different from the wild type control at p < 
0.01. 
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Discussion 
Earlier studies with Pseudomonas fluorescens and Staphylococcus aureus showed that 
the process of biofilm formation is complex and involves several convergent and divergent 
pathways (43, 59). To obtain an overall idea of the genes required for biofilm formation in 
the human pathogen E. coli O157:H7 EDL933, a global mutagenesis approach with mini-
Tn5km2 was performed. 
Previous studies with E. coli have shown that Tn5 and its mini-transposon derivatives 
insert randomly in the genome (14). Based on the assumption that there are 1,000 essential 
genes out of 5,361 open reading frames in the genome of E. coli O157:H7 EDL933(46), 
generating approximately 11,000 random mutants should give at least a 99% probability of 
inactivating 90% of nonessential genes. These studies uncovered several new genes that are 
involved in biofilm formation. Our approach was not complete however, as we also missed 
some genes already shown to be involved in biofilm formation in E. coli O157:H7 such as 
csgD, ompA, and cadA (58). This is because our screen was not saturating. In fact, 
approximately 55,000 random mutants would need to be generated for inactivating 100% of 
all non-essential genes with a 99% probability.  
This study identified 51 Bnp genes in E. coli O157: H7 of which 19 were O-island 
pathogen-associated genes, five were phage encoded, and three were located on pO157 
(Table 2.3). This suggests that some of the regulatory pathways involved in biofilm 
formation in E. coli O157:H7 are unique to that serotype. Previous studies have shown that 
Shiga toxin producing E. coli, including the O157:H7 serotype, are retained or persist in the 
ruminant gastrointestinal tract better than other E. coli pathotypes (11). The reason for this is 
unknown, but it is possible that genes unique to the O157:H7 serotype that are involved in 
biofilm development may enhance persistence in specific environmental situations such as 
those encountered in the bovine gastrointestinal tract or on food processing surfaces. 
Of the 51 Bnp genes identified, 20 have defined functions and 31 are either hypothetical 
or have only putative functions assigned. Among those 20 genes with known functions are 
those already demonstrated with a role in biofilm formation in other organisms. relA was 
shown to be required for efficient biofilm formation in L. monocytogenes, S. mutans and E. 
coli (2, 32, 56). It has also been demonstrated that relA mutants show lower levels of 
(p)ppGpp and higher levels of LuxS under amino acid starvation conditions (32, 56). The 
changes in the levels of LuxS and (p)ppGpp affect pathways that are required for biofilm 
formation. Our study showed that in E. coli O157:H7 relA is also involved in biofilm 
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formation. A more thorough transcriptional analysis of this gene may lead to the discovery of 
additional determinants of biofilm formation for E. coli O157:H7. 
Four independent insertions in the lipopolysaccharide (LPS) biosynthesis operon (waaL, 
waaP, waaD, waaJ) were identified that resulted in the loss of biofilm formation. In gram-
negative bacteria, LPS influences the physiochemical characteristics of the cell surface. In P. 
aeruginosa it has been shown that the production of A band or B band LPS influences the 
surface characteristics and modifies the binding capabilities of the bacterium (35). Four 
independent insertions in the LPS biosynthesis operon strongly suggests that LPS is directly 
involved in biofilm formation in E. coli O157:H7 as well. Thus, a more thorough study of 
this operon is needed to more accurately describe its role in biofilm development.  
In V. cholerae, galU, another Bnp gene, was shown to be essential for the formation of 
biofilms (5). In several organisms including E. coli O157:H7, galU encodes glucose-1-
phosphate uridylyl transferase and is responsible for synthesis of UDP glucose. The synthesis 
of UDP galactose via UDP-glucose is necessary for biosynthesis of exopolysaccharide, 
which is a binding substrate in biofilms. In Streptococcus mutans, aroC (chorismate 
synthase) has been shown to be involved in biofilm formation (53). cls (cardiolipin synthase) 
has also been shown in Mycobacterium ulcerans to be involved in biofilm formation (37). 
Lee et al. showed that disulfide bond isomerase A (dsbA) was involved in biofilm formation 
on abiotic surfaces in E. coli O157:H7, and ∆dsbA strains were reduced in attachment to HT-
29 epithelial cells and virulence in Caenorhabditis elegans (31).  
Another set of interesting genes identified in this study are the csg genes, which are 
responsible for the production of curli pili, a coiled surface structure produced by various 
microbes. Two operons, csgBA and csgDEFG are necessary for curli formation. csgA 
encodes the curlin subunit, CsgB is thought to nucleate CsgA curlin fibers, CsgD is a 
transcriptional activator of the csgBA operon, and CsgE, CsgF and CsgG are three putative 
curli assembly factors (61). Curli pili are highly adhesive proteinaceous structures required 
for bacterial adherence to surfaces as well as bacteria-to-bacteria binding (62), and are 
critical for both primary surface colonization and subsequent biofilm development in the 
formation of microcolonies (48). More detailed genetic studies showed that CsgD is a control 
unit for biofilm formation and coordinates both positive (csgAB, yaiC) and negative (pepD, 
yagS) determinants of biofilm formation (6, 21). It is possible that the curli pilin subunit 
(CsgA and CsgB) is directly involved in the attachment of the organism to the surface and 
that the regulator CsgD is involved in the maturation of the biofilm. Although this gene is 
one of the best studied biofilm-associated genes in E. coli O157:H7, questions remain about 
the actual mechanism of attachment of organisms to the substratum through curli pili.  
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Several Bnp genes identified in this study (Table 2.3) are uniquely associated with 
biofilm formation. Most of these are either hypothetical genes or have been assigned putative 
functions based on homology studies. How these genes might function in the development or 
maintenance of biofilms will require further study.  
Three of the fifty-one Bnp genes obtained in the initial screening, Bnp6, Bnp18 and 
Bnp44, were chosen for further study because of their location on the plasmid pO157. A role 
of translocator EhxD in biofilm formation was confirmed by deleting the gene ehxD (strain 
ISM1216) and complementing the biofilm-negative phenotype with plasmid pISM30 
expressing the ehxCABD operon (strain ISM2013). The role of ehxD in biofilm formation is 
unknown and needs further study. One possible hypothesis is the translocator ehxD functions 
independent of ehxB and transports factors that are critical to biofilm formation. Our study is 
the first to show the involvement of the plasmid pO157-encoded enterohemolysin operon 
ehxCABD in biofilm formation in E. coli O157:H7 although a recent study reported the 
importance of pO157 in biofilm development (33). In addition to ehxD, espP was also 
important to biofilm development. We can only speculate how this Type V-secreted serine 
protease (7, 19) might be involved in biofilm formation, but it must play an important role.  
We were also interested in testing whether ehxD and espP might have a role in adherence 
to T84 colonic adenocarcinoma cells, testing the hypothesis that biofilm formation and 
cellular adherence to epithelial cells are linked in E. coli O157. A previous study by Dziva et 
al. showed that EspP was critical to adherence to a bovine primary rectal epithelial cell line 
(19), so it was reasonable to think that other gene products on pO157 might also be involved 
in cell adherence. Clearly, cellular adherence occurs in vitro to T84 cells 1 hour after 
inoculation (Fig. 2.4). The loss of ehxD or espP, however, resulted in E. coli O157:H7 
incapable of T84 cell adherence. This was also true for a pO157-negative strain. 
Complementation of the ∆ehxD strain resulted in adherence suggesting that this protein along 
with EspP (19) has an important role in cellular adherence and possibly tissue interactions in 
vivo.  
In summary, through random mutagenesis we were able to identify genes not previously 
known to be involved in biofilm formation in E. coli O157. Two of these genes, espP and 
ehxD are located on the virulence plasmid pO157. In addition to biofilm formation, these 
genes are important for adherence to T84 colonic epithelial cells. Further analysis of these 
gene products and the pathways involved will provide a better understanding of the process 
of biofilm formation and colonization by E. coli O157:H7, which in turn should help to 
devise methods to decrease its prevalence in food animals and to control its dissemination in 
the environment. 
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Abstract 
During establishment of Escherichia coli O157:H7 infection, its capacity to adhere to 
host intestinal epithelial cells is the critical first step in pathogenesis. It also has the capability 
to form biofilms, and because both are surface activities, we sought to gain insight into a 
potential linkage between biofilm formation and adherence to epithelial cells. We conducted 
an adherence assay with fifty one biofilm-negative mutants and two human epithelial cell 
lines, T84 and HEp2. Our results show that unlike wild type cells, biofilm-negative mutants 
adhere poorly to epithelial cells. Some adhesin-negative mutants were fully competent in 
biofilm formation, however. Thus, biofilm forming activity in E. coli O157:H7 EDL933 is 
required for adherence to T84 and HEp2 cells, but it is not sufficient.  
 
Introduction 
Escherichia coli O157:H7, a major serotype of enterohemorrhagic E. coli (EHEC), is one 
of the more important gastrointestinal food borne pathogens. It causes more than 73,000 
illnesses and 61 deaths per year in United States (Rangel, et al., 2005). This pathogen is 
associated with sporadic cases and outbreaks of hemorrhagic colitis and Hemolytic Uremic 
Syndrome in humans (Pai, et al., 1988, Mead & Griffin, 1998). Human disease is initiated by 
the adherence of the bacterium to the host intestinal tissue where attaching and effacing 
lesions are induced, triggering diarrhea. The production of shiga-like toxins and other 
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putative virulence factors could trigger the onset of bloody diarrhea and colitis (hemorrhagic 
colitis). Shiga-like toxins then cross the epithelial barrier to the blood stream via damaged 
epithelium or transcellular pathways to cause systemic sequelae such as Hemolytic Uremic 
Syndrome (Paton & Paton, 1998). Thus, the ability of EHEC to attach to the intestinal 
epithelium is the initiating event that determines the pathogenic potential. Adherence assays 
with cultured intestinal cell lines are often used to determine differences in pathogenicity 
among EHEC strains in vitro (Torres, et al., 2005, Mellor, et al., 2009). Because E. coli 
O157:H7 adheres to the intestinal epithelial cells in vivo, the use of epithelial cell lines such 
as HEp2 and T84 yields a better understanding of differences in adherence properties in vivo. 
 In addition to adhering to host tissues, E. coli O157:H7 is capable of interacting with other 
surfaces outside their hosts such as plastics and glass through biofilms (Dewanti & Wong, 
1995). Biofilms are poorly defined, complex polysaccharide polymers on bacterial surfaces 
thought to have several functions, all of which impart a selective advantage to the organism. 
The control of biofilm formation in relation to other physiological processes is poorly 
understood, but profound changes in gene expression accompany the shift from planktonic to 
biofilm growth (Oosthuizen, et al., 2002, Beloin, et al., 2004). The mechanism(s) of 
regulation of a significant proportion of the total genome has not been defined, but quorum 
sensing seems to play an important role (Davies, et al., 1998, Lee, et al., 2007). How bacteria 
integrate other surface constituents within the biofilm architecture is not clear. For instance, 
there is anecdotal evidence that pili may play an important role in defining the structure of 
the biofilm (Costerton, 2007), and genetic exchange is significantly enhanced in biofilms 
(Wyndham, et al., 1994, Boles, et al., 2004). Other surface structures may play important 
roles or are important components of biofilms. In some bacteria, capsule synthesis seems 
linked to biofilm formation (Anderson, et al., 2010), while in others, the loss of capsule 
synthesis enhances biofilms (Davey & Duncan, 2006). Biofilms can play an important role in 
maintaining a pathogen outside a host offering it a selective advantage under adverse 
conditions, and the question remains whether biofilms play a role in the pathogenic process 
itself apart from adhering to implanted abiotic or engineered surfaces. While biofilm 
architecture and composition in mature biofilms has been the subject of numerous studies by 
the scientific community (Costerton, 2007), little attention has been given to studies of 
biofilm formation in relation to direct interactions with host tissues or in pathogenesis.  
The goal of this study was to determine whether biofilm-related genes in clearly non-adhesin 
loci contribute to cellular adherence. Previously, we constructed and screened 11,000 
transposon insertion mutants of E. coli O157:H7 EDL933 and identified fifty-one biofilm-
negative phenotype (Bnp) mutants using a simple functional definition of biofilms to identify 
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mutants (Puttamreddy, et al., 2010). Here, we expand these initial studies to include analysis 
of the Bnp mutants' biofilm formation on other abiotic surfaces (polypropylene, polyvinyl 
chloride, and glass) and their contribution to adherence to HEp2 and T84 epithelial cell lines. 
 
Materials and Methods 
Bacteria. The strains used in this study are shown in Table 3.1. A spontaneous nalidixic 
acid-resistant mutant of Escherichia coli O157:H7 strain EDL933 was used as wild type 
control. For all biofilm assays, the cultures were grown in Luria-Bertani (LB) broth for 24 h 
at 30 °C under stationary conditions. For adherence assays the cultures were grown overnight 
in LB broth at 37 °C and shaking at 200 rpm and diluted 1:20 with fresh LB broth and grown 
for another 2 h at 37 °C with shaking at 200 rpm. For all other experiments the cultures were 
grown overnight in LB broth at 37 °C with shaking at 200 rpm. Antibiotic concentrations 
were ampicillin (100 µg ml–1), kanamycin (50 µg ml–1) and nalidixic acid (20 µg ml-1) except 
where noted. All antibiotics were obtained from Sigma Chemical Co. (St. Louis, MO). For 
the Bnp mutants, growth was assessed as described earlier (Puttamreddy, et al., 2010). The 
fifty-one Bnp mutants of E. coli O157:H7 strain EDL933 used in this study were isolated and 
characterized as described previously (Puttamreddy, et al., 2010).  
Biofilm assay. The quantitative biofilm assay was performed as described (Puttamreddy, 
et al., 2010). For the general assay 12 x 75 mm polystyrene tubes (Fisher) were used. For 
other assays, 12 x 75 mm polypropylene tubes (Fisher), polyvinyl chloride 96-well plates 
(Costar) and 13 x 100 mm Kimax glass tubes were used. An overnight culture of each 
bacterial sample, plus controls, was diluted 1:100 into 2 ml of LB broth and incubated at 
30°C under stationary conditions for 24 h. The end point growth was determined by 
measuring the  OD 600 nm. The tubes were then rinsed twice with water and stained with 2.5 
ml of 0.01% crystal violet for 20 min. After washing three times with water, tubes were air 
dried and de-stained with 2.5 ml of 80% ethyl alcohol for 15 min. The tubes were vortexed, 
100 µl was transferred to a new 96 well plate, and the OD 595 nm was measured using a 
Spectra MAX 190 spectrophotometer (Molecular Devices, Union City, CA). OD values  
were used as a measure of the relative amounts of biofilms formed. All experiments were 
performed in triplicate.  
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Table 3.1. Strains, plasmids and primers.  
Strain or Plasmid Genotype or description Source  
E. coli strains   
 ISM1536 E. coli O157:H7 EDL933 N. Cornick 
 ISM1191 E. coli O157 :H7 EDL933, Nalr This study 
 ISM1205 BW19795pir+ pUTminiTn5Km2; Ampr, Kanr 
(Metcalf, et al., 
1994) 
 ISM1876-ISM1926 ISM1191+miniTn5Km2; bnp1-51; Nalr, Kanr 
(Puttamreddy, et al., 
2010) 
 ISM1978 ISM1536+pISM31 specr 
(Puttamreddy, et al., 
2010) 
 ISM1927-ISM1977 ISM1876-ISM1926+pISM31 specr, Nalr, Kanr This study 
 ISM2020 ISM1536 Δeae Kanr This study 
 ISM2021 ISM1536 ∆esp Kanr This study 
 ISM2022 ISM 2020+pISM31 specr, Kanr This study 
 ISM2023 ISM 2021+pISM31 specr, Kanr This study 
 ISM2024 ISM1191+miniTn5Km2; +pISM31 specr, Kanr This study 
Plasmids   
 pKD4 
Derivative of pANTSγ that contains an FRT-flanked Kanr 
gene from pCP15 
(Datsenko & 
Wanner, 2000) 
 pRedET 
Derivative of pSC101, Ampr, temperature sensitive, carries 
lambda red recombinase  Gene Bridges 
pISM31 pMHE6 expressing GFPuv Gregory Phillips 
Primers Sequence (5’→3’)  
eae F 
ATTATGCCCCGACTAAAACAATACATATTTTAGCCG
GGGTGGTTATGGAATGTGTAGGCTGGAGCTGCTTC  
eae R 
TATTAATATAATTTATTTCTCATTCTAACTCATTGTG
GTGGAGCCATAACCATATGAATATCCTCCTTA  
Test F TGTGTAGGCTGGAGCTGCTTC  
eae test R CCGGAAGATAAAATCCGATC  
esp F 
TTACCCAGCTAAGCGACCCGATTGCCCCATACGATT
CTGGACCTCAAGGATGTGTAGGCTGGAGCTGCTTC  
esp R 
GAAATTATTTGATATTAATTACTCAATAATTTTTTTG
TTTTCCTGAGAAACATATGAATATCCTCCTTA  
esp test R AAGTTATCGACTATAAGGAG  
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Construction of deletion mutants. To generate deletion mutations, a one-step gene 
inactivation method was used (Datsenko & Wanner, 2000). The temperature-sensitive 
plasmid pRedET (Gene Bridges, Dresden, Germany) encoding lambda red recombinase was 
transformed into E. coli O157:H7 EDL933. The kanamycin resistance gene was amplified 
from pKD4 (Datsenko & Wanner, 2000) using primer sets eae-F/eae-R and esp-F/esp-R 
(Table 3.1). Each primer sequence contained target homologous sequences as well as 
sequences for amplification of the kanamycin gene. The products of this reaction were 
electroporated (2000V, 129 Ω using a BTX electro cell manipulator model 600, Harvard 
Apparatus, Holliston, MA) into E. coli O157:H7 EDL933+pRedET, previously induced with 
0.4% L-arabinose for 1 h. The cells were incubated in SOC media (20 g tryptone, 5 g yeast 
extract, 2 g MgCl2•6H2O, 2.5 g MgSO4•7H2O, 3.6 g glucose per liter, pH 7.5) for 1 h and 
then plated on selective media (LB supplemented with 25 µg ml–1 of kanamycin) at 37 °C.  
Confirmation of mutant constructions and determination of the locations of the 
kanamycin gene insertions were done by PCR. Primer Test-F (homology within the 
kanamycin cassette) and primer eae-test-R or esp-test-R (homology immediately downstream 
of the gene sequences that were being replaced) were used to generate PCR products (Table 
3.1). To ensure curation of the temperature sensitive pRedET plasmid, confirmed mutants 
were first grown at 42 °C for 2 h, and then plated on LB plates and incubated over night at 37 
°C. The isolated colonies were picked and screened for kanamycin resistance and ampicillin 
sensitivity.  
Construction of Green fluorescent protein expressing strains. All the bacterial strains 
used in the adherence assay were transformed with pISM31, a derivative of pMHE6 (Fodor, 
et al., 2004) expressing GFPuv (Crameri, et al., 1996). The transformation was performed by 
electroporation (2000V, 129 Ω) using a BTX electro cell manipulator model 600 (Harvard 
Apparatus) 
Cell cultures. The cell cultures were maintained in either 25 or 75 cm2 (Falcon) tissue 
culture flasks as monolayers in a humidified 37 °C incubator with 5% CO2. The T84 human 
colon epithelial cells (ATCC CCL-248) were grown in DMEM/F12 medium (Invitrogen) 
supplemented with 2.5 mM L-glutamine, 5% fetal bovine serum and gentamicin (50 µg ml–
1). The HEp2 human laryngeal epithelial cells (ATCC CCL-23) were grown in MEM 
supplemented with 5% fetal bovine serum and gentamicin (50 µg ml–1). The T84 cells were 
passed every 7 days while the HEp2 cells were passed every 5 days by treatment with 0.5% 
trypsin, and media was replaced every other day. 
Bacterial adherence assays. Quantitative adhesion assays were performed using 
monolayers of cells grown in 24-well tissue culture plates (TPP polystyrene). Approximately 
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105 cells per well were seeded to 24-well tissue culture plates, allowed to attach overnight 
and were grown to 90-95% confluency. The monolayers were then washed with Hanks 
Balanced Salt Solution and replenished with 0.5 ml of culture media with no gentamicin. An 
overnight culture of bacteria was diluted 1:20 in fresh LB and grown for another 2 hr. 
Twenty µl of this culture (approximately 106 bacteria) was added to each well containing 
either T84 or HEp2 monolayer cultures. Bacterial cultures were serially diluted and plated to 
enumerate bacteria added. The tissue culture plates were then incubated at 37 °C and 5% CO2 
for 90 min. Following this, the plates were washed 3 times with phosphate-buffered saline 
(PBS) to remove non-adhered bacteria. The cells were then detached and lysed using 0.5 ml 
of 0.1% Triton X100 for 15 min. This solution was serially diluted in PBS, and plated to 
enumerate the bacteria adhered to cells. The percentage of adherence was calculated as 
follows: the number of adherent bacteria/number of bacteria added to the well  100. To 
control for adherence differences between experiments, the relative percentage of adherence 
was calculated as the percentage of adherence of mutant/percentage of adherence of wild 
type  100. All experiments were done in triplicate. The Student's t test was performed to 
identify statistical differences (p < 0.05). 
Microscopic analysis was performed using monolayers of T84 or HEp2 cells grown on 
glass cover slips. The glass cover slips were treated with 1 N HCl for 10 min, washed 3 times 
with sterile water and placed in 6-well tissue culture plates (Costar polystyrene, Corning, 
Corning, NY). Cells (4 X105) were seeded onto the glass cover slips in each well and allowed 
to attach overnight. The monolayers were then washed with Hanks Balanced Salt Solution 
and replenished with 1 ml of culture media without antibiotics. An overnight culture of 
bacteria was diluted 1:20 in fresh LB and grown for another 2 hr. One hundred µl of this 
culture (approximately 4 X106 bacteria) was added to each well containing monolayer 
cultures. The tissue culture plates were then incubated at 37 °C with 5% CO2 for 90 min. The 
cover slips were washed three times with PBS to remove non-adhered bacteria. The cells 
were fixed using 4% paraformaldehyde in PBS for 10 min. The cover slips were washed 
twice with PBS and treated with BSP buffer (250 mg bovine serum albumin, 100 mg 
saponin, per 100 ml PBS) for 5 min and then washed twice with BSP. The cells were stained 
for F-actin (Snider, et al., 2008) with Alexa Fluor 546-labeled phalloidin (Invitrogen) (1:200 
dilution in BSP) for 1 h, washed twice with BSP and then mounted on a glass slide using 
mounting solution with 4',6-diamidino-2-phenylindole. Once the slides were dry, cover slips 
were sealed using clear nail polish, and images were captured using green and red filters on 
an Olympus IX70 inverted fluorescence microscope equipped with a DP70 digital camera. 
The images were merged using ImageJ software (National Institute of Health).   
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Results 
Identification of biofilm negative phenotype mutants in E. coli O157:H7 EDL933. In 
our previous study (Puttamreddy, et al., 2010) a mini-Tn5 transposon insertion library was 
constructed in E. coli O157:H7 strain EDL933 and fifty-one distinct genes/intergenic regions 
were identified to be involved either directly or indirectly in biofilm formation. All of the 
fifty-one biofilm-negative mutants showed reduced biofilm formation in quantitative biofilm 
assay at p < 0.05.  
Characterization of Bnp mutants on different surfaces. To test whether biofilms on 
different surfaces may require different gene products, we subjected all fifty-one Bnp 
mutants to a quantitative biofilm test on polystyrene, polypropylene, polyvinyl chloride and 
glass. There was no statistical difference in the quantity of biofilms produced on any of the 
surfaces tested (Supporting Information, Fig. S3.1). 
Role of Bnp genes in adherence to T84 and HEp2 cells. To analyze the role of biofilm 
formation of E. coli O157:H7 in adherence to T84 (human colonic epithelial) and HEp2 
(human laryngeal epithelial) cells, wild type and Bnp mutants were tested for adherence in an 
in vitro adherence assay by both microscopic and quantitative analysis. We also constructed 
eae and esp deletion mutations as controls for potential adhesin-biofilm interactions. 
Additionally, we tested a biofilm-positive transposon mutant (M1) as a control for non-
specific transposon effects on cellular adherence. The quantitative adherence assay 
(significance p < 0.05) showed that all fifty-one Bnp mutants lost their adherence to both T84 
and HEp2 cells after a 90 min infection when compared to wild type (Fig. 3.1, Table S3.1). 
This was also true for the eae and espAB deletion mutants as expected (Fig. 3.1, Table S3.1) 
because both of these genes have been shown previously to be important to cellular 
adherence (Yu & Kaper, 1992, Ebel, et al., 1998).  
For microscopic analysis, all of the bacterial strains were transformed with a green 
fluorescent protein expressing plasmid, pISM31. Escherichia coli O157:H7 EDL933 wild 
type adhered to both cell types while all of the fifty-one Bnp mutants failed to adhere. A 
biofilm positive mini-Tn5Km2 mutant of E. coli O157:H7 EDL933 (M1) showed no 
significant loss in either biofilm formation or adherence when compared with the wild type 
(Figs 3.2 and 3.3, also see Fig. S3.2 for a higher magnification of wild-type adherence to the 
two cell types). This eliminates the possibility of a non-specific effect between mini-
Tn5Km2 insertions and loss of adherence. To identify whether loss of adherence leads to loss 
of biofilm phenotype, deletions in eae and espAB, both well known adhesins (Jerse, et al., 
1990), were constructed and tested for both biofilm formation and adherence to T84 and 
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HEp2 cells. The ∆eae mutant retained its biofilm phenotype (Fig. 3.2) but lost its adherence 
property to both T84 and HEp2 cells (Fig. 3.1, Table S3.1) as did the ∆espAB mutant (Figs. 
3.1-3.3). 
 
 
Fig. 3.1. Biofilm-negative 
mutants of Escherichia coli 
O157:H7 fail to adhere to 
T84 and HEp2 cells. 
Adherence to T84 (black 
bars) and HEp2 (white 
bars) cells was measured in 
all 51 Bnp mutants, the 
∆eae and ∆espAB mutants 
and the M1 strain, and was 
expressed as the relative 
adherence with reference to 
wild-type controls in each 
adherence assay. Percent 
adherence was determined 
after 1.5 h of incubation 
and washing as follows: 
CFUs of total cells after 
incubation/total cell input 
 100. Relative adherence 
was then calculated as % 
adherence of mutant/% 
adherence of wild type  
100. Data represent the 
mean ±SD of three 
replicates. 
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Fig. 3.2. Escherichia coli O157:H7 adherence mutants and control strains show no 
differences in growth and biofilm formation. Growth (dark gray bars) is shown as OD 600 nm 
after 24 h of stationary growth in polystyrene tubes after vortexing. Biofilms (white bars) 
were measured as OD 595 nm of solubilized crystal violet as described in Materials and 
Methods. Data represent the mean ± SD of three replicates.  
 
 
Discussion 
Most microorganisms adopt biofilm formation as a lifestyle in nature and for some of the 
pathogenic bacteria the biofilms are important for host infection (Anderson, et al., 2003, 
Cvitkovitch, et al., 2003, Garcia-Medina, et al., 2005, Hall-Stoodley, et al., 2006). 
Escherichia coli O157 has the capability to attach to several solid surfaces and form biofilms. 
In mature microbial biofilms, bacterial cells aggregate on the surface in microcolonies and 
are embedded in a complex extracellular matrix that has viscoelastic properties (Costerton, et 
al., 1999, O'Toole, et al., 2000). While our working definition of 'biofilm' includes the 
biofilm structure measured in the microtiter plate-based assay that if left unattended would 
continue to develop its complex architecture over several more days, we believe that our 
results are particularly relevant to the concept of the initial steps in matrix production that are 
essentially unknown and that may play pivotal roles in cellular adherence in combination 
with other surface structures, i.e., pili.  
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Fig. 3.3. Adherence to T84 and HEp2 cells by Escherichia coli O157:H7 depends on the 
biofilm phenotype. Escherichia coli O157:H7 (green) can be seen attached to cells stained 
with Alexa Fluor 546-labeled phalloidin for F-actin (red). Adherence to T84 and HEp2 cells 
is shown with a representative Bnp mutant (Bnp50) along with wild-type, M1, ∆eae and 
∆espAB mutants. Numerous bacteria are associated with both T84 and HEp2 cell types with 
wild-type and M1 strains (white arrows). The ∆eae, ∆espAB and Bnp50 strains failed to 
adhere to either cell type. This was also true for all Bnp mutants (data not shown). 
T84 HEp2
WT
M1
Bnp50
∆espAB
∆eae
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As a prelude to studies in more complex environments, we tested all fifty-one Bnp 
mutants on different surfaces to determine whether biofilm formation on different surfaces 
required different gene products. In EDL933, we were unable to clearly differentiate between 
our Bnp mutants based on their ability to form biofilms on polystyrene, polypropylene, 
polyvinyl chloride, and glass (Fig. S3.1), indicating that the loss of biofilm formation on 
polystyrene affected biofilm formation on other surfaces as well. Our data suggest that 
biofilms require a wide array of proteins and that biofilm formation may be more complex 
and integrated than once thought (Puttamreddy, et al., 2010). The fact that this phenotype 
persists in E. coli O157:H7 despite its high rate of evolution (Zhang, et al., 2006) suggests 
that biofilms play critical functions in both the external and host environments. 
There is growing evidence suggesting that some genes involved in biofilm formation are 
also involved in adherence and colonization of host tissues (Latasa, et al., 2005, Manetti, et 
al., 2007, Munoz-Elias, et al., 2008, Konto-Ghiorghi, et al., 2009). Thus, we sought a link 
between biofilm formation and adherence to host tissues. To examine this in vitro, all fifty-
one Bnp mutants were tested for their adherence to human HEp2 and T84 cells. The T84 cell 
is derived from a human colonic adenocarcinoma and forms cell aggregates in culture while 
the HEp2 cell line is derived from a human laryngeal epidermoid carcinoma and forms 
monolayers in culture. Our studies show that the ability to form biofilms is positively linked 
to adherence to the two distinctly different human epithelial-like cells (Figs. 3.1 and 3.3). 
Wild-type E. coli O157:H7 EDL933 adhered to both cell lines, but the adherence of all fifty-
one Bnp mutants was severely impaired (Fig. 3.1, Table S3.1). All of the adherence assays 
were performed at a 1.5 h time point to lower assay background and at a cell density that is 
unlikely to be undergoing quorum sensing (Surette & Bassler, 1998). Thus, the reduction of 
adherence to epithelial cells shows a possible role of early biofilm formation in the 
attachment of the bacterium to host tissues. In addition, it does not appear that quorum 
sensing is directly involved because bacterial cell densities in the adherence studies are 
below the threshold required for significant AI-2 quantities. Complementation of the 
phenotype resulted in resumption of cellular adherence suggesting that biofilm formation is 
critical to cellular adherence (Puttamreddy, et al., 2010). Thus, we have been able to 
genetically correlate biofilm formation on abiotic surfaces with cellular adherence in vitro. 
However as shown in Figs. 3.2 and 3.3, adherence requires both biofilm forming capabilities 
and additional surface activities. Deletion of two known adherence factors, eae (intimin) and 
espAB (type III secretion apparatus), eliminated adherence (Figs. 3.1 and 3.3). However, both 
of these strains were fully competent in biofilm formation (Fig. 3.2). This suggests that 
adherence requires two genetically tractable events, adhesin-cellular interactions and biofilm 
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formation. Further studies are needed to answer the questions such as how these two 
phenotypes are linked and what role they have in terms of colonization and pathogenesis.  
Clearly, the phenotype of strain EDL933 is different from that of other O157:H7 strains; 
it is constitutive in EDL933 while other strains generate little to no biofilms in the laboratory 
under our conditions. We have used this phenotype to our advantage, yet much is left to 
speculate about the contribution of biofilms to adherence in other strains. Are biofilms more 
tightly regulated in other strains than in EDL933? If so, what is the defective factor in 
EDL933 allowing a constitutive phenotype? Do biofilms form on cell surfaces with other 
strains, and if so, how is that regulated? Once these issues are answered, we will have a more 
comprehensive picture of the role of biofilms in animal persistence and pathogenesis. 
 
Acknowledgements 
We thank Nancy Cornick for providing help in tissue culture work. We also thank Bryan 
Bellaire for assistance with the microscopy, Gregory Phillips for the plasmid pISM31 and 
Melissa Madsen for critically evaluating the manuscript. 
 
References 
Anderson GG, Goller CC, Justice S, Hultgren SJ & Seed PC (2010) Polysaccharide capsule 
and sialic acid-mediated regulation promote biofilm-like intracellular bacterial 
communities during cystitis. Infect. Immun. 78: 963-975. 
Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J & Hultgren SJ (2003) Intracellular 
bacterial biofilm-like pods in urinary tract infections. Science 301: 105-107. 
Beloin C, Valle J, Latour-Lambert P, et al. (2004) Global impact of mature biofilm lifestyle 
on Escherichia coli K-12 gene expression. Mol. Microbiol. 51: 659-674. 
Boles BR, Thoendel M & Singh PK (2004) Self-generated diversity produces "insurance 
effects" in biofilm communities. Proc. Natl. Acad. Sci. U S A 101: 16630-16635. 
Costerton JW (2007) The Biofilm Primer. Springer, New York. 
Costerton JW, Stewart PS & Greenberg EP (1999) Bacterial biofilms: a common cause of 
persistent infections. Science 284: 1318-1322. 
Crameri A, Whitehorn EA, Tate E & Stemmer WP (1996) Improved green fluorescent 
protein by molecular evolution using DNA shuffling. Nat. Biotechnol. 14: 315-319. 
  
71  
Cvitkovitch DG, Li YH & Ellen RP (2003) Quorum sensing and biofilm formation in 
Streptococcal infections. J. Clin. Invest. 112: 1626-1632. 
Datsenko KA & Wanner BL (2000) One-step inactivation of chromosomal genes in 
Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U S A 97: 6640-6645. 
Davey ME & Duncan MJ (2006) Enhanced biofilm formation and loss of capsule synthesis: 
deletion of a putative glycosyltransferase in Porphyromonas gingivalis. J. Bacteriol. 188: 
5510-5523. 
Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW & Greenberg EP (1998) The 
involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280: 
295-298. 
Dewanti R & Wong AC (1995) Influence of culture conditions on biofilm formation by 
Escherichia coli O157:H7. Int. J. Food Microbiol. 26: 147-164. 
Ebel F, Podzadel T, Rohde M, et al. (1998) Initial binding of Shiga toxin-producing 
Escherichia coli to host cells and subsequent induction of actin rearrangements depend 
on filamentous EspA-containing surface appendages. Mol. Microbiol. 30: 147-161. 
Fodor BD, Kovacs AT, Csaki R, et al. (2004) Modular broad-host-range expression vectors 
for single-protein and protein complex purification. Appl. Environ. Microbiol. 70: 712-
721. 
Garcia-Medina R, Dunne WM, Singh PK & Brody SL (2005) Pseudomonas aeruginosa 
acquires biofilm-like properties within airway epithelial cells. Infect. Immun. 73: 8298-
8305. 
Hall-Stoodley L, Hu FZ, Gieseke A, et al. (2006) Direct detection of bacterial biofilms on the 
middle-ear mucosa of children with chronic otitis media. JAMA 296: 202-211. 
Jerse AE, Yu J, Tall BD & Kaper JB (1990) A genetic locus of enteropathogenic Escherichia 
coli necessary for the production of attaching and effacing lesions on tissue culture cells. 
Proc. Natl. Acad. Sci. U S A 87: 7839-7843. 
Konto-Ghiorghi Y, Mairey E, Mallet A, Dumenil G, Caliot E, Trieu-Cuot P & Dramsi S 
(2009) Dual role for pilus in adherence to epithelial cells and biofilm formation in 
Streptococcus agalactiae. PLoS Pathog. 5: e1000422. 
Latasa C, Roux A, Toledo-Arana A, Ghigo JM, Gamazo C, Penades JR & Lasa I (2005) 
BapA, a large secreted protein required for biofilm formation and host colonization of 
Salmonella enterica serovar Enteritidis. Mol. Microbiol. 58: 1322-1339. 
Lee J, Bansal T, Jayaraman A, Bentley WE & Wood TK (2007) Enterohemorrhagic 
Escherichia coli biofilms are inhibited by 7-hydroxyindole and stimulated by isatin. Appl. 
Environ. Microbiol. 73: 4100-4109. 
  
72  
Manetti AG, Zingaretti C, Falugi F, et al. (2007) Streptococcus pyogenes pili promote 
pharyngeal cell adhesion and biofilm formation. Mol. Microbiol. 64: 968-983. 
Mead PS & Griffin PM (1998) Escherichia coli O157:H7. Lancet 352: 1207-1212. 
Mellor GE, Goulter RM, Chia TW & Dykes GA (2009) Comparative analysis of attachment 
of Shiga-toxigenic Escherichia coli and Salmonella strains to cultured HT-29 and Caco-2 
cell lines. Appl. Environ. Microbiol. 75: 1796-1799. 
Metcalf WW, Jiang W & Wanner BL (1994) Use of the rep technique for allele replacement 
to construct new Escherichia coli hosts for maintenance of R6K gamma origin plasmids 
at different copy numbers. Gene 138: 1-7. 
Munoz-Elias EJ, Marcano J & Camilli A (2008) Isolation of Streptococcus pneumoniae 
biofilm mutants and their characterization during nasopharyngeal colonization. Infect. 
Immun. 76: 5049-5061. 
O'Toole G, Kaplan HB & Kolter R (2000) Biofilm formation as microbial development. 
Annu. Rev. Microbiol. 54: 49-79. 
Oosthuizen MC, Steyn B, Theron J, Cosette P, Lindsay D, Von Holy A & Brozel VS (2002) 
Proteomic analysis reveals differential protein expression by Bacillus cereus during 
biofilm formation. Appl. Environ. Microbiol. 68: 2770-2780. 
Pai CH, Ahmed N, Lior H, Johnson WM, Sims HV & Woods DE (1988) Epidemiology of 
sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year 
prospective study. J. Infect. Dis. 157: 1054-1057. 
Paton JC & Paton AW (1998) Pathogenesis and diagnosis of Shiga toxin-producing 
Escherichia coli infections. Clin. Microbiol. Rev. 11: 450-479. 
Puttamreddy S, Cornick NA & Minion FC (2010) Genome-wide transposon mutagenesis 
reveals a role for pO157 genes in biofilm development in Escherichia coli O157:H7 
EDL933. Infect. Immun. 78: 2377-2384. 
Rangel JM, Sparling PH, Crowe C, Griffin PM & Swerdlow DL (2005) Epidemiology of 
Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg. Infect. Dis. 11: 
603-609. 
Snider JL, Allison C, Bellaire BH, Ferrero RL & Cardelli JA (2008) The beta1 integrin 
activates JNK independent of CagA, and JNK activation is required for Helicobacter 
pylori CagA+-induced motility of gastric cancer cells. J. Biol. Chem. 283: 13952-13963. 
Surette MG & Bassler BL (1998) Quorum sensing in Escherichia coli and Salmonella 
typhimurium. Proc. Natl. Acad. Sci. U S A 95: 7046-7050. 
Torres AG, Zhou X & Kaper JB (2005) Adherence of diarrheagenic Escherichia coli strains 
to epithelial cells. Infect. Immun. 73: 18-29. 
  
73  
Wyndham RC, Cashore AE, Nakatsu CH & Peel MC (1994) Catabolic transposons. 
Biodegradation 5: 323-342. 
Yu J & Kaper JB (1992) Cloning and characterization of the eae gene of enterohaemorrhagic 
Escherichia coli O157:H7. Mol. Microbiol. 6: 411-417. 
Zhang W, Qi W, Albert TJ, et al. (2006) Probing genomic diversity and evolution of 
Escherichia coli O157 by single nucleotide polymorphisms. Genome Res. 16: 757-767. 
 
SUPPORTING INFORMATON 
 
Table S3.1. Adherence of Escherichia coli O157: H7 EDL933 to T84 and HEp2 cells.  
Strain 
Locus 
Tag 
% 
Adherence 
HEp2 cells p - Values 
% 
Adherence 
T84 cells p - Values 
Bnp1 Z3917 7.83 0.0010 4.49 0.0007 
Bnp2 Z4881 5.04 0.0005 2.05 0.0019 
Bnp3 Z5856 2.30 0.0021 4.54 0.0023 
Bnp4 Z2256 23.34 0.0042 7.27 0.0027 
Bnp5 Z5890 5.49 0.0014 1.76 0.0021 
Bnp6 L7020 6.59 0.0015 4.47 0.0016 
Bnp7 Z3635 18.90 0.0330 4.28 0.0035 
Bnp8 Z3182 4.64 0.0003 3.60 0.0007 
Bnp9 Z4625 10.03 0.0002 4.12 0.0039 
Bnp10 Z0472 3.26 0.0023 2.91 0.0017 
Bnp11 Z1555 9.97 0.0036 4.77 0.0011 
Bnp12 Z2436 8.03 0.0002 1.74 0.0020 
Bnp13 Z1921 5.59 0.0005 13.63 0.0033 
Bnp14 Z0151 8.40 0.0008 8.73 0.0053 
Bnp15 Z1456/57 12.67 0.0011 11.15 0.0039 
Bnp16 Z3592 4.19 0.0019 4.96 0.0010 
Bnp17 Z2026 8.46 0.0000 7.33 0.0029 
Bnp18 L7049 3.95 0.0059 9.64 0.0013 
Bnp19 Z3497 2.56 0.0023 11.54 0.0018 
Bnp20 Z4099 8.86 0.0133 12.16 0.0011 
Bnp21 Z5049 10.75 0.0081 6.66 0.0057 
Bnp22 Z3199/200 4.53 0.0030 8.06 0.0019 
Bnp23 Z5050 3.68 0.0039 8.90 0.0011 
Bnp24 Z2163 11.39 0.0014 8.00 0.0068 
 
Wild type (WT), biofilm-negative phenotype mutants (Bnp1-Bnp51), 
miniTn5Km2 biofilm-positive phenotype mutant (M1). 
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Table S3.1. (continued) 
Strain 
Locus 
Tag 
% 
Adherence 
HEp2 cells p - Values 
% 
Adherence 
T84 cells p - Values 
Bnp25 Z1675/ 76 4.81 0.0049 14.18 0.0179 
Bnp26 Z2086 7.53 0.0018 11.96 0.0068 
Bnp27 Z3660 7.56 0.0017 8.74 0.0056 
Bnp28 Z5214 14.37 0.0035 4.61 0.0078 
Bnp29 Z5051 9.58 0.0113 3.83 0.0044 
Bnp30 Z1670 5.83 0.0037 2.89 0.0045 
Bnp31 Z1212/ 13 2.66 0.0012 4.57 0.0037 
Bnp32 Z1213 3.54 0.0042 2.56 0.0031 
Bnp33 Z2012/ 13 6.81 0.0037 0.38 0.0023 
Bnp34 Z3195/ 96 5.18 0.0014 4.38 0.0046 
Bnp35 Z0340 9.74 0.0082 2.76 0.0032 
Bnp36 Z1676 9.91 0.0084 4.38 0.0022 
Bnp37 Z0905 8.71 0.0133 9.51 0.0100 
Bnp38 Z5054 7.75 0.0021 3.51 0.0036 
Bnp39 Z4328 3.75 0.0022 4.67 0.0064 
Bnp40 Z0700 8.31 0.0011 7.11 0.0061 
Bnp41 Z3918 5.48 0.0017 10.54 0.0119 
Bnp42 Z1494 4.33 0.0020 4.70 0.0027 
Bnp43 Z0021 5.05 0.0019 4.60 0.0028 
Bnp44 L7047/48 9.40 0.0016 7.08 0.0078 
Bnp45 Z1977 8.29 0.0007 4.98 0.0055 
Bnp46 Z0408/ 09 5.03 0.0008 4.71 0.0034 
Bnp47 Z3197 13.70 0.0081 8.76 0.0199 
Bnp48 Z0904 3.05 0.0002 6.94 0.0050 
Bnp49 Z4327 6.40 0.0021 4.00 0.0029 
Bnp50 Z5392 9.54 0.0021 8.29 0.0085 
Bnp51 Z1177/ 78 7.62 0.0012 5.48 0.0027 
WT  69.31  73.92  
M1  67.70 0.5387 66.48 0.1543 
∆espAB  8.41 0.0049 3.24 0.0031 
∆eae  4.42 0.0003 4.30 0.0029 
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Fig. S3.1. Quantification of biofilms by Escherichia coli O157:H7 on various abiotic surfaces.  
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Fig. S3.2. High-resolution images (X60) of wild-type Escherichia coli O157:H7 adhering to T84 and HEp2 cells. 
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CHAPTER 4. INSIGHTS INTO THE FUNCTION OF CRYPTIC PHAGE 
GENE Z2086 USING MUTATIONAL AND TRANSCRIPTOME 
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Abstract 
In these studies we confirmed the involvement of phage genes Z0304, Z1457, Z1494 and 
Z2086 in biofilm formation in the human food-borne pathogen Escherichia coli O157:H7, 
and gained insight into the function of the putative phage encoded regulator Z2086. Whole 
genome transcriptional analysis identified 363 genes (p < 0.01) that were differentially-
regulated between wild type and ∆Z2085/6, of which 357 genes (98.3%) were down-
regulated in ∆Z2085/6 while 6 genes (1.6%) were up-regulated. The down-regulated genes 
included 213 that were phage-encoded and 16 that were encoded on the virulence plasmid 
p0157 including stx2, type II secretory genes, and espP. Metabolic, ribosomal, structural, 
virulence-related, biofilm-forming, and adherence-related genes were differentially-regulated 
in the Z2086 deletion mutant when compared with the wild type strain showing that 
prophage genes in E. coli O157:H7 may play important roles in virulence, as well as biofilm 
formation. These results suggest that Z2086 is a global regulator and its targets are not 
limited to prophage genes. 
 
Introduction 
Enterohemorrhagic Escherichia coli O157:H7 is an important foodborne human pathogen 
that is involved in both sporadic cases and outbreaks in developed nations around the world 
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including the United States, the United Kingdom and Japan (14). Escherichia coli O157:H7 
causes a spectrum of illnesses ranging from mild, self-limiting diarrhea to hemorrhagic 
colitis to lethal hemolytic uremic syndrome characterized by thrombotic microangiopathy, 
haemolytic anaemia and acute renal failure (30, 31). Apart from causing a significant number 
of clinical outbreaks, this organism is highly problematic in the food industry and is a major 
economic burden in terms of food recalls due to product contamination as described in the 
Food Safety and Inspection Service web page 
(http://www.fsis.usda.gov/FSIS_Recalls/index.asp).  
Escherichia coli O157:H7 has the capability to form biofilms on inert surfaces such as 
stainless steel, glass and plastic surfaces (7). Biofilms are highly complex, dynamic, 
heterogeneous fluid structures that constantly fluctuate over time and space (28). The 
genetics behind biofilm formation is highly complex and involves several genes and genetic 
pathways (12). Biofilms are thought to be involved in the persistence of this organism 
outside the host environment. Escherichia coli O157:H7 biofilms pose significant risks to a 
variety of food products through continuous contamination (16, 24, 38). To reduce the risks 
that biofilms pose to the food industry and to protect the public health, further research is 
needed to understand biofilm formation.  
The E. coli O157:H7 strain EDL933 chromosome is 5.5 megabases in length and encodes 
5416 genes (20). This organism also consists of a large 92 kb virulence plasmid called pO157 
containing another 100 open reading frames (ORFs) (3). Comparison of the E. coli O157:H7 
EDL933 genome sequence with the E. coli K12 strain MG1655 K12 genome sequence shows 
that the two strains share a common backbone of 4.1 mega bases (20). The regions that are 
unique to the O157 genome are primarily O-islands and comprise 1.34 mega bases coding for 
1,387 genes. Of the 1,387 O-island genes, 40% have assigned function and 24% genes are in 
18 prophage or prophage-like bacteriophage related clusters (20). Only BP-933 phage is 
shown to be complete and infectious while all others designated as CP-933 are cryptic. The 
phages are highly mobile genetic elements and play an important role in evolution and 
genomic variability (2). In E. coli O157:H7, the phage genes encode numerous genes related 
to virulence such as the Shiga toxin 1 and 2 (21, 32).  
In earlier studies focused on the identification of genes involved in biofilm formation of 
E. coli O157:H7 strain EDL933, we isolated mutations in phage encoded genes and showed 
that they are involved either directly or indirectly in biofilm formation of this organism (22). 
In this study, we confirmed the involvement of phage genes in biofilm formation, and 
through whole genome microarray analysis, gained insight into the function of the putative 
phage encoded regulator (Z2086). We show that phage encoded genes, metabolic, ribosomal, 
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structural, virulence, biofilm, and adherence related genes are differentially regulated in a 
Z2086 deletion mutant when compared with the wild type strain showing that prophage 
genes in E. coli O157:H7 play important roles in virulence as well as biofilm formation.  
  
Materials and Methods 
Bacteria. The strains used in this study are shown in Table 1. A spontaneous nalidixic 
acid-resistant mutant of E. coli O157:H7 strain EDL933 was used as the wild type control. 
For all biofilm assays, the cultures were grown in Luria-Bertani (LB) broth for 24 h at 30 °C 
under stationary conditions. For the microarray analysis, the cultures were grown in LB broth 
with no antibiotics at 37 °C with shaking at 200 rpm for 4 h when they enter the early log 
phase. For all other experiments, the cultures were grown overnight in LB broth at 37 °C 
with shaking at 200 rpm. Antibiotic concentrations were ampicillin (100 µg/ml), kanamycin 
(50 µg/ml) and nalidixic acid (20 µg/ml) except where noted. All antibiotics were obtained 
from Sigma Chemical Co. (St. Louis, MO). 
Assay for biofilm formation. The quantitative biofilm assay was performed in 12 x 75 
mm polystyrene tubes (Fisher) as described (22). An overnight culture of each bacterial 
sample, plus controls, was diluted 1:100 into 2 ml of LB broth and incubated at 30 °C under 
stationary conditions for 24 h. The end point growth was determined by measuring the 
optical density at 600 nm. The tubes were then rinsed twice with water and stained with 2.5 
ml of 0.01% crystal violet for 20 min. After washing three times with water, tubes were air 
dried and de-stained with 2.5 ml of 80% ethyl alcohol for 15 min. The tubes were vortexed, 
100 µl was transferred to a new 96 well plate, and the optical density was measured at 595 
nm using a Spectra MAX 190 spectrophotometer (Molecular Devices, Union City, CA). The 
optical density measurements were used as a measure of relative amounts of biofilms formed. 
All experiments were performed in triplicate. 
Construction of deletion mutants. To generate deletion mutations, a one-step gene 
inactivation method was used (6). The temperature-sensitive plasmid pRedET (Gene Bridges, 
Dresden, Germany) encoding lambda red recombinase was transformed into E. coli O157:H7 
EDL933. The kanamycin resistance gene was amplified from pKD4 (6) using primer sets that 
are shown in Table 4.2. Each primer sequence contained target homologous sequence, as 
well as sequence for amplification of the kanamycin gene. The products of this reaction were 
electroporated (2000V, 129 ohms using a BTX electro cell manipulator model 600, Harvard 
Apparatus, Holliston, MA) into E. coli O157:H7 EDL933+pRedET, previously induced with 
0.4% L-arabinose for 1 h. The cells were incubated in SOC media (20 g tryptone, 5 g yeast 
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extract, 2 g MgCl2•6H2O, 2.5 g MgSO4•7H2O, 3.6 g glucose per liter, pH 7.5) for 1 h and 
then plated on selective media (LB supplemented with 25 µg/ml of kanamycin) at 37 °C.  
Confirmation of mutant constructions and determination of the locations of the 
kanamycin gene insertions were done by PCR using the test primers. The primer Test F has 
homology within the kanamycin cassette and primers test R have homology immediately 
downstream of the gene sequences that were being replaced (Table 4.2). To ensure curation 
of the temperature sensitive pRedET plasmid, confirmed mutants were first grown at 42 °C 
for 2 h, and then plated on LB plates and incubated over night at 37 °C. The isolated colonies 
were picked and screened for kanamycin resistance and ampicillin sensitivity. 
 
Table 4.1. E. coli strains and plasmids. 
 
Strain or 
Plasmid 
Genotype or Description* Source 
Strains   
BW19795 
RP4-2-tet::Mu-1kan::Tn7 integrant/srlC300 creC510 hsdR17 
endA1 zbf-5 uidA(MluI)::pir+ thi G. Phillips 
DH5 
F– 80lacZM15 (lacZYA-argF)U169 recA1 endA1 hsdR17 (rK– 
mK+) phoA supE44 – thi-1 gyrA96 relA1 Invitrogen 
ISM1536 E. coli O157:H7 EDL933 N. Cornick 
 ISM1191 E. coli O157 :H7 EDL933, Nalr (22) 
 ISM1888 ISM1191+miniTn5Km2 in Z1921 Nalr, Kanr  
 ISM1890 ISM1191+miniTn5Km2 in Z1456/57 Nalr, Kanr  
 ISM1901 ISM1191+miniTn5Km2 in Z2086 Nalr, Kanr  
 ISM1910 ISM1191+miniTn5Km2 in Z0340 Nalr, Kanr  
 ISM1910 ISM1191+miniTn5Km2 in Z1494 Nalr, Kanr  
 ISM1226 ISM1536 ΔZ0340 Kanr This study 
 ISM1228 ISM1536 ΔZ1457 Kanr This study 
 ISM1229 ISM1536 ΔZ1495 Kanr This study 
 ISM1206 ISM1536 ΔZ2085/6 Kanr This study 
Plasmids   
 pKD4 Derivative of pANTSγ that contains an FRT-flanked Kanr gene 
from pCP15  
 pRedET Derivative of pSC101, Ampr, temperature sensitive, carries 
lambda red recombinase  Gene Bridges 
* Nalr, nalidixic acid resistant; Kanr, kanamycin resistant; Ampr, ampicillin resistant. 
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Table 4.2. Primers used in this study 
 
Primer Sequence (5’-3’) 
Recombineering Primers  
Z0340-F GTGACTAGTTATTCAAACTTTTCCAATCAAATAAAGAAA 
CCATCAATAATAAATTCGATTGTGTAGGCTGGAGCTGCTTC 
Z0340-R 
 
TTATTTTTGAATTGATTTAAACATCCCATCGAGTGTAATTT 
ATTTATGTCGGTTTTCTTCATATGAATATCCTCCTTA 
Z0340 test R TTATTTTTGAATTGATTTAAAC 
Z1457-F 
 
AACTTAACAAACCCAGCTTCGGCTGGGTTTTTTATTGCTGA 
ATTTTCAATGTGAGAGGACTGTGTAGGCTGGAGCTGCTTC 
Z1457-R 
 
AGAATGCCGGGTGAAACCATTCCTTACAGATTTTGCATTT 
CCTTCGCGCTGGTTTAGCCACATATGAATATCCTCCTTA 
Z1457 test R GGGCAGCACCACCACTGATTTG 
Z1494-F 
 
GTGCTGTTGCTGGAGCAGTAATTGGCGGCATTGCTGGTTCT 
TTGTTTTAAGGAGTGGTGATGTGTAGGCTGGAGCTGCTTC 
Z1494-R 
 
ATAAAAAAACCCGGCACAATGGCCGGGCATCAGGAAATG 
GTATTAATGGAATATCGTGAACATATGAATATCCTCCTTA 
Z1494 test R CTGAATAGGCCATACAGACTCC 
Z1495-F 
 
AACAGAATTACGCCCAGTAATTCACGATATTCCATTAATAC 
CATTTCCTGTGTGTAGGCTGGAGCTGCTTC 
Z1495-R 
 
AAGATTATTTTGCTCATAAATGCTATTCGCCATTACCGTTG 
CTGCTTCAGCCATATGAATATCCTCCTTA 
Z1495 test R TCAGATCGCCTAATAACATATC 
Z2085-86-F 
 
GTGTTATGGGTGGATTCTCTGTATCCGGCGTTAATTGTTAA 
CTGGTTAACGTCACCTGGATGTGTAGGCTGGAGCTGCTTC 
Z2085-86-R 
 
TCATTCTGCCATTGCGCAAGATGGTTGCGGTTTTTCTTCA 
TCATTTTCTTCTTCTGTTTCCATATGAATATCCTCCTTA 
Z2085-86 test R TCATTCTGCCATTGCGCAAGAT 
Test F TGTGTAGGCTGGAGCTGCTTC 
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Table 4.2. (continued) 
 
Primer Sequence (5’-3’) 
RT-PCR Primers  
espP - L7020F ACGCTGTTTACAGGAGGGATCACA 
espP - L7020R TCAGCACCGTTCTCTATGGTTGCT 
csgD  - Z1673F TGAAGATTACCCGTACCGCGACAT 
csgD  - Z1673R TGACAACGCGTTCTTGATCCTCCA 
Z1921F ATGAAGATGCAGGCCGAAGGGATA 
Z1921R TCAGTTCCTTCAGCAAGTGCTCCT 
etpL - L7041F ACATCTGCAACAGTCGACGGGTAA 
etpL - L7041R TGCCTGTAAGCGTATCGTTGAGGT 
L7027F TTGGTATGGTACTGGCTGAAGCGT 
L7027R ACAGCGTCCCTGTCACATTCTTCT 
agp - Z1421F AAAGTCGGCAACTCGCTGGTAGAT 
agp -  Z1421R ACACCTTCCACTGCTGGTCAGATT 
 
 
 
Preparation of cultures and RNA isolation. To obtain the cultures for microarray 
analysis, overnight cultures were diluted to 1 in 100 dilution (10 mL of LB broth in 100-mL 
Erlenmeyer flasks was inoculated with 100 µl of an overnight culture) and were incubated at 
37 °C with shaking at 200 rpm for 4 h. Two milliliter of the culture was quickly mixed with 4 
ml RNAprotect Bacteria Reagent (Qiagen, Valencia, CA) by vortexing for 15 sec. The 
samples were incubated at room temperature for 5 min and pelleted by centrifugation at 5000 
x g for 10 min. The supernatant was aspirated and pellets were stored at -70 °C until the 
RNA was isolated. 
The RNA isolation and preparation was conducted as described previously (5). Total 
RNA was isolated using the RNeasy Mini Kit (Qiagen) following the manufacturer’s lysis 
and digestion kit protocol. Each 100 µl sample was then treated with 4 µl of DNAse (Turbo 
DNAse, Ambion, Austin, TX) for 35 min at 37 °C. Samples were then purified and 
concentrated using Microcon YM-30 columns (Millipore, Billerica, MA). The quantity of the 
RNA samples was determined using a Nanodrop spectrophotometer (Wilmington, DE), and 
the quality of the RNA was assessed using a 2100 Bioanalyzer (Agilent Technologies, Santa 
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Clara, CA). Only samples having an RNA integrity number of 8.9 and higher were used for 
cDNA synthesis (27).  
Double stranded cDNA synthesis. The first strand cDNA was synthesized using 
superscript II reverse transcriptase (Invitrogen) and random hexamers following the 
manufacturer’s protocol. The reaction was done at 42 °C for 1 h.  For the second strand 
synthesis, the above mixture from the first stand synthesis was briefly centrifuged and the 
following reagents (NEB, Ipswich, MA) were added in order: 87.5 µl of 
diethylpyrocarbonate-treated water, 30 µl of DNA ligase buffer, 3 µl of 10 mM dNTP mix, 5 
units of DNA ligase, 40 units of DNA polymerase I and 2.5 units of RNase. The reaction was 
incubated for 2 h at 16 °C. To the above reaction mixture, 10 units of T4 DNA polymerase 
was then added and incubated for another 5 min at 16 °C. The samples were then stored at -
20 °C after adding 10 µl of 0.5 M EDTA. The RNase cleanup and cDNA preparation was 
performed according to the Roche NimbleGen Array user’s guide protocol. The double 
stranded cDNA was quantified and the quality assessed as before. Labeling, hybridization 
and scanning were performed by Roche NimbleGen (Madison, WI). 
Microarrays and data analysis. The microarray analysis was performed using a 
NimbleGen array. The E. coli O157:H7 array was designed as a 4-plex format (4X72K) with 
72,000 probes per array. Each slide contains 4 arrays and allows four independent samples to 
be hybridized on each slide. Four E. coli O157:H7 EDL933 ∆Z2085/6 mutant RNA samples 
and four E. coli O157:H7 EDL933 wild type samples were analyzed. Hybridization was 
performed so that each slide received two mutant and 2 wild type samples to reduce slide-to-
slide variation. The background corrected data obtained from NimbleGen was analyzed as 
described previously (10). Briefly, the data were normalized by Robust Multiarray Averages 
and a separate linear mixed model analysis was conducted for each probe sequence (37). To 
determine the differential expression between control and treatment, a student t-test was 
performed for each probe. The p-values were then used to estimate the q-values using the 
method of Storey & Tibshirani (29). Fold changes of gene expression between control and 
treatment were estimated by taking the inverse natural logarithm of the estimated mean 
treatment difference from the linear mixed model analyses. 
Semi-quantitative real-time PCR (qRT-PCR).  To validate the data obtained from the 
microarray analysis, qRT-PCR was performed on 6 genes (L7020, L7027, L7041, Z1673, 
Z1921 and Z2086). Gene Z1421 was used as a reference gene for with-in sample 
normalization of mRNA abundance. The same RNA samples used for the microarray 
analysis were used for qRT-PCR. The SensiMix SYBR No-ROX One-Step Kit (Bioline USA 
inc, Tauton, MA) was used on the Mx3005P QPCR System with MxPro 4.1 software 
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(Stratagene, La Jolla, CA). The reaction was performed in a 96 well plate with a reaction 
volumes of 15 µl per well (3.8 µl of water, 7.5 µl 2x reaction mix, 0.6 µl of each primer at 2.5 
µM, 5 µl of sample RNA at a concentration of 4 ng/µl) using the following thermal cycling 
conditions: a cDNA synthesis step at 50 ºC for 30 min; an RT deactivation/Taq activation 
step at 95 ºC for 10 min; 40 PCR cycles of 95 ºC for 30 sec, 60 ºC for 30 sec, and 70 ºC for 
30 sec; and a melt curve step of 95 ºC for 10 min, 55 ºC for 30 sec, and 95 ºC for 30 sec. 
Initially a test plate was run with all the test and reference primer sets to test the inhibition 
and specificity. A mixture of equal volumes of all RNA samples (4 wild type and 4 
∆Z2085/6) of 4 ng/µl was used as a template in a test plate. This plate was arranged so that 
each primer pair was tested with 8 dilutions (1:3 serial dilution for an in-well dilution of 1:9), 
and the linear regression and the R2 values were used to decide the best dilutions to use for 
sample plates. The sample plates were organized so that each plate contained all the 
biological replicates (3 dilutions each) for a particular gene and the reference gene. Once the 
Ct values were obtained, all the Ct values were averaged for the biological replicates for each 
dilution and corrected for efficiency of amplification and the dilution factor (Ct*). The fold 
change was calculated using the following formula: 2 (Ct*of WT reference gene - Ct*of M reference gene) / 
2(Ct*of WT test gene - Ct*of M test gene) (9) 
 
Results 
Role of phage encoded genes in biofilm formation. In our previous study (22), we 
constructed and screened 11,000 mini-Tn5 transposon insertion mutants of E. coli O157:H7 
EDL933, identifying fifty-one distinct genes/intergenic regions that are involved either 
directly or indirectly with a biofilm-negative phenotype (Bnp). Within this set of fifty-one 
Bnp genes, there were five genes/intergenic regions that are phage encoded, Z0304, Z1457, 
Z1494, Z1921 and Z2086 (22). The genes Z0304, Z1921 and Z2086 are encoded on 
prophage CP-933; Z1457 and Z1494 are encoded on bacteriophage BP-933. The genes 
Z0340, Z1921 and Z1494 are hypothetical, gene Z1457 is a putative DNA binding protein, 
and gene Z2086 is related to the division inhibition protein DicB and is considered a putative 
regulator.  
To confirm the linkage between specific phage genes and the biofilm phenotype, in-
frame deletion mutants were constructed in genes Z0304, Z1457, Z1494 and Z2086 by 
recombineering, four of the phage-encoded genes that were biofilm-negative during 
screening. Due to their small size and difficulty in getting gene-specific deletion mutants, we 
deleted genes Z2086 and Z2085 together. The deletion mutant strains ∆Z0304, ∆Z1457, 
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∆Z1494 and ∆Z2085/6 were then compared for their growth and biofilm phenotype using a 
quantitative tube assay with the corresponding mini-Tn5 insertion mutants Tn5Z0304, 
Tn5Z1457, Tn5Z1494 and Tn5Z2086, respectively. Three of the deletion mutants; ∆Z0304 
∆Z1457 and ∆Z2085/6 behaved in similar manner as their corresponding mini-Tn5 insertion 
mutants Tn5Z0304, Tn5Z1457, and Tn5Z2086 (Fig. 1). One of the deletion mutants, 
∆Z1494, showed no difference in biofilm formation when compared to wild type, but their 
corresponding mini-Tn5km2 insertion mutant (Tn5Z1494) was deficient in biofilm 
formation. The gene Z1494 is a part of an operon, so we hypothesized that the inconsistency 
was due to a polarity effect of the transposon insertion, which we showed previously in the 
hly operon on the pO157 plasmid (22). To test this hypothesis, we constructed a deletion 
mutation of the downstream gene of Z1494 (∆Z1495) and tested it for the biofilm phenotype. 
Our quantitative assay showed that the deletion of Z1495 caused the lack of biofilm 
phenotype (Fig. 1) confirming our hypothesis.  
     
 
 
 
            
 
Figure 4.1. Comparing growth and biofilm formation in E. coli O157:H7 EDL933 
mutants. Growth is shown by the white bars with OD595 readings. Biofilm formation is 
shown by black bars with OD600 readings. ∆ indicates mutants constructed by deleting the 
indicated gene. Tn indicates transposon mutant selected for loss of biofilm formation. 
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Microarray expression profiling. One of the phage-encoded genes identified in our 
biofilm negative screen, Z2086, has a putative regulator function. We sought to confirm its 
role as a regulator and identify its targets for regulation. This was done by comparing the 
transcriptional profile of a strain of E. coli O157:H7 EDL933 carrying a deletion of Z2086 
with the wild type strain using microarray analysis. The array contained 5224 E. coli 
O157:H7 ORFs (NimbleGen). Statistical analysis showed 363 genes that were differentially 
expressed in ∆Z2085/6 when compared to the wild type strain (p < 0.01), 357 (98.3%) were 
down-regulated and 6 (1.6%) were up-regulated (Table S1). The false discovery rate was less 
than 0.5%. All of the up-regulated genes were associated with the curli operon (Table S1). Of 
the 357 down-regulated genes, 213 (59.6%) were phage-encoded and 16 (4.5%) were 
plasmid pO157-encoded (Table 4.3). One hundred and twenty two genes have assigned 
function, and the rest are either hypothetical or have putative unconfirmed functions. Eleven 
of the 356 down-regulated genes were previously shown to be involved either directly or 
indirectly in biofilm formation in E. coli O157:H7 (Table 4.3).  There were 20 differentially 
regulated genes that are involved in virulence such as shiga like toxin 2 katP, type II 
secretion proteins, etc. (Table 4.3). Among the other differentially regulated genes, there 
were genes involved in metabolic pathways, genes that encode ABC transporters, ribosomal 
proteins and DNA binding proteins (Table S4.1). 
qRT-PCR results. Transcription of 5 of the differentially-transcribed genes shown by 
the microarray analysis (L7020, L7027, L7041, Z1673 and Z1921) were confirmed by qRT-
PCR. Transcription levels of these genes by qRT-PCR correlated with expression levels 
identified in the microarray experiments in terms of direction of differential expression. 
Validation of the microarray data by qRT-PCR is shown in Fig. 2. In every case, the degree 
of transcriptional difference as measured by qRT-PCR was greater than that measured by 
microarray as has been described previously (18). Even though Z2086 was deleted, the gene 
did not show transcriptional differences in our microarray analysis, but Z2086 has high 
homology with sequences elsewhere in the genome. In microarray hybridization those 
cDNAs could bind to homologous regions and give false results. By qRT-PCR we showed a 
distinct reduction in the Z2086 product of the deletion mutant compared to wild type, but we 
failed to demonstrate a complete loss of product, further substantiating our hypothesis that 
closely homologous sequences elsewhere in the chromosome were binding to our array and 
causing a false negative reaction.  
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Table 4.3. Differentially expressed plasmid genes, biofilm/adherence genes and virulence genes 
 
Locus Gene ID Function *FC p-Value q-Value 
L7017a c katP EHEC-catalase/peroxidase 1.6 0.007545 0.003248 
L7020 a b c espP putative exoprotein precursor 1.9 4.78E-05 5.39E-05 
L7026 a  hypothetical protein 1.5 0.009682 0.003996 
L7027 a  hypothetical protein 1.6 0.009514 0.003938 
L7031 a  hypothetical protein 1.6 0.001025 0.000665 
L7036 a b c etpG type II secretion protein 1.6 8.53E-06 1.24E-05 
L7037 a b c etpH type II secretion protein 1.7 2.66E-06 4.53E-06 
L7038 a b c etpI type II secretion protein 1.5 0.008844 0.003702 
L7039 a b c etpJ type II secretion protein 1.5 0.002961 0.001514 
L7041 a b c etpL type II secretion protein 1.6 0.00014 0.000138 
L7042 a b c etpM type II secretion protein 1.6 0.002971 0.001514 
L7043 a b c etpN type II secretion protein 1.8 0.001677 0.000971 
L7044 a b c etpO type II secretion protein 1.7 5.60E-05 6.11E-05 
L7045 a  hypothetical protein 1.7 0.000563 0.000402 
L7046 a  hypothetical protein 1.6 0.004656 0.002208 
L7100 a ypt2 hypothetical protein 1.5 0.004283 0.002044 
Z1456 b  unknown protein encoded by BP-933W 1.6 0.002346 0.001267 
Z1457 b  putative DNA-binding protein of BP-933W 1.7 0.002762 0.001432 
Z1494 b  unknown protein encoded by BP-933W 1.9 0.000168 0.000158 
Z1670 b  csgG curli assembly/transport component -1.6 0.00055 0.000396 
Z1671 b  csgF curli assembly protein CsgF -1.8 4.00E-12 3.00E-11 
Z1672 b  csgE curli assembly protein CsgE -1.7 4.61E-08 1.25E-07 
Z1673 b  csgD DNA-binding transcriptional regulator  -1.7 2.22E-08 6.65E-08 
Z1675 b  csgB minor curlin subunit precursor -1.5 9.02E-07 1.76E-06 
Z1676 b  csgA cryptic major curlin subunit -1.4 3.09E-05 3.85E-05 
Z1921 b   unknown protein encoded by CP-933X 1.7 1.69E-05 2.28E-05 
 
a Genes on pO157. 
b Genes previously shown to be involved in biofilm formation or cellular adherence. 
c Genes previously shown to be involved in pathogenesis and virulence. 
* FC-Fold Change-Positive values indicate down-regulation and negative values indicate up-
regulation in ∆Z2085/6 
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Table 4.3. (continued) 
Locus Gene ID Function *FC p-Value q-Value 
Z1464 c stx2A shiga-like toxin II A encoded by  BP-933W 2.0 2.99E-07 6.50E-07 
Z1465 c stx2B shiga-like toxin II B encoded by BP-933W 1.9 1.89E-08 5.79E-08 
Z2761 c katE hydroperoxidase II / catalase 2.4 1.64E-06 2.95E-06 
Z5105 b c espB secreted protein EspB 1.7 0.002351 0.001267 
Z5106 b c espD secreted protein EspD 2.0 6.22E-06 9.42E-06 
Z5107 b c espA secreted protein EspA 2.1 0.000243 0.000207 
 
 
               
Figure 4.2. qRT-PCR analysis of selected genes in wild type compared to ∆Z2086. The 
indicated genes were targeted for qRT-PCR analysis by comparing to wild type cells grown 
under identical conditions (see Materials and Methods). Z7020 = EspP, a putative exoprotein 
precursor; L7027 = hypothetical protein; L7041 = EtpL, a member of the type II secretion 
apparatus; 1673 = CsgD a DNA-binding regulator for the curli operon; Z1921 = hypothetical 
protein encoded by phage CP-933X; Z2086 = putative CP-933X phage regulator. 
 
Discussion 
The remnants of prophage are part of the genomes of almost all the bacteria (4). Apart 
from participating in the evolution of the organism, the prophagic elements often carry 
virulence attributes and can be involved in the physiology of the organism. In E. coli 
O157:H7 EDL933, there are 18 regions of known bacteriophages (20). Only the phage region 
that encodes the shiga-like toxin, BP-933W, is known to be capable of lytic growth and 
production of infectious particles (21). The other phage regions, CP-933, lack the full 
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complement of functional genes and are considered cryptic. They vary in size from 7.5 kb 
(CP-933L) to 61.6 kb (BP-933W) and occupy 5% of the E. coli O157:H7 total genome (20). 
Despite the abundance of prophage genes, their role in the physiology of E. coli O157:H7 
remains undocumented. In several organisms, such as Pseudomonas aeruginosa and E. coli 
K12, phage genes have been shown to be induced during biofilm formation (8, 36). 
Additionally, deletion of phage clusters in E. coli K12 supported the role of phage genes in 
biofilm formation and antibiotic resistance (33). There are also some studies that showed a 
linkage between prophage excision and biofilm formation in Pseudomonas (34, 35). 
However, there are no conclusive studies regarding the direct participation of prophage gene 
products in biofilm formation. In this study we provide evidence for the involvement of 
cryptic phage genes in biofilm formation in strain EDL933. Also, upon deletion of Z2086, 
numerous phage-related genes are repressed showing that it is a global regulator and not 
limited to prophage genes. While most of the genes controlled by Z2086 are prophage genes, 
there are some notable exceptions. 
Apart from phage genes, genes encoded on pO157 are also repressed such as the etp 
operon, Type II secretory genes and espP. In pO157 at the 5ʹ′ end of the EHEC hemolysin 
operon there is a functional type II secretion apparatus consisting of 13 open reading frames 
designated etpC to etpO (26). Since its discovery, this system has been implicated in several 
functions related to adherence and intestinal colonization (11). Loss of Z2086 results in 
down-regulation of the operon suggesting either a direct or indirect control. The reduction in 
adherence to epithelial cells and biofilm formation of ∆Z2085/6 may be due to the down 
regulation of this system (23). The type II secretory system secretes effectors such as adfO 
(13), yodA (13) and stcE (17). All of these effectors have been shown to be involved either in 
adherence or biofilm formation. The zinc metalloprotease, stcE, mediates increased intimate 
adherence by cleaving mucins and glycocalyx matrix and by reduction of the mucous 
glycocalyx cell surface barrier, allowing a closer interaction between the bacterium and host 
(11). 
In this study several virulence- and biofilm-related genes were down-regulated 
suggesting a role for Z2086 in the virulence of E. coli O157:H7. The repression of virulence 
genes such as stx2 and the etp operon in the absence of Z2086 (Table 3) indicates there 
should be reduced virulence in a Z2086 minus background strain of E. coli O157:H7. This 
requires further confirmation. This study also showed down-regulation of several previously 
known biofilm-associated and adherence genes (Table 3). These results suggest that Z2086 is 
a global activator for most genes it regulates. The one exception, the curli genes, are up-
regulated in the mutant strain suggesting that the relationship between curli pili formation, 
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biofilms and tissue adherence is complex. Curli pili are required for biofilm formation and 
tissue adherence (1, 15, 19, 23, 25), but how Z2086 helps to control curli expression is not 
understood and requires further study.  
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CHAPTER 5. DISCUSSION 
 
General Discussion 
Escherichia coli is one of the many groups of bacteria that live in the intestines of healthy 
humans and most warm-blooded animals and helps to maintain the balance of normal 
intestinal flora against pathogens and synthesize some vitamins such as vitamin K and biotin. 
However, some of the E. coli strains such as E. coli O157:H7 have acquired virulence 
attributes and become pathogenic. Escherichia coli O157:H7 is an important cause of 
bacterial diarrhea. It can be differentiated from other E. coli by the production of a potent 
shiga toxin that damages the lining of the intestinal wall causing bloody diarrhea. In 1982, E. 
coli O157:H7 was initially identified as the cause of bloody diarrhea from eating hamburger 
meat contaminated with the bacteria. Since that time, outbreaks of E. coli O157:H7 have 
been associated with other types of foods such as spinach, lettuce, sprouts, salami, and 
drinking water, and thus is a continual problem in both the health and food industries. While 
there has been substantial research performed with E. coli O157:H7 regarding its 
pathogenesis, there remains a need for further study in the area of its persistence and 
dissemination in the environment to properly control the contamination and restrict the 
outbreaks of human disease. There is a prevalent hypothesis in the sceintific community that 
biofilm formation is one of the reasons for the high persistence of this organism in the 
environment, but we also contend that biofilm formation is critical to persistence in cattle, the 
major reservoir for E. coli O157:H7.  
In this dissertation we focused on obtaining a global picture of the genetics of the early 
stages of biofilm formation in E. coli O157:H7. We took advantage of the strong biofilm 
forming strain EDL933 that was isolated from a 1982 outbreak involving undercooked 
hamburgers. These studies combined high throughput techniques such as screening a large 
mutant transposon library using a microtiter plate assay for biofilm formation and microarray 
analysis.  
In the first study identifying the genes involved in biofilm formation, a reverse genetic 
approach was used. A large mutant library of 11,000 random mutants was generated using a 
mini-Tn5 transposon. The screening of the library with the high throughput microtiter plate 
assay was informative. We followed the identification of biofilm-negative mutants with the 
sequencing across the Tn5 insertion sites, which revealed 51 biofilm-negative phenotpye 
(Bnp) genes that are involved either in the formation of biofilms either directly by the 
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production of EPS and altering the surface structures or indirectly as regulators, transporters, 
etc. The high number of genes involved is not a surprise considering the complexity and 
dynamism of the biofilms. At that point, the focus of the research shifted to specific groups 
of Bnp genes that are of special interest, a set of genes on the virulence plasmid pO157 and 
several cryptic phage encoded genes in the genome. These genes were interesting because 
they were potentially linked to either virulence or would reveal roles for cryptic phage in E. 
coli O157:H7. We hypothesized that these studies would reveal something fundamental 
about the formation of biofilms of this pathogen and maybe about intestinal biofilm 
formation. By confirming the importance of plasmid genes ehxD and espP in biofilm 
formation through deletion and complementation studies, we were able to gain insight into 
the potential pathways for the transport of biofilm substrates.  
Biofilm formation on biotic surfaces such as epithelial cells is thought to be important in 
the pathogenesis of this pathogen. We hypothesized that biofilms formed inside the intestine 
of cattle are responsible for the high persistence and the intermittent shedding in the 
ruminants that are the reservoirs of this organism. This persistence is the ultimate cause of 
food contamination. In an attempt to model the cellular interactions of the intestinal mucosa, 
we chose two types of human epithelial-like cells to study, HEp2, a human laryngeal 
epidermoid carcinoma cell line that forms monolayers in culture, and T84, a human colonic 
epithelial cell line. Cell adherence studies with T84 cells initially showed that our plasmid 
encoded Bnp mutant ehxD lacked the cellular adherence capabilities when compared to the 
wild type strain. This prompted us to examine all of our Bnp plasmid mutants for adherence 
to that cell type. 
Biofilms can play an important role in maintaining a pathogen outside a host, offering it a 
selective advantage under adverse conditions. The question also remains whether biofilms 
can play a role in the pathogenic process itself apart from contributing to adherence to 
implanted abiotic or engineered surfaces. While biofilm architecture and composition in 
mature biofilms has been the subject of numerous studies by the scientific community, little 
attention has been given to studies of biofilm formation in relation to direct interactions with 
host tissues or in pathogenesis. Most microorganisms adopt biofilm formation as a lifestyle in 
nature and for some of the pathogenic bacteria, biofilms are important for host infection. 
While our working definition of 'biofilm' includes the biofilm structure measured in the 
microtiter plate-based assay that if left unattended would continue to develop its complex 
architecture over several more days, we believe that our results are particularly relevant to 
the concept of the initial steps in biofilm formation. 
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As a prelude to studies in more complex environments, we tested all fifty-one Bnp 
mutants on different surfaces to determine whether biofilm formation on different surfaces 
required different gene products. In EDL933, we were unable to clearly differentiate between 
our Bnp mutants based on their ability to form biofilms on polystyrene, polypropylene, 
polyvinyl chloride, and glass (Fig. S3.1), indicating that the loss of biofilm formation on 
polystyrene affected biofilm formation on other surfaces as well. Our data suggest that 
biofilms require a wide array of proteins and that biofilm formation may be more complex 
and integrated than once thought. There is a growing body of evidence suggesting that some 
genes involved in biofilm formation are also involved in adherence and colonization of host 
tissues. Thus, we sought a link between biofilm formation and adherence to host tissues.  
We continued the line of study that began with the initial observations on loss of 
adherence to T84 cells in Chapter 2 by adding a second cell line to the analysis, HEp2, and 
performing both qualitative (microscopically) and quantitative (enumeration) adherence 
assays with all 51 Bnp mutants. The goal of this study was to determine whether biofilm-
related genes in clearly non-adhesin-associated loci contribute to cellular adherence. Our 
results showed that the ability to form biofilms in E. coli O157:H7 EDL933 is positively 
linked to adherence to the two distinctly different human epithelial-like cells; all 51 Bnp 
mutants failed to adhere to the two cell types while wild-type E. coli O157:H7 EDL933 
adhered to both cell lines. By including strains deleted of known adhesins in the study, we 
demonstrated that biofim formation alone is not sufficient for cellular adherence; eae and 
espAB deletion mutants were fully competent for biofilm formation but failed to adhere to 
either cell line.  
The genome of E. coli O157:H7 EDL933 contains 18 prophage or prophage-like 
bacteriophage related clusters in O-islands, the regions that are unique to the O157:H7. In the 
third study, the importance of phage genes in biofilm formation of E. coli O157:H7 was 
demonstrated along with the role of one of the phage genes of phage CP_933X, Z2086, in 
global gene regulation. This was one of the more unique aspects of the Bnp list of genes. The 
first two studies had shown that these genes were involved in biofilm formation by 
identifying it as a Bnp gene, and that they were required for adherence to T84 and HEp2 cells 
as well. The third study focused on the role of Z2086 in gene regulation while confirming its 
role in biofilm formation. The positive effects of Z2086 on gene expression across the 
genome was unexpected. While most of the genes shown to be up-regulated by Z2086 were 
phage associated, there were notable exceptions showing that phage lysogens can contribute 
significantly to pathogenesis. 
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In summary, these results have expanded our knowledge of the genetics of biofilm 
formation in E. coli O157:H7 EDL933 and have contributed to a better understanding of the 
total process of cellular adherence.  
 
Recommendations for Future Research 
The initial phase of this study, the transposon library screen, identified fifty-one genes 
that are linked to biofilm formation. Thirty-six of the fifty-one Bnp genes identified were not 
previously identified as having a role in biofilm formation, and of these, the pO157-
associated and the phage-encoded genes were studied further. The function of several of 
these genes remains undefined, and of those with known functions, their role in biofilm 
formation is not clear. Clearly, additional studies focusing on these genes and their products 
are warranted.  
Future research could concentrate on genes such as the pleiotropic regulator hns that 
encodes a DNA-binding protein and dsbA that encodes protein disulfide isomerase I. A 
transcriptional microarray analysis could be performed to get insight into the targets of these 
global regulators and correlate those results with our Bnp gene list to get a more complete 
global picture of biofilm formation.  
Even though the role of the pO157-encoded membrane translocator EhxD in biofilm 
formation was confirmed, the proteins that it translocates and their role in biofilm formation 
are still hypothetical. More protein-based research is needed to find these targets, which will 
enhance our understanding of the process of biofilm formation and colonization by E. coli 
O157:H7. By understanding biofilm production better, improved methods to decrease its 
prevalence in food animals and control its dissemination in the environment might be 
possible. 
In Chapter 3, two different phenotypes, biofilm formation on abiotic surfaces and cellular 
adherence, are linked. How they are linked, however, is poorly understood. Further, the 
relationship of biofilm formation with colonization of the host and pathogenesis is not well 
understood. The details of the adherence assay performed here gives further insight into the 
mechanism of the linkage. The adherence assays were performed at a 90 min infection time, 
an early time point in biofilm development. Also, the assay was performed at a cell density 
that was too low for quorum sensing, an environmental signal that has been linked to biofilm 
induction in other bacteria. Thus, the linkage under discussion occurs at the early or initial 
stages of biofilm formation.  
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The E. coli O157:H7 strain EDL933 used in this study is a strong biofilm former under 
laboratory conditions, displaying a constituitive phenotype not present in other O157:H7 
strains. Important questions to answer regarding this strain include why does strain EDL933 
differ from other strains in biofilm formation? Can other strains produce biofilms under 
better-defined restrictive conditions, i.e. what is the trigger for biofilm formation in these 
strains? How does the regulation occur? While it is generally assumed that all pathogenic 
O157:H7 strains adhere to epithelial cells, it is not clear that they adhere to T84 and HEp2 
cells? If they do, does biofilm formation occur in these other O157:H7 strains as they interact 
with eukaryotic cell surfaces? Answering these questions will get to the heart of biofilm 
formation and the function that keeps them intact in the O157 genome despite their enormous 
energy requirements. 
In the third study, the prophage gene Z2086 was shown to be essential for biofilm 
formation. Our microarray analysis showed that this gene is a global regulator not only for 
phage genes but also for numerous genes encoded on both plasmid and genomic DNA. How 
this gene regulates other genes needs further investigation. 
Finally, the long-term, overall hypothesis concerning E. coli O157:H7 in the Minion 
laboratory is that biofilm formation in the bovine intestinal tract explains the persistence and 
intermittent shedding. Because of the studies presented here, that hypothesis can be tested 
directly by constructing Bnp gene knockout mutations in strain 86-24, a non-biofilm forming 
strain in vitro, and testing their ability to colonize and persist in vivo. According to the 
hypothesis, knockout mutations in any of the Bnp genes should result in loss of persistence in 
a ruminant infection model. Such a study could have a significant impact on how we view 
biofilms and their role in patgogenesis.  
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Gene ID Function p value q value *FC 
Z2046 putative regulator of cell division encoded by prophage CP-933O 9.92E-19 7.43E-17 5.2 
Z2063 unknown protein encoded by prophage CP-933O 1.12E-17 5.61E-16 5.0 
Z2082 putative transposase within CP-933O; partial 1.76E-16 6.60E-15 5.8 
Z2077 unknown protein encoded by prophage CP-933O 6.78E-16 2.03E-14 6.1 
Z2048 unknown protein encoded by prophage CP-933O 1.82E-15 3.93E-14 4.8 
Z2040 unknown protein encoded by prophage CP-933O 1.84E-15 3.93E-14 5.2 
Z2053 putative intestinal colonization factor encoded by prophage CP-933O 1.24E-14 2.32E-13 4.7 
Z2047 unknown protein encoded by prophage CP-933O 2.78E-14 4.62E-13 4.6 
Z2041 unknown protein encoded by prophage CP-933O 3.78E-14 5.67E-13 5.5 
Z2075 unknown protein encoded by prophage CP-933O 5.40E-14 7.35E-13 5.5 
Z2049 unknown protein encoded by prophage CP-933O 7.64E-14 9.54E-13 4.2 
Z2060 putative DNA adenine methyltransferase encoded by prophage CP-933O 1.38E-13 1.59E-12 5.0 
Z1478 unknown protein encoded by bacteriophage BP-933W 2.65E-13 2.84E-12 2.3 
Z2084 putative integrase within CP-933O; partial 3.67E-13 3.67E-12 5.7 
Z2078 putative transposase within CP-933O 7.26E-13 6.80E-12 5.7 
Z2058 unknown protein encoded by prophage CP-933O 1.86E-12 1.64E-11 5.0 
Z2052 unknown protein encoded by prophage CP-933O 2.36E-12 1.96E-11 4.8 
Z2055 unknown protein encoded by prophage CP-933O 3.47E-12 2.74E-11 5.0 
Z1671 curli production assembly/transport component, 2nd curli operon 4.00E-12 3.00E-11 -1.8 
Z2085 putative exonuclease VIII within CP-933O; partial 2.54E-11 1.81E-10 5.1 
Z2187 hypothetical protein 4.30E-11 2.93E-10 1.8 
Z2076 unknown protein encoded by prophage CP-933O 4.50E-11 2.93E-10 4.9 
Z2056 unknown protein encoded by prophage CP-933O 9.97E-11 6.22E-10 3.8 
Z2188 hypothetical protein 1.07E-10 6.39E-10 2.2 
Z4698 elongation factor EF-2 3.02E-10 1.74E-09 1.6 
Z1355 unknown protein encoded by cryptic prophage CP-933M 7.59E-10 4.18E-09 3.7 
Z1811 putative tail component encoded by prophage CP-933N 7.80E-10 4.18E-09 4.2 
Z2051 unknown protein encoded by prophage CP-933O 1.24E-09 6.42E-09 4.0 
Z1480 unknown protein encoded by bacteriophage BP-933W 1.99E-09 9.92E-09 1.9 
Z2042 unknown protein encoded by prophage CP-933O 2.25E-09 1.09E-08 3.4 
Z1914 putative minor tail fiber protein of prophage CP-933X 2.53E-09 1.19E-08 3.4 
Z6040 putative head-tail adaptor of cryptic prophage CP-933P 3.40E-09 1.54E-08 2.9 
Z1362 unknown protein encoded by cryptic prophage CP-933M 3.54E-09 1.56E-08 2.9 
Z2045 similar to DicA, regulator of DicB encoded by prophage CP-933O 4.05E-09 1.73E-08 4.6 
Z1812 putative tail assembly chaperone encoded by prophage CP-933N 4.31E-09 1.79E-08 3.0 
Z1367 unknown protein encoded by cryptic prophage CP-933M 6.37E-09 2.58E-08 3.0 
Z1369 unknown protein encoded by cryptic prophage CP-933M 7.75E-09 3.06E-08 2.7 
Z2057 putative endonuclease of prophage CP-933O 9.32E-09 3.58E-08 3.3 
Z2083 unknown protein encoded within CP-933O 1.09E-08 4.07E-08 3.6 
Z1910 unknown protein encoded by prophage CP-933X 1.18E-08 4.32E-08 2.6 
Z4452 hypothetical protein 1.27E-08 4.47E-08 1.3 
Z6076 unknown protein encoded by cryptic prophage CP-933P 1.28E-08 4.47E-08 3.1 
Z6037 putative tail component of cryptic prophage CP-933P 1.45E-08 4.95E-08 3.0 
Z1913 putative tail component of prophage CP-933X 1.60E-08 5.32E-08 3.0 
Z3316 unknown protein encoded within prophage CP-933V 1.67E-08 5.42E-08 2.7 
Z1356 unknown protein encoded by cryptic prophage CP-933M 1.75E-08 5.59E-08 2.9 
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Z4926 hypothetical protein 1.85E-08 5.79E-08 1.7 
Z1465 shiga-like toxin II B subunit encoded by bacteriophage BP-933W 1.89E-08 5.79E-08 1.9 
Z1673 putative 2-component transcriptional regulator for 2nd curli operon 2.22E-08 6.65E-08 -1.7 
Z2145 putative tail component of prophage CP-933O 2.77E-08 8.14E-08 3.4 
Z2230 30S ribosomal subunit protein S22 3.20E-08 9.23E-08 1.3 
Z1374 unknown protein encoded by cryptic prophage CP-933M 3.51E-08 9.92E-08 2.8 
Z6075 unknown protein encoded by cryptic prophage CP-933P 4.37E-08 1.21E-07 2.7 
Z1672 curli production assembly/transport component, 2nd curli operon 4.61E-08 1.25E-07 -1.7 
Z3320 unknown protein encoded within prophage CP-933V 5.10E-08 1.36E-07 2.7 
Z1479 unknown protein encoded by bacteriophage BP-933W 6.12E-08 1.61E-07 2.2 
Z2043 unknown protein encoded by prophage CP-933O 6.64E-08 1.71E-07 2.6 
Z3334 unknown protein encoded within prophage CP-933V 1.18E-07 2.97E-07 2.6 
Z1361 unknown protein encoded by cryptic prophage CP-933M 1.19E-07 2.97E-07 2.6 
Z3323 unknown protein encoded within prophage CP-933V 1.25E-07 3.08E-07 2.6 
Z1360 unknown protein encoded by cryptic prophage CP-933M 1.33E-07 3.22E-07 2.6 
Z3318 putative tail component of prophage CP-933V 1.45E-07 3.44E-07 2.7 
Z2059 unknown protein encoded by prophage CP-933O 1.63E-07 3.82E-07 3.3 
Z1366 unknown protein encoded by cryptic prophage CP-933M 1.74E-07 4.00E-07 2.5 
Z6047 putative DNAse encoded by cryptic prophage CP-933P 1.78E-07 4.04E-07 2.8 
Z3326 unknown protein encoded within prophage CP-933V 1.86E-07 4.15E-07 2.4 
Z1923 unknown protein encoded by prophage CP-933X 2.85E-07 6.29E-07 1.5 
Z1464 shiga-like toxin II A subunit encoded by bacteriophage BP-933W 2.99E-07 6.50E-07 2.0 
Z1806 unknown protein encoded by prophage CP-933N 3.18E-07 6.82E-07 2.5 
Z1359 unknown protein encoded by cryptic prophage CP-933M 3.24E-07 6.83E-07 2.7 
Z1903 unknown protein encoded by prophage CP-933X 4.65E-07 9.68E-07 2.2 
Z3327 unknown protein encoded within prophage CP-933V 4.96E-07 1.02E-06 2.2 
Z1810 unknown protein encoded by prophage CP-933N 6.83E-07 1.38E-06 2.6 
Z3927 unknown protein encoded by prophage CP-933Y 8.36E-07 1.67E-06 2.2 
Z1675 minor curlin subunit precursor, similar ro CsgA 9.02E-07 1.76E-06 -1.5 
Z1467 unknown protein encoded by bacteriophage BP-933W 9.05E-07 1.76E-06 2.0 
Z1493 unknown protein encoded by bacteriophage BP-933W 1.07E-06 2.06E-06 1.5 
Z2189 putative LACI-type transcriptional regulator 1.34E-06 2.54E-06 2.3 
Z1363 unknown protein encoded by cryptic prophage CP-933M 1.39E-06 2.61E-06 2.1 
Z1364 unknown protein encoded by cryptic prophage CP-933M 1.45E-06 2.69E-06 2.2 
Z1905 unknown protein encoded by prophage CP-933X 1.62E-06 2.95E-06 2.3 
Z2761 catalase; hydroperoxidase HPII(III) 1.64E-06 2.95E-06 2.4 
Z3325 unknown protein encoded within prophage CP-933V 1.76E-06 3.13E-06 2.2 
Z1492 unknown protein encoded by bacteriophage BP-933W 1.94E-06 3.43E-06 1.9 
Z1814 unknown protein encoded by prophage CP-933N 2.20E-06 3.83E-06 2.8 
Z1915 putative tail protein (partial) of prophage CP-933X 2.23E-06 3.85E-06 2.3 
L7037 type II secretion protein 2.66E-06 4.53E-06 1.7 
Z1372 unknown protein encoded by cryptic prophage CP-933M 2.77E-06 4.66E-06 2.5 
Z1368 unknown protein encoded by cryptic prophage CP-933M 2.96E-06 4.92E-06 2.2 
Z2054 
putative killer protein encoded by prophage CP-933O; paralogous 
proteins disrupt host membranes when produced in excess 3.63E-06 5.98E-06 2.9 
Z3328 putative portal protein for prophage CP-933V 4.01E-06 6.52E-06 2.2 
Z1357 unknown protein encoded by cryptic prophage CP-933M 4.16E-06 6.70E-06 2.3 
Z1809 unknown protein encoded by prophage CP-933N 5.20E-06 8.28E-06 2.1 
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Z1813 unknown protein encoded by prophage CP-933N 5.46E-06 8.61E-06 2.4 
Z1902 putative head-tail adaptor of prophage CP-933X 5.84E-06 9.11E-06 2.3 
Z2068 unknown protein encoded by prophage CP-933O 5.92E-06 9.15E-06 2.3 
Z5106 secreted protein EspD 6.22E-06 9.42E-06 2.0 
Z1483 putative tail fiber protein of bacteriophage BP-933W 6.22E-06 9.42E-06 1.9 
Z3106 putative holin protein of prophage CP-933U 6.49E-06 9.72E-06 2.8 
Z5632 periplasmic maltose-binding protein 7.44E-06 1.10E-05 2.1 
Z1922 unknown protein encoded by prophage CP-933X 8.34E-06 1.23E-05 1.7 
L7036 type II secretion protein 8.53E-06 1.24E-05 1.6 
Z2065 
similar to conserved hypothetical phage protein YjhS encoded within 
prophage CP-933O 1.04E-05 1.50E-05 2.0 
Z1912 unknown protein encoded by prophage CP-933X 1.09E-05 1.56E-05 2.3 
Z4925 hypothetical protein 1.33E-05 1.87E-05 1.3 
Z0900 cytochrome d terminal oxidase, polypeptide subunit I 1.34E-05 1.88E-05 1.4 
Z3336 putative endopeptidase Rz for prophage CP-933V 1.49E-05 2.07E-05 1.9 
Z1491 unknown protein encoded by bacteriophage BP-933W 1.52E-05 2.09E-05 1.9 
Z3322 putative major tail subunit encoded within prophage CP-933V 1.62E-05 2.21E-05 2.4 
Z1921 unknown protein encoded by prophage CP-933X 1.69E-05 2.28E-05 1.7 
Z5634 maltoporin precursor 1.78E-05 2.37E-05 2.0 
Z2096 unknown protein encoded within prophage CP-933O 1.79E-05 2.37E-05 2.1 
Z1371 putative tail assembly chaperone encoded by cryptic prophage CP-933M 1.86E-05 2.45E-05 2.3 
Z3319 unknown protein encoded within prophage CP-933V 1.89E-05 2.46E-05 2.2 
Z4665 DNA-directed RNA polymerase alpha subunit 1.90E-05 2.46E-05 1.6 
Z1358 unknown protein encoded by cryptic prophage CP-933M 1.96E-05 2.51E-05 2.6 
Z4566 probable sigma-54 modulation protein 2.08E-05 2.64E-05 1.2 
Z2304 glyceraldehyde-3-phosphate dehydrogenase 2.23E-05 2.81E-05 1.6 
Z1676 curlin major subunit, coiled surface structures; cryptic 3.09E-05 3.85E-05 -1.4 
Z1783 putative Gef-like protein encoded by prophage CP-933N 3.19E-05 3.95E-05 1.6 
Z1803 putative terminase encoded by prophage CP-933N 3.70E-05 4.54E-05 2.3 
Z1349 
conserved hypothetical protein similar to yjhS for cryptic prophage CP-
933M 3.72E-05 4.54E-05 2.1 
Z2342 
partial putative outer membrane protein Lom precursor encoded by 
prophage CP-933R 3.79E-05 4.57E-05 2.1 
Z1788 unknown protein encoded by prophage CP-933N 3.81E-05 4.57E-05 2.4 
Z2861 PTS enzyme IIC, mannose-specific 3.85E-05 4.57E-05 1.5 
Z1354 putative endopeptidase of cryptic prophage CP-933M 3.87E-05 4.57E-05 1.8 
Z6019 putative transposase fragment 3.97E-05 4.65E-05 2.1 
Z3890 putative yhbH sigma 54 modulator 4.36E-05 5.06E-05 1.2 
Z1793 unknown protein encoded by prophage CP-933N 4.59E-05 5.29E-05 2.0 
Z3104 putative endolysin of prophage CP-933U 4.63E-05 5.29E-05 1.9 
Z1916 putative tail protein (partial) of prophage CP-933X 4.74E-05 5.38E-05 2.2 
L7020 putative exoprotein-precursor 4.78E-05 5.39E-05 1.9 
Z0105 cell division protein FtsZ 4.92E-05 5.50E-05 1.5 
Z4671 50S ribosomal protein L15 4.95E-05 5.50E-05 1.5 
Z2346 partial putative phage tail protein encoded by prophage CP-933R 5.47E-05 6.03E-05 2.0 
L7044 type II secretion protein 5.60E-05 6.11E-05 1.7 
Z1352 putative endolysin of cryptic prophage CP-933M 5.62E-05 6.11E-05 1.9 
Z2709 hypothetical protein 6.33E-05 6.83E-05 1.4 
Z4667 30S ribosomal protein S11 6.75E-05 7.23E-05 1.4 
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Z4689 50S ribosomal protein L23 7.18E-05 7.63E-05 1.8 
Z1796 putative endolysin of prophage CP-933N 7.88E-05 8.31E-05 1.9 
Z3107 unknown protein encoded within prophage CP-933U 8.07E-05 8.46E-05 2.1 
Z3926 unknown protein encoded by prophage CP-933Y 9.04E-05 9.41E-05 1.9 
Z2066 unknown protein encoded by prophage CP-933O 9.36E-05 9.67E-05 2.0 
Z2372 unknown protein encoded within prophage CP-933R 9.45E-05 9.70E-05 1.9 
Z0124 pyruvate dehydrogenase (decarboxylase component) 0.000113 0.000115 1.6 
Z4677 30S ribosomal protein S14 0.000114 0.000116 1.6 
Z1486 unknown protein encoded by bacteriophage BP-933W 0.000118 0.000118 1.8 
Z6063 putative cell killing protein encoded within cryptic prophage CP-933P 0.000131 0.000131 1.6 
Z4687 30S ribosomal protein S19 0.000132 0.000131 1.7 
L7041 type II secretion protein 0.000140 0.000138 1.6 
Z3059 chaperone protein HchA 0.000144 0.000141 1.4 
Z1351 unknown protein encoded by cryptic prophage CP-933M 0.000149 0.000145 1.9 
Z2377 unknown protein encoded within prophage CP-933R 0.000153 0.000148 1.9 
Z2869 hypothetical protein 0.000155 0.000149 1.2 
Z3332 unknown protein encoded within prophage CP-933V 0.000159 0.000152 2.4 
Z0367 unknown protein encoded in ISEc8 0.000164 0.000156 1.8 
Z1494 unknown protein encoded by bacteriophage BP-933W 0.000168 0.000159 1.9 
Z4927 putative transport system permease protein 0.000170 0.000159 1.7 
Z6045 putative terminase subunit encoded by cryptic prophage CP-933P 0.000171 0.000159 2.4 
Z4697 elongation factor Tu 0.000172 0.000159 1.6 
Z1466 unknown protein encoded by bacteriophage BP-933W 0.000173 0.000159 1.8 
Z5794 putative acyl coenzyme A dehydrogenase 0.000174 0.000159 1.4 
Z0882 succinyl-CoA synthetase subunit beta 0.000176 0.000160 1.7 
Z2868 cold shock protein 0.000182 0.000165 1.4 
Z0880 2-oxoglutarate dehydrogenase (decarboxylase component) 0.000188 0.000169 1.6 
Z4673 30S ribosomal protein S5 0.000189 0.000169 1.5 
Z4690 50S ribosomal protein L4 0.000192 0.000170 1.8 
Z4691 50S ribosomal protein L3 0.000197 0.000174 1.7 
Z1468 putative lysis protein S of bacteriophage BP-933W 0.000201 0.000176 1.6 
Z1485 unknown protein encoded by bacteriophage BP-933W 0.000213 0.000185 1.7 
Z1475 putative terminase small subunit of bacteriophage BP-933W 0.000223 0.000193 2.0 
Z5553 elongation factor Tu 0.000226 0.000194 1.5 
Z2079 putative IS encoded protein within CP-933O 0.000242 0.000207 1.9 
Z5107 secreted protein EspA 0.000243 0.000207 2.1 
Z1901 unknown protein encoded by prophage CP-933X 0.000252 0.000213 1.9 
Z0901 cytochrome d terminal oxidase polypeptide subunit II 0.000267 0.000225 1.4 
Z3309 putative tail fiber protein encoded within prophage CP-933V 0.000274 0.000229 2.0 
Z3473 outer membrane protein 1b (Ib;c) 0.000278 0.000231 1.8 
Z1477 putative portal protein of bacteriophage BP-933W 0.000313 0.000258 1.8 
Z1469 putative lysozyme protein R of bacteriophage BP-933W 0.000314 0.000258 1.8 
Z1481 unknown protein encoded by bacteriophage BP-933W 0.000315 0.000258 1.8 
Z1495 unknown protein encoded by bacteriophage BP-933W 0.000317 0.000258 1.8 
Z2243 nitrite extrusion protein 2 0.000320 0.000259 1.6 
Z3365 putative host-nuclease inhibitor protein Gam of prophage CP-933V 0.000325 0.000261 1.6 
Z5401 hypothetical protein 0.000326 0.000261 1.2 
Z1353 putative antirepressor protein of cryptic prophage CP-933M 0.000351 0.000280 1.8 
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Z3342 unknown protein encoded within prophage CP-933V 0.000354 0.000281 1.7 
Z5986 purine nucleoside phosphorylase 0.000363 0.000285 1.4 
Z2704 pyruvate kinase 0.000364 0.000285 1.6 
Z1438 putative host-nuclease inhibitor protein Gam of bacteriphage BP-933W 0.000378 0.000294 1.6 
Z4686 50S ribosomal protein L22 0.000379 0.000294 1.6 
Z0125 dihydrolipoamide acetyltransferase 0.000380 0.000294 1.6 
Z4241 glycine cleavage system protein H 0.000398 0.000305 1.8 
Z1476 partial putative terminase large subunit of bacteriophage BP-933W 0.000399 0.000305 1.7 
Z1432 unknown protein encoded by bacteriophage BP-933W 0.000402 0.000306 1.8 
Z1375 putative tail component encoded by cryptic prophage CP-933M; partial 0.000444 0.000336 1.8 
Z1381 
putative outer membrane protein Lom precursor encoded by cryptic 
prophage CP-933M 0.000459 0.000345 2.0 
Z2192 putative ATP-binding component of a transport system 0.000462 0.000345 1.5 
Z1908 putative tail component of prophage CP-933X 0.000463 0.000345 2.2 
Z1927 unknown protein encoded by ISEc8 in prophage CP-933X 0.000472 0.000350 1.8 
Z1396 probable third cytochrome oxidase, subunit II 0.000476 0.000351 1.6 
Z1428 unknown protein encoded by bacteriophage BP-933W 0.000489 0.000358 1.9 
Z3761 uracil phosphoribosyltransferase 0.000490 0.000358 1.6 
Z3364 putative host killing protein Kil of prophage CP-933V 0.000517 0.000376 1.5 
Z3681 PTS system protein HPr 0.000532 0.000385 1.2 
Z1670 curli production assembly/transport component, 2nd curli operon 0.000550 0.000396 -1.6 
Z1487 unknown protein encoded by bacteriophage BP-933W 0.000554 0.000397 1.8 
L7045 hypothetical protein 0.000564 0.000402 1.7 
Z0366 unknown protein encoded in ISEc8 0.000588 0.000417 1.8 
Z1370 putative tail component encoded by cryptic prophage CP-933M 0.000617 0.000436 2.2 
Z1928 unknown protein encoded by ISEc8 in prophage CP-933X 0.000625 0.000440 1.8 
Z6052 unknown protein encoded by cryptic prophage CP-933P 0.000644 0.000451 1.8 
Z5576 DNA-binding protein HU-alpha (HU-2) 0.000656 0.000457 1.4 
Z1257 30S ribosomal protein S1 0.000673 0.000467 1.5 
Z3902 16S rRNA-processing protein 0.000686 0.000474 1.5 
Z0106 UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase 0.000711 0.000488 1.4 
Z1454 putative DNA N-6-adenine-methyltransferase of bacteriophage BP-933W 0.000720 0.000493 1.7 
Z4675 50S ribosomal protein L6 0.000746 0.000508 1.4 
Z3115 putative endonuclease encoded within prophage CP-933U 0.000761 0.000516 1.9 
Z3353 unknown protein encoded within prophage CP-933V 0.000818 0.000552 1.4 
Z5631 part of maltose permease, periplasmic 0.000831 0.000559 1.7 
Z1802 unknown protein encoded by prophage CP-933N 0.000845 0.000564 1.9 
Z1350 putative holin protein of cryptic prophage CP-933M 0.000848 0.000564 1.7 
Z1342 putative cell killing protein encoded within cryptic prophage CP-933M 0.000939 0.000622 1.6 
Z3123 unknown protein encoded within prophage CP-933U 0.000947 0.000625 1.7 
Z1762 
spermidine/putrescine ABC transporter periplasmic substrate-binding 
component 0.000954 0.000627 1.6 
Z1426 unknown protein encoded by bacteriophage BP-933W 0.001002 0.000656 1.8 
Z0881 dihydrolipoamide acetyltransferase 0.001016 0.000662 1.6 
L7031 hypothetical protein 0.001026 0.000665 1.6 
Z1365 unknown protein encoded by cryptic prophage CP-933M 0.001056 0.000682 1.7 
Z1484 putative tail fiber protein of bacteriophage BP-933W 0.001074 0.000691 1.5 
Z3682 PEP-protein phosphotransferase system enzyme I 0.001117 0.000715 1.3 
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Z0365 unknown protein encoded in ISEc8 0.001150 0.000733 1.7 
Z1448 regulatory protein Cro of bacteriophage BP-933W 0.001154 0.000733 1.5 
Z1442 putative antitermination protein N of bacteriophage BP-933W 0.001159 0.000733 1.7 
Z1435 putative exonuclease of bacteriophage BP-933W 0.001181 0.000744 1.7 
Z4679 50S ribosomal protein L24 0.001190 0.000746 1.4 
Z3355 putative DNA replication protein P of prophage CP-933V 0.001199 0.000749 1.6 
Z3352 unknown protein encoded within prophage CP-933V 0.001214 0.000755 1.5 
Z0607 putative amino acid/amine transport protein 0.001226 0.000759 1.4 
Z6034 putative tail component of cryptic prophage CP-933P 0.001235 0.000761 2.0 
Z6026 unknown protein encoded by cryptic prophage CP-933P 0.001253 0.000770 1.7 
Z5233 ATP synthase subunit D 0.001283 0.000784 1.5 
Z2731 phosphoenolpyruvate synthase 0.001288 0.000784 1.5 
Z2080 putative IS encoded protein within CP-933O 0.001339 0.000813 1.7 
Z1482 unknown protein encoded by bacteriophage BP-933W 0.001383 0.000835 1.7 
Z1430 unknown protein encoded by bacteriophage BP-933W 0.001391 0.000837 1.8 
Z0883 succinyl-CoA synthetase alpha subunit 0.001427 0.000855 1.6 
Z1105 pyruvate dehydrogenase 0.001433 0.000856 1.2 
Z1439 putative Kil protein of bacteriphage BP-933W 0.001450 0.000862 1.5 
Z2127 putative IS encoded protein encoded within prophage CP-933O 0.001484 0.000879 1.8 
Z4240 glycine dehydrogenase 0.001490 0.000879 1.7 
Z2244 cryptic nitrate reductase 2, alpha subunit 0.001501 0.000882 1.5 
Z1460 unknown protein encoded by bacteriophage BP-933W 0.001581 0.000926 1.5 
Z1459 antitermination protein Q of bacteriophage BP-933W 0.001624 0.000947 1.8 
L7043 type II secretion protein 0.001678 0.000972 1.8 
Z3373 unknown protein encoded within prophage CP-933V 0.001680 0.000972 1.6 
Z3960 4-aminobutyrate aminotransferase 0.001703 0.000981 1.5 
Z1431 unknown protein encoded by bacteriophage BP-933W 0.001712 0.000983 1.7 
Z1429 unknown protein encoded by bacteriophage BP-933W 0.001778 0.001017 1.8 
Z1488 unknown protein encoded by bacteriophage BP-933W 0.001828 0.001041 1.7 
Z1424 integrase for bacteriophage BP-933W 0.001836 0.001042 1.7 
Z1500 unknown protein encoded by bacteriophage BP-933W 0.001863 0.001054 1.6 
Z1503 unknown protein encoded by bacteriophage BP-933W 0.001908 0.001069 1.8 
Z1747 hypothetical protein 0.001911 0.001069 1.3 
Z1433 unknown protein encoded by bacteriophage BP-933W 0.001911 0.001069 1.6 
Z5232 ATP synthase subunit A 0.001928 0.001074 1.6 
Z1917 putative outer membrane protein of prophage CP-933X 0.001949 0.001082 1.9 
Z2108 
hypothetical phage protein similar to YjhS encoded within prophage CP-
933O 0.002011 0.001112 1.8 
Z2710 putative ATP-binding component of a transport system 0.002048 0.001126 1.4 
Z2340 putative tail fiber protein encoded by prophage CP-933R 0.002052 0.001126 1.6 
Z1418 curved DNA-binding protein; functions closely related to DnaJ 0.002124 0.001161 1.4 
Z3797 cysteine desulfurase 0.002296 0.001251 1.4 
Z4666 30S ribosomal protein S4 0.002335 0.001267 1.4 
Z1456 unknown protein encoded by bacteriophage BP-933W 0.002347 0.001267 1.6 
Z5105 secreted protein EspB 0.002351 0.001267 1.7 
Z4692 30S ribosomal protein S10 0.002367 0.001271 1.4 
Z3541 NADH dehydrogenase subunit H 0.002378 0.001273 1.5 
Z0126 dihydrolipoamide dehydrogenase 0.002428 0.001295 1.5 
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Z5744 aspartate ammonia-lyase (aspartase) 0.002476 0.001316 1.4 
Z2194 putative kinase 0.002522 0.001335 1.5 
Z3310 putative Lom-like outer membrane protein of prophage CP-933V 0.002623 0.001384 1.9 
Z5985 phosphopentomutase 0.002636 0.001386 1.5 
Z3659 permease of transport system for 3 nucleosides 0.002676 0.001401 1.5 
Z2190 putative transport system permease protein 0.002686 0.001401 1.5 
Z1498 unknown protein encoded by bacteriophage BP-933W 0.002693 0.001401 1.4 
Z1457 putative DNA-binding protein Roi of bacteriophage BP-933W 0.002762 0.001432 1.7 
Z2822 hypothetical protein 0.002914 0.001506 1.5 
Z2099 unknown protein encoded within prophage CP-933O 0.002941 0.001514 1.4 
Z1453 unknown protein encoded by bacteriophage BP-933W 0.002959 0.001514 1.5 
L7039 type II secretion protein 0.002961 0.001514 1.5 
L7042 type II secretion protein 0.002971 0.001514 1.6 
Z4287 S-adenosylmethionine synthetase 0.003026 0.001537 1.6 
Z1343 unknown protein encoded by cryptic prophage CP-933M 0.003089 0.001564 1.8 
Z2147 putative tail fiber protein of prophage CP-933O 0.003121 0.001575 1.6 
Z1382 putative tail component encoded by cryptic prophage CP-933M; partial 0.003146 0.001582 1.6 
Z1434 unknown protein encoded by bacteriophage BP-933W 0.003192 0.001599 1.8 
Z4672 50S ribosomal protein L30 0.003208 0.001602 1.4 
Z1489 
putative outer membrane protein Lom precursor of bacteriophage BP-
933W 0.003229 0.001607 1.7 
Z3542 NADH dehydrogenase gamma subunit 0.003283 0.001629 1.5 
Z5231 ATP synthase subunit C 0.003397 0.001680 1.6 
Z5353 uridine phosphorylase 0.003458 0.001704 1.3 
Z4259 putative actin 0.003646 0.001791 1.4 
Z5165 acetolactate synthase large subunit 0.003681 0.001803 1.5 
Z5633 ATP-binding component of transport system for maltose 0.003708 0.001810 1.7 
Z4242 aminomethyltransferase 0.003834 0.001865 1.7 
Z4683 50S ribosomal protein L29 0.003896 0.001889 1.5 
Z3074 putative tail fiber protein of prophage CP-933U 0.004029 0.001948 1.6 
Z1379 putative tail component encoded by cryptic prophage CP-933M; partial 0.004078 0.001965 1.7 
Z3901 tRNA (guanine-N(1)-)-methyltransferase 0.004141 0.001989 1.4 
Z1425 putative excisionase for bacteriophage BP-933W 0.004247 0.002033 1.7 
L7100 hypothetical protein 0.004284 0.002044 1.5 
Z1490 unknown protein encoded by bacteriophage BP-933W 0.004396 0.002091 1.6 
L7046 hypothetical protein 0.004657 0.002208 1.6 
Z5036 export protein SecB 0.004727 0.002234 1.4 
Z3903 30S ribosomal protein S16 0.004802 0.002261 1.4 
Z4567 phosphotransferase system enzyme IIA, regulates N metabolism 0.004821 0.002261 1.3 
Z5557 50S ribosomal protein L1 0.004828 0.002261 1.4 
Z1798 putative endopeptidase of prophage CP-933N 0.004851 0.002264 1.6 
Z5367 
4-enzyme protein: 3-hydroxyacyl-CoA dehydrogenase; 3-
hydroxybutyryl-CoA epimerase; delta(3)-cis-delta(2)-trans-enoyl-CoA 
isomerase; enoyl-CoA hydratase 0.004942 0.002300 1.4 
Z1734 3-oxoacyl-(acyl carrier protein) synthase 0.004989 0.002314 1.4 
Z1153 hypothetical protein 0.005033 0.002328 1.3 
Z3827 serine hydroxymethyltransferase 0.005361 0.002472 1.6 
Z1446 unknown protein encoded by bacteriophage BP-933W 0.005415 0.002489 1.5 
Z4664 50S ribosomal protein L17 0.005446 0.002495 1.6 
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Z3354 putative exclusion protein ren of prophage CP-933V 0.005507 0.002516 1.5 
Z1437 putative Bet recombination protein of bacteriophage BP-933W 0.005658 0.002577 1.6 
Z0456 
alcohol dehydrogenase class III; formaldehyde dehydrogenase, 
glutathione-dependent 0.005711 0.002593 1.5 
Z3526 hypothetical protein 0.005787 0.002620 1.3 
Z0002 bifunctional aspartokinase I/homeserine dehydrogenase I 0.005871 0.002650 1.6 
Z1501 unknown protein encoded by bacteriophage BP-933W 0.005902 0.002654 1.8 
Z2148 unknown protein encoded within prophage CP-933O 0.005915 0.002654 1.5 
Z3790 aminopeptidase B 0.006043 0.002703 1.5 
Z0532 cytochrome o ubiquinol oxidase subunit IV 0.006175 0.002754 1.4 
Z2101 putative endonuclease encoded within prophage CP-933O 0.006462 0.002873 1.7 
Z1473 putative endopeptidase Rz of bacteriophage BP-933W 0.006485 0.002875 1.7 
Z3791 hypothetical protein 0.006731 0.002965 1.4 
Z2732 hypothetical protein 0.006732 0.002965 1.4 
Z1445 unknown protein encoded by bacteriophage BP-933W 0.006748 0.002965 1.5 
Z1373 unknown protein encoded by cryptic prophage CP-933M 0.007015 0.003074 1.6 
Z4668 30S ribosomal protein S13 0.007098 0.003095 1.4 
Z1443 unknown protein encoded by bacteriophage BP-933W 0.007106 0.003095 1.6 
Z3017 cytoplasmic alpha-amylase 0.007231 0.003134 1.3 
Z4680 50S ribosomal protein L14 0.007236 0.003134 1.3 
Z1095 putative enzyme 0.007293 0.003149 1.2 
L7017 EHEC-catalase/peroxidase 0.007545 0.003249 1.6 
Z3260 fructose-bisphosphate aldolase 0.007972 0.003423 1.6 
Z0311 partial O replication protein for prophage CP-933H 0.008060 0.003445 1.5 
Z3956 hypothetical protein 0.008069 0.003445 1.2 
Z0984 unknown protein encoded by prophage CP-933K 0.008196 0.003489 1.4 
Z1451 putative replication protein P of bacteriophage BP-933W 0.008246 0.003500 1.5 
Z1450 putative replication protein O of bacteriophage BP-933W 0.008489 0.003593 1.5 
Z4669 50S ribosomal protein L36 0.008566 0.003616 1.2 
Z1444 putative serine/threonine kinase encoded by bacteriophage BP-933W 0.008776 0.003694 1.6 
L7038 type II secretion protein 0.008845 0.003703 1.5 
Z4961 dipeptide transport protein 0.008848 0.003703 1.4 
Z5560 DNA-directed RNA polymerase beta subunit 0.008911 0.003703 1.6 
Z4688 50S ribosomal protein L2 0.008911 0.003703 1.5 
Z5732 lysyl-tRNA synthetase 0.008921 0.003703 1.4 
L7027 hypothetical protein 0.009514 0.003938 1.6 
L7026 hypothetical protein 0.009682 0.003997 1.5 
Z3372 unknown protein encoded within prophage CP-933V 0.009748 0.004013 1.5 
L7028 hypothetical protein 0.010027 0.004116 1.7 
Z1452 unknown protein encoded by bacteriophage BP-933W 0.010150 0.004154 1.3 
Z2019 oligopeptide transport; periplasmic binding protein 0.010173 0.004154 1.4 
Z4525 polynucleotide phosphorylase; cytidylate kinase activity 0.010215 0.004159 1.4 
L7069 plasmid partitioning protein 0.010285 0.004176 1.5 
Z1397 phosphoanhydride phosphorylase; pH 2.5 acid phosphatase; periplasmic 0.010361 0.004196 1.6 
Z4738 phosphoglycolate phosphatase 0.010444 0.004218 1.5 
Z3538 NADH dehydrogenase kappa subunit 0.010474 0.004219 1.5 
Z0950 unknown protein encoded by prophage CP-933K 0.010646 0.004270 1.5 
Z3306 unknown protein encoded within prophage CP-933V 0.010657 0.004270 1.5 
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Z1307 outer membrane protein 3a (II*;G;d) 0.010949 0.004366 1.3 
Z1795 unknown protein encoded by prophage CP-933N 0.010956 0.004366 1.6 
Z5122 sepZ 0.011008 0.004375 1.5 
L7089 hypothetical protein 0.011054 0.004382 1.2 
Z5044 2-amino-3-ketobutyrate coenzyme A ligase 0.011287 0.004441 1.4 
Z0952 putative Bet recombination protein of prophage CP-933K 0.011320 0.004441 1.5 
Z4265 phosphoglycerate kinase 0.011320 0.004441 1.4 
Z4737 tryptophanyl-tRNA synthetase 0.011322 0.004441 1.4 
Z3961 transport permease protein of gamma-aminobutyrate 0.011455 0.004481 1.5 
Z6017 putative transposase fragment 0.011491 0.004484 1.7 
Z4895 universal stress protein; broad regulatory function? 0.011647 0.004533 1.2 
Z1440 putative single-stranded DNA binding protein 0.011702 0.004543 1.5 
Z3781 nucleoside diphosphate kinase 0.011770 0.004557 1.5 
Z3374 unknown protein encoded within prophage CP-933V 0.012097 0.004672 1.5 
Z3545 NADH dehydrogenase I chain C, D 0.012207 0.004702 1.4 
Z2553 hypothetical protein 0.012489 0.004799 1.1 
Z0908 translocation protein TolB precursor 0.012624 0.004817 1.4 
Z1677 putative curli production protein 0.012641 0.004817 -1.3 
Z3366 putative recombination protein Bet of prophage CP-933V 0.012647 0.004817 1.6 
L7062 plasmid maintenance protein 0.012697 0.004817 1.3 
Z2395 unknown protein encoded within prophage CP-933R 0.012697 0.004817 1.6 
Z4670 preprotein translocase SecY 0.012763 0.004820 1.3 
Z3555 hypothetical protein 0.012772 0.004820 1.3 
Z3307 partial putative tail fiber protein encoded within prophage CP-933V 0.012928 0.004867 1.4 
Z2862 PTS enzyme IID, mannose-specific 0.013592 0.005098 1.4 
Z3382 D-lactate dehydrogenase, FAD protein, NADH independent 0.013631 0.005098 1.4 
L7091 putative nickase 0.013643 0.005098 1.4 
Z2114 unknown protein encoded within prophage CP-933O 0.013992 0.005215 1.5 
Z0909 peptidoglycan-associated lipoprotein 0.014335 0.005323 1.4 
Z1383 unknown protein encoded by cryptic prophage CP-933M 0.014353 0.005323 1.4 
L7059 hypothetical protein 0.015042 0.005556 1.6 
Z3796 hypothetical protein 0.015055 0.005556 1.4 
Z4674 50S ribosomal protein L18 0.015227 0.005606 1.4 
Z3349 putative DNA methyltransferase encoded within prophage CP-933V 0.015384 0.005650 1.5 
Z3543 NADH dehydrogenase I chain F 0.015562 0.005701 1.4 
Z5630 part of maltose permease, inner membrane 0.015679 0.005730 1.6 
Z2103 unknown protein encoded within prophage CP-933O 0.015932 0.005809 1.6 
Z3371 unknown protein encoded within prophage CP-933V 0.016000 0.005819 1.5 
Z3198 GDP-mannose dehydratase 0.016209 0.005878 1.4 
Z2624 7-alpha-hydroxysteroid dehydrogenase 0.016242 0.005878 1.3 
L7097 hypothetical protein 0.016390 0.005918 1.6 
Z5043 L-threonine 3-dehydrogenase 0.016497 0.005937 1.4 
Z2102 unknown protein encoded within prophage CP-933O 0.016522 0.005937 1.6 
Z0949 unknown protein encoded by prophage CP-933K 0.016767 0.006003 1.5 
Z5497 catalase; hydroperoxidase HPI(I) 0.016787 0.006003 1.4 
Z3544 ATP synthase subunit E 0.016956 0.006039 1.3 
L7081 hypothetical protein 0.016968 0.006039 1.4 
Z5709 hypothetical protein 0.017213 0.006108 1.3 
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Z5782 protease specific for phage lambda cII repressor 0.017242 0.006108 1.4 
Z4279 transketolase 0.017384 0.006143 1.4 
Z2191 putative transport system permease protein 0.017590 0.006202 1.4 
L7096 putative transposase 0.017753 0.006237 1.6 
Z4376 hypothetical protein 0.017774 0.006237 1.2 
Z0877 succinate dehydrogenase catalytic subunit 0.017818 0.006238 1.4 
Z5781 protease specific for phage lambda cII repressor 0.018472 0.006452 1.3 
Z5208 hypothetical protein 0.018566 0.006470 1.4 
Z3370 unknown protein encoded within prophage CP-933V 0.018667 0.006485 1.5 
Z2246 cryptic nitrate reductase 2, delta subunit, assembly function 0.018721 0.006485 1.4 
Z4684 50S ribosomal protein L16 0.018741 0.006485 1.4 
Z1992 cation transport regulator 0.018784 0.006485 -1.2 
Z4261 putative transport protein 0.019368 0.006671 1.4 
Z2818 glyceraldehyde-3-phosphate dehydrogenase 0.020015 0.006847 1.5 
Z0351 hypothetical protein 0.020018 0.006847 1.4 
Z3963 putative transcriptional regulator 0.020070 0.006847 1.4 
Z0938 putative isomerase 0.020086 0.006847 1.4 
L7078 hypothetical protein 0.020105 0.006847 1.5 
Z1395 probable third cytochrome oxidase, subunit I 0.020297 0.006896 1.6 
Z5104 hypothetical protein 0.020497 0.006949 1.6 
Z4685 30S ribosomal protein S3 0.020565 0.006956 1.4 
Z3916 hypothetical protein 0.020755 0.007004 1.6 
Z3536 NADH dehydrogenase subunit M 0.021033 0.007082 1.5 
Z5102 hypothetical protein 0.021199 0.007097 1.6 
Z0998 excinuclease ABC subunit B 0.021219 0.007097 1.3 
Z0277 hypothetical protein 0.021220 0.007097 1.4 
Z3143 hypothetical protein 0.021346 0.007124 1.5 
Z5008 aldehyde dehydrogenase B (lactaldehyde dehydrogenase) 0.021606 0.007193 1.3 
Z5748 chaperonin GroEL 0.021649 0.007193 1.3 
L7023 hypothetical protein 0.021736 0.007206 1.6 
Z1344 putative endonuclease of cryptic prophage CP-933M 0.021935 0.007255 1.6 
Z3098 putative head-tail preconnector protein of prophage CP-933U 0.022001 0.007261 1.4 
L7025 hypothetical protein 0.022301 0.007344 1.5 
Z5281 branched-chain amino acid aminotransferase 0.022616 0.007431 1.5 
Z5235 ATP synthase subunit C 0.023552 0.007722 1.3 
Z3719 phosphate acetyltransferase 0.023663 0.007741 1.4 
Z4700 30S ribosomal protein S12 0.023731 0.007747 1.3 
Z0606 glutaminase 0.023852 0.007763 1.2 
Z3540 NADH dehydrogenase subunit I 0.023882 0.007763 1.4 
Z5819 transport of D-alanine, D-serine, and glycine 0.023970 0.007774 1.5 
Z5047 
ADP-heptose--lps heptosyltransferase II; lipopolysaccharide core 
biosynthesis 0.024400 0.007895 1.4 
Z5556 50S ribosomal protein L11 0.024449 0.007895 1.3 
Z2343 
partial putative outer membrane protein Lom precursor encoded by 
prophage CP-933R 0.024512 0.007899 1.6 
L7064 resolvase 0.024919 0.008012 1.4 
Z3522 naphthoate synthase 0.025037 0.008033 1.4 
Z3521 O-succinylbenzoate synthase 0.025193 0.008066 1.4 
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Z0128 aconitate hydratase 0.025365 0.008097 1.4 
Z5762 fumarate reductase 0.025423 0.008097 1.4 
Z0004 threonine synthase 0.025451 0.008097 1.4 
L7005 hypothetical protein 0.025709 0.008155 1.5 
L7067 rep protein E1 0.025743 0.008155 1.6 
Z0180 30S ribosomal protein S2 0.025964 0.008208 1.4 
Z1275 aspartate aminotransferase 0.026184 0.008260 1.5 
Z5721 alpha-galactosidase 0.026246 0.008262 1.4 
Z1878 putative Bor protein of prophage CP-933X 0.026368 0.008267 1.6 
Z3792 [2FE-2S] ferredoxin, electron carrer protein 0.026422 0.008267 1.4 
Z2678 superoxide dismutase, iron 0.026556 0.008267 1.5 
Z5252 D-ribose periplasmic binding protein 0.026795 0.008267 1.4 
L7032 type II secretion protein 0.026878 0.008267 1.4 
Z4676 30S ribosomal protein S8 0.027009 0.008267 1.4 
Z4094 phosphopyruvate hydratase 0.027043 0.008267 1.3 
Z4786 sn-glycerol-3-phosphate dehydrogenase (aerobic) 0.027105 0.008267 1.3 
L7095 putative cytotoxin 0.027200 0.008267 1.3 
Z3086 putative tail fiber component G of prophage CP-933U 0.027287 0.008267 1.4 
Z1976 hypothetical protein 0.027529 0.008267 -1.1 
Z5635 periplasmic protein of mal regulon 0.027538 0.008267 1.5 
Z5279 acetolactate synthase II large subunit 0.027667 0.008267 1.5 
L7033 type II secretion protein 0.028480 0.008267 1.3 
Z1449 putative regulatory protein CII of bacteriophage BP-933W 0.029203 0.008267 1.5 
Z2146 putative outer membrane protein Lom precursor of prophage CP-933O 0.029209 0.008267 1.7 
Z3721 transketolase 0.029437 0.008267 1.4 
Z5810 primosomal replication protein N 0.029692 0.008267 1.4 
Z5467 hypothetical protein 0.029737 0.008267 1.3 
Z5282 dihydroxy-acid dehydratase 0.029899 0.008267 1.5 
Z0951 putative exonuclease encoded by prophage CP-933K 0.030177 0.008267 1.4 
Z5366 acetyl-CoA acetyltransferase 0.030373 0.008267 1.3 
Z1001 molybdopterin biosynthesis, protein B 0.030375 0.008267 1.4 
Z4054 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase 0.030558 0.008267 1.4 
Z0030 isoleucyl-tRNA synthetase 0.030610 0.008267 1.4 
Z1869 putative replication protein P of prophage CP-933X 0.031011 0.008267 1.3 
Z3764 polyphosphate kinase 0.031029 0.008267 1.3 
Z2071 putative endolysin of prophage CP933-O; partial 0.031077 0.008267 1.5 
Z3909 protein used in recombination and DNA repair 0.031839 0.008267 1.5 
Z1391 probable Ni/Fe-hydrogenase 1 b-type cytochrome subunit 0.032046 0.008267 1.5 
Z5230 ATP synthase subunit B 0.032254 0.008267 1.5 
Z4983 glycyl-tRNA synthetase beta subunit 0.032407 0.008267 1.4 
Z1175 
putative phage inhibition, colicin resistance and tellurite resistance 
protein 0.032521 0.008267 1.4 
Z5809 30S ribosomal protein S6 0.032559 0.008267 1.4 
Z3346 unknown protein encoded within prophage CP-933V 0.032604 0.008267 1.5 
Z6033 putative tail component of cryptic prophage CP-933P 0.032797 0.008267 1.5 
Z3962 hypothetical protein 0.032899 0.008267 1.4 
Z4817 cytoplasmic glycerophosphodiester phosphodiesterase 0.033121 0.008267 1.4 
L7092 hypothetical protein 0.033206 0.008267 1.4 
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Z2970 putative regulator for prophage CP-933T 0.033206 0.008267 1.4 
Z3405 galactose-binding transport protein; receptor for galactose taxis 0.033238 0.008267 1.4 
Z5977 hyperosmotically inducible periplasmic protein 0.033386 0.008267 1.1 
Z3197 fucose synthetase 0.033422 0.008267 1.4 
Z4002 recombinase A 0.033518 0.008267 1.3 
Z4229 peptide chain release factor 2 0.033557 0.008267 1.4 
Z2705 murein lipoprotein 0.033716 0.008267 1.3 
Z3988 S-ribosylhomocysteinase 0.033860 0.008267 1.3 
Z3187 imidazole glycerol phosphate synthase subunit HisF 0.033868 0.008267 1.4 
Z0837 phosphoglucomutase 0.033931 0.008267 1.4 
Z0208 regulator in colanic acid synthesis; interacts with RcsB 0.034064 0.008267 1.4 
Z0298 aminoacyl-histidine dipeptidase (peptidase D) 0.034105 0.008267 1.4 
L7050 hemolysin transport protein 0.034243 0.008267 1.4 
Z5760 succinate dehydrogenase 0.034258 0.008267 1.3 
Z3311 putative tail fiber protein of prophage CP-933V 0.034287 0.008267 1.5 
Z3537 NADH dehydrogenase subunit L 0.034441 0.008267 1.5 
L7063 plasmid maintenance protein 0.034471 0.008267 1.3 
Z1441 unknown protein encoded by bacteriophage BP-933W 0.034518 0.008267 1.6 
Z4304 hypothetical protein 0.034931 0.008267 1.3 
Z3703 hypothetical protein 0.035005 0.008267 1.3 
Z0682 hypothetical protein 0.035016 0.008267 1.6 
L7075 hypothetical protein 0.035221 0.008267 1.5 
Z0086 leucine transcriptional activator 0.035254 0.008267 1.6 
Z5229 ATP synthase subunit epsilon 0.035430 0.008267 1.4 
Z4314 unknown protein encoded by ISEc8 0.035485 0.008267 1.5 
Z5846 cytochrome b (562) 0.035511 0.008267 1.3 
Z5657 excinuclease ABC subunit A 0.035639 0.008267 1.4 
Z4695 putative iron storage homoprotein, bacterioferritin 0.036013 0.008267 1.3 
Z4763 ferrous iron transport protein A 0.036079 0.008267 1.4 
Z0169 vitamin B12-transporter protein BtuF 0.036174 0.008267 1.5 
Z4762 hypothetical protein 0.036204 0.008267 1.4 
Z4105 putative transport protein 0.036317 0.008267 1.6 
Z3793 chaperone protein HscA 0.036442 0.008267 1.4 
L7003 hypothetical protein 0.036826 0.008267 1.5 
Z2550 tryptophan synthase subunit beta 0.036875 0.008267 1.4 
Z5216 
ATP-binding component of high-affinity phosphate-specific transport 
system 0.036985 0.008267 1.4 
L7008 replication initiation protein 0.037165 0.008267 1.4 
Z1784 unknown protein encoded by prophage CP-933N 0.037186 0.008267 1.5 
Z3934 unknown protein encoded by prophage CP-933Y 0.037394 0.008267 1.4 
Z4530 transcription elongation factor NusA 0.037443 0.008267 1.3 
Z5345 hypothetical protein 0.037718 0.008267 1.6 
Z3559 phosphate acetyltransferase 0.037908 0.008267 1.3 
Z5726 putative 2-component transcriptional regulator 0.038088 0.008267 1.5 
Z3186 
1-(5-phosphoribosyl)-5-[(5- phosphoribosylamino)methylideneamino] 
imidazole-4-carboxamide isomerase 0.038289 0.008267 1.5 
L7082 hypothetical protein 0.038645 0.008267 1.5 
L7015 transposase 0.039019 0.008267 1.4 
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L7099 F pilin acetylase 0.039024 0.008267 1.5 
Z1223 hypothetical protein 0.039188 0.008267 1.5 
Z5728 hypothetical protein 0.039217 0.008267 1.3 
Z4091 hypothetical protein 0.039245 0.008267 1.6 
Z1474 putative Bor protein precursor of bacteriophage BP-933W 0.039263 0.008267 1.6 
Z5192 DNA polymerase III subunit beta 0.039347 0.008267 1.4 
L7024 regulatory protein 0.039373 0.008267 1.4 
Z0534 cytochrome o ubiquinol oxidase subunit I 0.039499 0.008267 1.5 
Z4616 acetyl-CoA carboxylase 0.039550 0.008267 1.4 
Z5515 acetylornithine deacetylase 0.039600 0.008267 1.4 
Z0312 partial O replication protein for prophage CP-933H 0.039655 0.008267 1.3 
Z5280 acetolactate synthase II, valine insensitive, small subunit 0.039687 0.008267 1.4 
Z5499 hypothetical protein 0.039759 0.008267 1.6 
Z4857 hypothetical protein 0.040034 0.008267 1.4 
L7094 transposase 0.040167 0.008267 1.4 
Z4772 maltodextrin phosphorylase 0.040288 0.008267 1.5 
Z1458 unknown protein encoded by bacteriophage BP-933W 0.040533 0.008267 1.4 
Z5765 putative periplasmic binding protein 0.040564 0.008267 1.5 
L7052 hypothetical protein 0.040643 0.008267 1.3 
Z1258 integration host factor beta subunit 0.040707 0.008267 1.1 
Z1733 acyl carrier protein 0.040722 0.008267 1.1 
Z3073 unknown protein encoded within prophage CP-933U 0.040751 0.008267 1.4 
Z5856 aspartate carbamoyltransferase catalytic subunit 0.040952 0.008267 1.5 
Z0259 hypothetical protein 0.040973 0.008267 1.5 
Z1184 hypothetical protein 0.041045 0.008267 1.6 
Z3105 unknown protein encoded within prophage CP-933U 0.041210 0.008267 1.6 
Z4156 diaminopimelate decarboxylase 0.041260 0.008267 1.5 
Z4818 ATP-binding component of sn-glycerol 3-phosphate transport system 0.041372 0.008267 1.4 
Z3539 NADH dehydrogenase subunit J 0.041419 0.008267 1.3 
Z5686 putative kinase 0.041476 0.008267 1.4 
Z5038 hypothetical protein 0.041758 0.008267 1.4 
Z3345 putative antitermination protein Q for prophage CP-933V 0.041854 0.008267 1.5 
Z4746 hypothetical protein 0.041923 0.008267 1.6 
Z5112 putative translocated intimin receptor protein 0.042153 0.008267 1.5 
Z4870 transport of nickel, membrane protein 0.042458 0.008267 1.4 
Z5288 rep helicase, a single-stranded DNA dependent ATPase 0.042725 0.008267 1.4 
L7090 stable plasmid inheritance protein 0.042752 0.008267 1.2 
Z2686 cyclopropane fatty acyl phospholipid synthase 0.042819 0.008267 1.2 
Z5563 heat shock protein C 0.043220 0.008267 1.6 
Z5223 putative fimbrial chaperone 0.043283 0.008267 1.6 
Z3116 unknown protein encoded within prophage CP-933U 0.043548 0.008267 1.5 
Z4392 outer membrane channel precursor protein 0.044057 0.008267 1.3 
Z5984 thymidine phosphorylase 0.044125 0.008267 1.4 
Z5407 putative GTP-binding factor 0.044158 0.008267 1.4 
L7093 putative transposase 0.044242 0.008267 1.4 
Z4993 putative xylose transport, membrane component 0.044312 0.008267 1.5 
Z5181 hypothetical protein 0.044533 0.008267 1.5 
Z5234 ATP synthase subunit B 0.044638 0.008267 1.3 
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Z0541 trigger factor 0.044642 0.008267 1.3 
Z4958 putative ATP-binding component of dipeptide transport system 0.044833 0.008267 1.5 
Z5452 rhamnose transport 0.044988 0.008267 1.5 
Z3525 menaquinone-specific isochorismate synthase 0.045126 0.008267 1.3 
L7073 hypothetical protein 0.045205 0.008267 1.4 
Z5332 hypothetical protein 0.045398 0.008267 1.6 
Z5420 putative dehydrogenase 0.045475 0.008267 1.4 
Z4593 serine endoprotease 0.045498 0.008267 1.3 
Z1447 putative repressor protein CI of bacteriophage BP-933W 0.045730 0.008267 1.3 
Z0131 spermidine synthase 0.045732 0.008267 1.4 
Z0862 putative carboxylase 0.045755 0.008267 1.3 
Z5855 aspartate carbamoyltransferase regulatory subunit 0.045764 0.008267 1.6 
Z4771 4-alpha-glucanotransferase (amylomaltase) 0.045861 0.008267 1.5 
Z5514 phosphoenolpyruvate carboxylase 0.046021 0.008267 1.4 
Z4930 glutamate decarboxylase isozyme 0.046058 0.008267 1.1 
Z4540 degrades sigma32, integral membrane peptidase, cell division protein 0.046152 0.008267 1.2 
Z4263 fructose-bisphosphate aldolase 0.046254 0.008267 1.4 
L7088 hypothetical protein 0.046344 0.008267 1.3 
Z2137 putative tail component of prophage CP-933O 0.046459 0.008267 1.4 
Z5427 putative acetyltransferase 0.046494 0.008267 1.4 
Z4803 putative ATP-dependent DNA helicase (together with adjacent 3 orfs) 0.046515 0.008267 1.5 
Z5501 fructose-6-phosphate aldolase 0.046547 0.008267 1.5 
Z3378 putative ATP-binding component of a transport system 0.046722 0.008267 1.3 
Z4306 adenine glycosylase; G.C --> T.A transversions 0.046750 0.008267 1.5 
Z2860 PTS enzyme IIAB, mannose-specific 0.046775 0.008267 1.4 
Z5006 hypothetical protein 0.046914 0.008267 1.5 
Z4747 hypothetical protein 0.047055 0.008267 1.6 
Z5085 putative permease 0.047120 0.008267 1.5 
L7035 type II secretion protein 0.047163 0.008267 1.6 
Z5749 hypothetical protein 0.047329 0.008267 1.4 
Z4277 PTS system, mannitol-specific enzyme II component, cryptic 0.047451 0.008267 1.6 
Z4162 2-deoxy-D-gluconate 3-dehydrogenase 0.047455 0.008267 1.5 
Z3402 dihydropyrimidine dehydrogenase 0.047461 0.008267 1.4 
Z1865 isocitrate dehydrogenase 0.047479 0.008267 1.3 
Z5111 hypothetical protein 0.047491 0.008267 1.4 
Z4758 phosphoenolpyruvate carboxykinase 0.047606 0.008267 1.4 
Z5491 orf; hypothetical protein in IS (partial) 0.047697 0.008267 1.5 
L7021 hypothetical protein 0.047726 0.008267 1.4 
Z0926 galactose-1-epimerase (mutarotase) 0.047849 0.008267 1.4 
Z6061 putative endonuclease encoded by cryptic prophage CP-933P 0.047960 0.008267 1.5 
Z4739 ribulose-phosphate 3-epimerase 0.048116 0.008267 1.4 
Z5747 co-chaperonin GroES 0.048147 0.008267 1.2 
Z3375 putative integrase for prophage CP-933V 0.048262 0.008267 1.4 
Z4699 30S ribosomal protein S7 0.048384 0.008267 1.4 
Z3182 histidinol dehydrogenase 0.048417 0.008267 1.4 
Z5668 acetyl-coenzyme A synthetase 0.048548 0.008267 1.3 
Z1253 phosphoserine aminotransferase 0.048638 0.008267 1.4 
Z3959 succinate-semialdehyde dehydrogenase, NADP-dependent activity 0.048701 0.008267 1.4 
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Z5287 hypothetical protein 0.048882 0.008267 1.5 
Z4942 C4-dicarboxylate transport protein 0.048933 0.008267 1.4 
Z5426 D-tyrosyl-tRNA deacylase 0.048984 0.008267 1.4 
L7098 DNA helicase 0.049240 0.008267 1.4 
L7040 type II secretion protein 0.049300 0.008267 1.4 
Z4479 putative transport protein 0.049345 0.008267 1.5 
Z5913 fimbrial protein 0.049469 0.008267 1.5 
Z0233 hypothetical protein 0.049667 0.008267 1.4 
Z4787 hypothetical protein 0.049740 0.008267 1.5 
Z3680 cysteine synthase A, O-acetylserine sulfhydrolase A 0.049772 0.008267 1.3 
Z0165 glutamate-1-semialdehyde aminotransferase 0.049835 0.008267 1.4 
 
* FC- Fold Change 
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